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Abstract
Epidemiological associations between birthweight and cardiovascular disease
in adult life are supported by rodent experiments showing that undernutrition in fetal
life programmes adult blood pressure. In rats, the feeding of a maternal low protein
(MLP) diet during gestation programmes hypertension. Given interest in the
mechanistic role of epigenetic modification of gene expression in programming, this
study aimed to assess the potential for a nutritional insult to impact across several
generations. Pregnant female Wistar (F0) rats were fed a control (n=10) or MLP diet
(n=10) throughout gestation. At delivery all animals were fed the same standard
laboratory chow diet. At approximately 10 weeks of age, F1 generation offspring
were mated to produce a second generation (F2) without any further dietary change.
The same procedure was adhered to, to produce the F3 generation. Physiological
analysis confirmed F1 generation MLP exposed offspring exhibited raised (P<0.001)
systolic blood pressure and reduced nephron number (P<0.001) compared with
controls. Raised blood pressure and reduced nephron number were also noted in the
F2 generation (P<0.001) and this intergenerational transmission occurred via both the
maternal and paternal lines, No effect was noted in the F3 generation.
Microarray analysis highlighted a number of genes that were differentially
expressed however upon RT-PCR analysis results were not significant. DNA
methylation analysis noted in a trend towards hypomethylation in MLP exposed rats
and their offspring as described in previous studies.
In conclusion, data within this thesis shows for the first time, that fetal protein
restriction may play a critical role in determining blood pressure and overall disease
risk in a subsequent generation. It is clear from the data that both males and females
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can transmit their phenotype to a subsequent generation. This finding suggests that
maternal diet can influence the nature of epigenetic markers in germ line cells.
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11.0 General Introduction- Cardio-Vascular Disease
1.1 Introduction
An estimated 17.5 million people world-wide died from cardiovascular
disease (CVD) in 2005. This represented 30% of all deaths. Approximately 80% of
these deaths occurred in low- and middle-income countries. If the current trend of
increasing CVD prevalence is allowed to continue, an estimated 20 million people
per annum will die from CVD by 2015 (WHO, 2005).
The World Health Organisation (WHO) describes cardiovascular disease as
being a chronic, non-communicable disease affecting the heart or blood vessels
(WHO, 2005). The seriousness of CVD stems primarily due to the personal level of
suffering endured by those affected and also from the spiralling costs associated with
the disease and its associated conditions. CVD, places a heavy burden on the
economies of many countries. In 2004, CVD cost the United Kingdom (UK)
economy £29.1 billion with cerebrovascular disease and coronary heart disease
(CHD) accounting for 56% (£16.5 billion) of the total (Luengo-Fernandez et al.,
2006). It has been estimated that between 2006 and 2015, China will lose $558
billion in foregone national income due to heart disease, stroke and diabetes (WHO,
2005).
Cardiovascular disease is the generic name for a group of diseases that affect
the heart and the blood vessels (WHO, 2005). These include,
x Coronary heart disease – disease of blood vessels supplying the heart
muscles.
x Cerebrovascular disease – disease of the blood vessels supplying the
brain.
2x Peripheral arterial disease – disease of blood vessels supplying the
limbs.
x Rheumatic heart disease – damage to the heart muscle and heart
valves from rheumatic fever (an autoimmune inflammatory disease
that develops after infection with streptococcal bacteria).
x Congenital heart disease – malformations of the heart structure.
x Deep vein thrombosis – blood clots in the leg veins which may
dislodge and translocate to the heart or lungs.
x Hypertension – A blood pressure greater than a systolic blood
pressure of 140 mmHg, or a diastolic blood pressure of 90 mmHg or
over.
Coronary heart disease, cerebrovascular disease and peripheral arterial
disease are common problems associated with chronic CVD. These conditions are all
manifestations of atherosclerosis, which is the process where plaques build up on the
inner surface of arteries. These plaques later harden and restrict blood flow through
the effected arteries. Plaques may also break away from the surface of the arteries,
becoming lodged in the arteries supplying the heart or the brain and subsequently
causing heart attacks or strokes (WHO, 2005).
1.1.1 CVD Risk Factors
To date over 300 separate risk factors have been associated with the
development of CVD. In the developed world over 30% of all CVD is attributed to
five main risk factors; namely high blood pressure, obesity, high circulating
cholesterol and tobacco and alcohol use (WHO, 2005). These factors also rank
3highly in developing countries with low mortality, such as China, and developing
countries with high mortality, such as India, where the populations also face the
burden of communicable diseases and undernutrition (WHO, 2005). The main risk
factors can be characterised into three different categories, major modifiable risk
factors, other modifiable risk factors and non-modifiable risk factors (Table 1.1)
Table 1.1 Summary of CVD risk factors (WHO, 2005).
Major modifiable risk
factors
Other modifiable risk
factors
Non-modifiable risk
factors
High blood pressure Low socioeconomic status Advancing age
Dyslipidaemia Mental ill-health Genetics
Tobacco use Psychosocial stress Gender
Physical inactivity Alcohol use Ethnicity/ race
Obesity Use of certain medication
Elevated homocysteine Lipoprotein(a)
Diabetes mellitus Left ventricular
hypertrophy
Considerable health benefits can be achieved by increasing physical activity
and reducing alcohol and tobacco usage combined with eating a “healthy diet”. In the
United Kingdom (UK) the Food Standards Agency (FSA) classifies a “healthy diet”
as a diet consisting of a third of fruit and vegatables which should include at least
five 80g portions of fruit and vegetables per day, and a third starchy foods such as
potatoes, wholegrain breakfast cereals and lentils. The final third of the diet should
consist of a mixture of dairy foods such as milk and cheese, and non-dairy sources of
protein like meat and fish. Consumption of foods and drinks rich in fat and sugar
should be kept to the mimium. This has been summerised in the much publicised
FSA “eatwell plate” (Figure 1.1).
4Figure 1.1 The Eatwell plate (FSA, 2000)
1.1.2 Metabolic syndrome
The metabolic syndrome is a combination of metabolic and physical
abnormalities that increase the risk of developing CVD. Although the concept of the
metabolic syndrome, also known as Syndrome X (Reaven, 1988), has existed since
the 1920’s when a Swedish physician, Kylin (1923) described the syndrome as the
clustering of hypertension, hyperglycaemia, and gout, (Kylin, 1923), it was not until
1988 that there was an attempt to achieve an agreement on an internationally
recognised definition in order to provide a tool for researchers and clinicians. The
World Health Organisation (WHO, 2005) proposed that in order to be diagnosed
with the metabolic syndrome an individual must have diabetes or impaired fasting
glycaemia or impaired glucose tolerance or insulin resistance, plus 2 or more of the
following criteria:
x Hypertension: blood pressure> 140/90 mm Hg
x Microalbuminuria: albumin excretion > 20µg/min
5x Obesity: BMI >30 or a waist to hip ratio >0.9
x Dyslipidaemia: triglycerides >1.7mmol/L or HDL cholesterol
<0.9mmol/L
Subsequently the National Cholesterol Education Programs Adult Treatment
Panel III (NCEP:ATPIII) and the European Group for the Study of Insulin
Resistance have formulated different definitions (Ferrannini, 1997; NIH, 2001;
WHO, 2005). All three definitions agree on essential components; hypertension,
obesity, glucose intolerance and dyslipidaemia. However they do differ in detailed
criteria (Table 1.2). It is important to note that insulin resistance is very much at the
centre of the metabolic syndrome and is tied into the spectrum of CVD risk factors,
this is summarised in Figure 1.2.
Figure 1.2 CVD risk factors.
Insulin Resistance
Obesity Diabetes
Glucose
Intolerance
Vascular
Dysfunction
Inflamation
Increased
ClottingCVD
Dyslipidaemia
High Blood
Pressure
Renal
Impairment
Micro-
albuminuria
6Table 1.2 Overview of metabolic syndrome definitions.
WHO NCEP:ATPIII European group for the
study of insulin
resistance
Diabetes or impaired
fasting glycaemia or
impaired glucose tolerance
(hyperinsulinaemic,
euglycaemic clamp-
glucose uptake in lowest
25%)
Insulin resistance –
hyperinsulinaemia: top
25% of fasting insulin
values from non-diabetic
population
Plus 2 or more of
following
3 or more of the
following
Plus 2 or more of
following
Obesity: BMI> 30 Central obesity: waist
circumference > 102cm
Central obesity: waist
circumference > 94cm
Dyslipidaemia:
Triglycerides> 1.7mmol/L
HDL Cholesterol>
0.9mmol/L
Hypertriglyceridaemia:
triglycerides > 1.7mmol/L
Dyslipidaemia:
Triglycerides> 2.0mmol/L
HDL Cholesterol>
1.0mmol/L
Hypertension: blood
pressure> 140/90 mm Hg
Low HDL cholesterol<
1.0mmol/L
Hypertension: blood
pressure> 140/90 mm Hg
and/or medication
Microalbuminuria:
albumin excretion >
20µg/min
Hypertension: blood
pressure> 135/85 mm Hg
or medication
Fasting plasma glucose>6
mmol/L
Fasting plasma
glucose>6.1 mmol/L
Table 1.2 shows an overview of the different definitions of the metabolic syndrome taken from
(Ferrannini, 1997; NECPATPIII, 2002; WHO, 2005).
1.1.3 WHO Strategy
The WHO has devised a global strategy for prevention and control of CVD.
This strategy is integrated into the overall WHO chronic disease prevention and
control framework for the Department of Chronic Disease and Health Promotion.
The objectives of the strategy are to raise awareness of the global CVD epidemic and
7to provide healthy environments for the poor and disadvantaged populations. The
primary aim is to slow and reverse the trends of CVD risk factors, such as physical
inactivity and unhealthy diet and therefore prevent premature deaths and avoidable
disability (WHO, 2005). In order to devise an effective strategy, researchers,
clinicians and policy-makers need to have a full understanding of the contribution
that diet, activity, social factors, deprivation and other modifiable risk factors make
to the aetiology of CVD.
1.2 Traditional view of disease risk
Until relatively recently, it was believed that the risk that an individual would
develop a non-communicable disease, such as coronary heart disease CHD or type 2
diabetes, was largely determined by a persons genetic susceptibility. Recent
advances in the field of genetics has led to the recognition of monogenic forms of
familial hypertension and CVD (Guidi et al., 2001), and new insights in research into
the impact of the role single nucleotide polymorphisms (SNP) such as ApoE
(Minihane et al., 2007) play in the development of such diseases have provided
evidence that genetic susceptibility is of high importance. Indeed a genetic
predisposition coupled with an individuals modified interaction with the adult
environment, encompassing lifestyle factors such as diet, physical activity levels,
smoking and alcohol consumption are paramount in determining the disease risk
(Langley-Evans, 2004). However, over the last decade there has been a wealth of
interest in prenatal, or programmed, factors and the role they play in contributing to
the onset of disease.
81.3 Fetal Programming
Evolution occurs as a consequence of adaptations to the genome that ensure
the survival of species. Plants and animals alike are capable of developing in a
variety of ways, developing specific characteristics in order to adapt to the
environments in which they live (Bateson et al., 2004). Many organisms are able to
express specific adaptive responses to prevailing conditions within their
environments. These responses can be short-term or intermediate changes in
physiology and behaviour (Bateson et al., 2004). For example the offspring of a
freshwater crustacean Daphnia develop a defensive helmet that protects them from
predators if the mother has been exposed to chemical traces of a predator. The
protective helmet can however be a liability in a predator free environment as its
construction cost reduces competitive success relative to non-helmeted individuals
(Tollrian, 1999). However, it is becoming increasingly apparent that changes may be
induced in the earliest stages of development as a primary response to prevailing
conditions. These responses are important in the context of disease as they are likely
to exert permanent effects on developing tissues. Thus early life factors can alter the
phenotype that is expressed from the inherited genotype.
Preliminary research in this area began with Kermack et al., (1934), who
inspired the original hypothesis that early life events were linked to later health
outcomes (Kermack et al., 2001). However it was Rose in 1964 who sparked off
current interest in the topic. Rose noted that the incidence of ischaemic heart disease
was up to twice as great in individuals who had siblings that were stillborn, or that
had died in early infancy (Rose, 1964). Forsdahl expanded on this concept by adding
that cardiovascular mortality was of the highest incidence in areas with a high level
9of infant mortality (Forsdahl, 1977). In 1979, Ellison presented data linking low birth
weight and high blood pressure in 7 year olds (Ellison, 1979). Following that,
Simpson et al., (1981) reported a negative association between birth weight and
blood pressure (Simpson, 1981). These observations were followed by a number of
similar investigations (Gennser et al., 1988; Ounsted, 1985; Wadsworth et al., 1985).
Finally Barker (1989) expanded on these original ideas to produce the “fetal origins”
hypothesis (Barker, 1994). The Barker hypothesis suggested that maternal
undernutrition promotes the retardation of fetal growth and that the principal markers
of this are a low birth weight or disproportion (Barker, 1994). The hypothesis was
based on the assumption that environmental stimuli are able to reset the
developmental path of the embryo leading to restricted intrauterine growth. It has
been proposed that it is this reset that predisposes an individual to non-
communicable adult diseases (Moore and Davies, 2001).
Lucas (1991) was the first to try and define programming in the context of
human biology and health. He described programming as the permanent response of
an organism to a stimulus or insult during a critical period of development. The
developing fetus is said to go through a number of critical or vulnerable, periods
where organogenesis and differentiation take place. These critical periods are the
stages of development when the fetus is most vulnerable to variations in nutrient or
oxygen supply (Lucas, 1992). It is proposed that physiological programming occurs
by two possible means. Firstly, the induction, deletion or impaired development of a
somatic structure, resulting from an adverse stimulus or insult during a critical period
of development, will perturb long-term function. Secondly a physiological “setting”
may occur in response to an early stimulus or insult in a critical period. This causes
long-term changes in function (Lucas, 1998). In simple terms, this definition
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suggests that when a fetus or neonate is exposed to a suboptimum environment
during a rapid phase of growth, the resulting adaptive response may become
permanently fixed in place. In terms of health and well-being many years later, the
effects of programming may be profound, as irreversible maladaption may result in
detriment to organ function or longevity (Langley-Evans, 2004). This principle has
been demonstrated by the classic Hertfordshire, Preston and Sheffield cohort studies
(Section 1.4.3), where Barker and colleagues suggested that a variety of
anthropometric markers at birth, including low birth weight, low ponderal index and
reduced head circumference were directly related to elevated levels of coronary heart
disease (CHD) risk factors and increased CHD mortality (Barker et al., 1989; Hales
et al., 1991; Osmond et al., 1993; Phipps et al., 1993).
1.4 Epidemiological studies
Research into the fetal programming of disease in humans is at a relatively
early stage. From a practical perspective, it is implausible to directly examine the
relationship between maternal undernutrition and fetal growth, development and
subsequent progression towards disease at a cellular or molecular level. It is not
ethical to control maternal nutritional intake in humans (Worthington-Roberts, 2000).
Human epidemiological research is therefore mainly restricted to cross-sectional
retrospective studies that assess relationships between proxy markers of maternal
nutrition such as birth weight and other body measurements at birth (Barker et al.,
1989). The criticisms of such an approach are discussed in section (1.6) and the
research has so far provided insufficient conclusive data to either support or reject
the fetal origins hypothesis. However, more recently prospective cohort studies have
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been initiated which will examine the impact of maternal nutrition on the subsequent
development of the offspring (Section 1.4.4). The following sections (1.41-1.4.4)
will summarise the epidemiological evidence currently available.
1.4.1 Dutch Hunger Winter (1944-1945)
The Dutch Hunger Winter has spawned a broad body of epidemiological
evidence supporting the hypothesis that prenatal nutrition is linked to an increased
susceptibility to adult diseases. It occurred towards the end of the Second World War
during the winter of 1944-1945 in the western parts of the Netherlands
Near the end of World War II food supplies in the Netherlands became
increasingly sparse. After the D-Day landings of June 1944, allied forces broke
through Nazi lines and by early September had taken back control of the majority of
France, Luxembourg and Belgium. On the 14th September the allies entered the
Netherlands and consequently soon liberated the southern part of the country.
However their liberation efforts faltered when operation “Market Garden” (an
attempt to gain control of the bridge across the Rhine at Arnhem) failed. In order to
further allied liberation efforts the exiled Dutch government appealed for a railway
strike, the Nazi’s retaliated by putting an embargo on all food transports to the
western Netherlands. By November 1944 the embargo was partially lifted, allowing
restricted food transports over water, however the unusually harsh and early Dutch
winter had set in, and the canals had frozen making them impassable for barges.
Food supplies within the western cities of the Netherlands soon ran out and a severe
rationing scheme was put into practice. The retreating Nazi army destroyed bridges
and locks in order to flood the country and halt the allied advance. These factors
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combined to make the Netherlands one of the main western battlefields, resulting in
the destruction of agricultural land and making transport of existing food stocks
impossible. By the end of November 1944 adult rations in cities such as Amsterdam
had dropped below 1000 Kcal per day and by the end of February 1945 had fallen
further, to just 580 Kcal per day (Stein, 1975). The famine lasted for many months
during which over 20,000 people died. During the start of the rationing period of the
winter, pregnant women received extra allowances however as the famine grew more
severe it became impossible to maintain these extra allowances and many pregnant
women went without. Even during the most severe parts of the famine women still
conceived and gave birth (Roseboom, 2001).
The Dutch Hunger Winter has provided a unique research opportunity, as
there are only a few such famines in which data for daily food intake is available,
After liberation (June 1945) food rations were returned to normal (~2000kcal per
day) and the offspring of the Dutch Hunger Winter were not subjected to further
bouts of famine. The Dutch Hunger Winter therefore provides an opportunity to
research the effects of a nutritional insult on the programming of adult diseases and
researchers have extensively studied hospital records in order to track individuals for
assessment for a range of conditions associated with adult diseases (Ravelli, 1998,
1999; Ravelli, 1976; Roseboom, 2000, 2001).
In 1976 Ravelli and colleagues performed a cohort study of 300,000 19-year
old men exposed to the Dutch Hunger famine of 1944-1945 in order to test the
hypothesis that prenatal and postnatal nutrition impact upon obesity. The outcomes
of the study were dependant on the time of exposure. It appeared that if the fetus was
subjected to the famine in the last trimester of pregnancy, or the first months of
postnatal life, the subsequent risk of obesity was reduced. However if the fetus was
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exposed during the first half of pregnancy, this resulted in significantly higher
obesity rates (Ravelli, 1976). Further to this Ravelli and colleagues showed the same
effect in 50-year old women, but did not observe any effect on adiposity in men
(Ravelli, 1999).
In 1998 Ravelli and colleagues studied glucose and insulin responses in 702
people born between Nov 1, 1943 and Feb 28, 1947 in Amsterdam for whom they
had detailed birth records. They compared results of people who had been exposed to
the famine at any stage of gestation, with people who were born the year before, or
conceived the year after the famine. The results of this study showed that prenatal
exposure to famine, particularly during late gestation was linked to decreased
glucose tolerance in adulthood and that the effect of famine on fetal growth was
relatively small (Ravelli, 1998). More recently Roseboom and colleagues (2000)
have reported that exposure to famine was linked to an increased atherogenic lipid
profile (Roseboom, 2000), and also associated with a higher than average BMI and
subsequent risk of coronary heart disease (CHD) in adulthood, (Roseboom, 2001).
Painter and colleagues (2005) also demonstrated that the occurance of
microalbuminuria (MA) an indicator endothelial dysfunction and an important
prognostic marker for kidney disease, diabetes and hypertension was increased by
5% in individuals who were exposed to the Dutch famine in mid gestation which is a
critical time in determining nephron endowment in humans (Painter et al., 2005).
This suggests a link between fetal nutrition, nephron endowment and the subsequent
development of MA and disease in later life.
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1.4.2 Leningrad Siege Study
The Siege of Leningrad, also known as the Leningrad Blockade, was one of
the major events of the Second World War. This event provides researchers with a
unique opportunity to study the effects of more severe and prolonged nutritional
programming on later health outcomes. The Leningrad siege was one of the longest
sieges in modern history lasting from 8th September 1941 until 27th January 1944,
during which a Nazi blockade prevented supplies from reaching the city for 872
days. At its worst, the city’s inhabitants received a limited bread ration equivalent to
300 kcal per day.
In 1947 Antonov (Antonov, 1947) noted that birth weights were significantly
reduced in children born during this time and since then, Stanner and colleagues have
performed a number of studies on the individuals exposed to the famine in utero. In
contrast to the results found by Ravelli et al., (1998) and Roseboom et al., (2000,
2001) in the Dutch Hunger Winter, there was no evidence that fetal exposure to
undernutrition was linked to dyslipidaemia, glucose intolerance, hypertension or
cardiovascular disease (Stanner, 1997). However an increased risk of obesity in
individuals exposed to the famine was apparent (Stanner, 1997). The differing results
obtained from the Dutch and Soviet cohorts may be due in part to the duration of
exposure to the famine, coupled with the differing conditions experienced by the
affected people in both pre- and post- famine eras.
1.4.3 Retrospective Cohort Studies
Other studies which suggest a link between birth weight and disease include
the Hertfordshire, Sheffield and Preston cohort studies which considered people born
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in the UK during the 1920’s and 1930’s. These studies suggested that low birth
weight, increased ratio of placental weight to birth weight, low ponderal index,
abdominal circumference and reduced head circumference were all associated with
increased CHD risk factors and mortality (Barker et al., 1989). Lower birth weight
has also been linked to impaired glucose tolerance, non-insulin dependent diabetes
and high blood pressure (Hales and Barker, 1992; Hales et al., 1991). Another study
which inferred a link between birth measurements and type II diabetes and
hypertension was the Helsinki cohort, in which 13 517 men and women born at
Helsinki hospital in 1924-1944 were observed to have a higher risk of type II
diabetes and hypertension if their birth weight was less than 3kg and pre-pubertal
BMI was in the highest quartile, compared to those whose birth weight was more
than 4kg and whose BMI was in the lowest quartile (Barker et al., 2002a). The
relationship was observed to be stronger when CHD risk was assessed relative to
ponderal index (birth weight/birth length) in men, and to length at birth, in women.
Disease risk was also related to rate of growth in childhood.
When analyzing associations in epidemiological studies it is important to
appreciate their limitations. Clearly data from the Dutch and Leningrad studies
conflict and it is important to understand that these studies are retrospective and that
although the general food intake of the participants was known, it is unrealistic to
assume that these values are absolute and consistent. Also the studies of the Dutch
Hunger Winter assessed offspring according to different prenatal exposure time
points whereas the Leningrad study simply assessed those who were, or were not,
exposed (Stanner and Yudkin, 2001). This point is particularly relevant as a wide
range of animal studies have shown that nutritional restriction at specific time points
in fetal development have differing effects (Langley-Evans, 1999a; Langley-Evans et
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al., 1996b). It has also been noted that conception rates, especially in the poorer
social classes, declined during both the Dutch Hunger Winter and the Leningrad
siege. It has therefore been hypothesized that the observed programming could be
due to social class of the parents rather than nutrition (Stein et al., 2004). It is also
important to note that the impact of wartime stress can not be dissected out from the
impact of undernutrition.
1.4.4 Prospective cohort studies
Currently underway in both the United States and Southampton, UK are
several ground-breaking prospective longitudinal cohort studies including “Project
Viva”, the “Avon longitudinal study of pregnancy and childhood” and the
“Southampton Women’s Study” (Inskip et al., 2009; Lawlor et al., 2005; Ong et al.,
2000). These studies aim to improve the health of the mother and child by looking at
the effects of diet and other environmental factors during pregnancy.
Project Viva is an ongoing study funded by the National Institutes of Health
(NIH), which began enrolling pregnant women in April 1999, and to date has
enrolled a total of 2670 subjects. The study is in its seventh year and has so far
yielded some interesting results. Gillman and colleagues (2004) analysed 4091
Dinamap blood pressure measurements from a total of 936 6-month old infants.
Second trimester food frequency questionnaires of the mothers were also analysed
and it was determined that every 500-mg increment of maternal calcium
supplementation during the second trimester of pregnancy resulted in a 3.0 mm Hg
decrease in systolic blood pressure in the children at 6-months of age (Gillman,
2004). Similarly Lawlor and colleagues (2005) recently performed a prospective
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cohort study that examined the association between birth weight and cardiovascular
disease end points in 10,803 singleton individuals born within the 1950s, which was
a time when environmental circumstances, (indexed by low infant mortality rates),
were relatively advantageous for infants. This study suggested that birth weight is
inversely associated with CHD and stroke (Lawlor et al., 2005). A further
prospective study was performed by Ong and colleagues (2000) who analysed the
association between postnatal catch-up growth and obesity in childhood in 848 full
term singletons from a 10% random sample of the Avon longitudinal study of
pregnancy and childhood and found that Children who demonstrated catch-up
growth by 2 years of age exhibited more central adiposity at 5 years of age than other
children (Ong et al., 2000).
1.5 Hypotheses of Fetal Programming
1.5.1 The Thrifty Genotype Hypothesis
The fundamental origins of non-communicable disease are clearly multi-
factorial. To date opinion has favoured the role of genetic susceptibility, where a
specific genotype, that is apparent in different ethnic groups, has the potential to infer
a predisposition to disease (Groop and Orho-Melander, 2001; Neel, 1962). The
thrifty genotype hypothesis was derived when Neel and colleagues observed that
certain ethnic groups had a tendency to develop type II (non-insulin dependant)
diabetes mellitus with an ever increasing prevalence, Neel (1962) postulated that
evolutionary pressures from consistent famine had created a new human genotype.
This new genotype had increased chances of survival at times of severe nutritional
sparsity, (Neel, 1962). However in times of abundance these genes predispose their
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carriers to diseases caused by excess nutritional intake, such as obesity, due to the
genes having evolved to maximize metabolic efficiency, lipid storage and food
searching behaviour (Neel, 1962). The thrifty genotype hypothesis assumes that
several thrifty gene varients act simultaneously, inducing altered glucose and fat
metabolism via changes to organ function. The hypothesis assumes that disease is
directly due to gene-environment interactions and to date the list of thrifty candidate
genes thought to be involved in the origins of disease is extensive. Peroxisome
proliferator activated receptors and ß-adrenergic receptors, represent a few examples
from a long list (Groop, 2000).
1.5.2 The Thrifty Phenotype Hypothesis
Following the emergence of the “thrifty genotype” hypothesis Hales and
Barker (1992) proposed an alternative “thrifty phenotype” hypothesis. This
hypothesis incorporated understanding of the aetiology of non-communicable
diseases such as type II diabetes. Hales and Barker (1992) proposed that such
diseases are a consequence of environmental conditions, such as poor fetal nutrition,
that are central to disease susceptibility and that genetics contributes only mildly
(Hales, 2001). The biological basis of the hypothesis is that fetal undernutrition
causes “brain-sparing”, the situation where a fetus subjected to undernutrition diverts
blood flow to the brain at the expense of the other organs. The other organs adapt to
an environment of sparse nutrition and this can have a major effect on their resulting
structure and later function (Hales and Barker, 1992). The thrifty phenotype also
represents a way in which a pregnant female can modify the development of her
unborn fetus so that it will be prepared for survival in an environment in which
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resources are likely to be scarce. The acquisition of a thrifty metabolism will provide
a survival advantage if environmental conditions remain the same once the fetus has
been born, consequently increasing the probability the fetus will reproduce (Hales,
2001). Similar to the thrifty genotype hypothesis the thrifty phenotype is likely to be
a disadvantage and the individual may suffer disease due to metabolic efficiency in
an environment where energy is consumed in excess (Langley-Evans, 2004; Leon,
2004).
The thrifty phenotype, with enhanced metabolism, can be observed in many
different populations throughout the world which have undergone the transition from
poverty to relative affluence (Langley-Evans, 2004). For example, Cohen et al.,
(1988) noted that a group of Jewish migrants known as the Falashas who moved
from Ethiopia to Israel, and therefore from an area of common famine to a
westernised nation, exhibited a rise from 0.5% to 18% prevalence of non-insulin-
dependant diabetes within 5 years. This was twice as high as the rest of the Israeli
population and 30 times greater than the prevalence among Ethiopians living in
Ethiopia (Cohen, 1988). This concept is particularly relevant for the next few
decades, as there is expected to be an explosion of the prevalence of obesity, type 2
diabetes and cardiovascular disease in countries such as India, China and South
Africa as they are making the economic and nutritional transformation to become
more westernised, after many generations that would select for thrift (Robinson,
2001).
More recently the thrifty phenotype hypothesis has been adapted and now
encompasses other factors such as obesity, aging and physical activity which are
believed to be critically influential on the outcome of disease (Hales, 2001). Prentice
and Moore (2005) suggested that a combination of both the thrifty phenotype and
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thrifty genotype influence the health of populations and that thrift has increased
certain populations susceptibility to non-communicable diseases (Prentice, 2005). In
essence all of these previous ideas contribute to the newly emerging concept of a
“lifespan” model of disease where gene-environment interactions occur throughout
life (Kuh, 2003). The response of the individual to the environmental challenges at
any stage of life will essentially reflect the cumulative influence of responses to such
cues at earlier stages of life.
1.5.3 Predictive adaptive response hypothesis
The thrifty phenotype hypothesis is consistent with the “predictive adaptive”
response theory of Gluckman and Hanson (2004), which proposes that prenatal
stimuli cause the fetus to predict the future postnatal environment, and adapt
accordingly for life outside the womb (Gluckman and Hanson, 2004). These
adaptations may aid long-term survival, adaptations ensures survival through natural
selection then the adaption is likely to be passed across generations. However it is
when a mismatch between pre- and postnatal environments occurs that the adaptation
is likely to be unsuitable and lead to disease (Gluckman and Hanson, 2004).
1.5.4 The Fetal insulin hypothesis
As an alternative to the fetal programming hypothesis Hattersley and
colleagues (1998) proposed the fetal insulin hypothesis for the association of low
birth weight and type II diabetes and insulin resistance. In essence they suggested
that insulin regulates fetal growth and that subsequent birth weight is directly
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determined by fetal insulin secretion and insulin action, both of which are regulated
by fetal genotype (Hattersley, 1998). Hattersley and co-workers developed this
hypothesis after analysing birth weight and the presence or absence of glucokinase
mutations in the fetus and mother. They investigated 58 children from 23 nuclear
families from 10 extended glucokinase pedigrees. In the 58 offspring, birth weight
was higher in the presence of a maternal mutation and lower in the presence of a fetal
mutation. However when both the mother and the fetus had the mutation, birth
weight was not significantly different from when neither mother nor the fetus had the
mutation. Hence a significant difference in birth weight was only seen when both the
fetus and mother were discordant for the glucokinase mutation (Hattersley, 1998). As
glucokinase will clearly influence glucose homeostasis and carry a diabetes risk, the
presence of these mutations confounds relationships between birthweight and
diabetes risk. These observations have demonstrated that there are important
implications for the study of genetics in adult diseases. Although glucokinase
mutations are relatively rare within the population and not numerically important in
type II diabetes (Hattersley, 1998), it is clear that genes have the potential to
influence birth weight. Although environmental influences such as undernutrition
and maternal smoking clearly have some impact, the study of the genetics of low
birth weight may help to remove some of the uncertainties surrounding diabetes and
hypertension.
1.5.5 Summary of disease factors
It is clear that the aetiology of disease is multi-factorial. Disease risk will
stem from interactions of all factors genotypic and phenotypic and these factors have
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the potential to influence well-being at all stages of the life course. It is also
important to recognise the complexity of the disease process and accept that our
understanding of the process is limited. For example it is now apparent that the
Falashas carry a haplotype that predisposes the population to ȕ-cell destruction and
therefore type 1 diabetes (Zung et al., 2004). This further complicates interpretation
of data which supports the thrifty phenotype hypothesis. Data from both human and
animal studies continue to provide essential insights into the process of disease.
1.6 Criticisms of the programming hypothesis.
Research into the impact of fetal programming on humans is at a relatively
early stage and the full list of factors that may act as stimuli are not known.
However, work done by Barker and colleagues has proposed maternal nutrition to be
of prime importance in determining the long-term risk of disease (Barker et al.,
1993). Barker suggested that maternal undernutrition promotes retardation of fetal
growth, which is observable as low birth weight or disproportion (Barker, 1994).
This is now known as the Barker hypothesis. However, unlike many other species,
the growth of the human fetus does not seem to be very susceptible to alterations in
maternal diet, and human growth rates appear to be largely determined genetically,
although they may be constrained by lower socio-economic status (partly diet,
smoking and maternal size) (Campbell, 1991). Some studies show some impact of
undernutrition on birth weight, but these are extreme cases where a severe famine
has taken place, and even then the effects on birth weight are marginal (Prentice,
1987).
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Women in the United Kingdom have been the subject of many studies on the
relationship between diet and birth weight and there is very little evidence that
variation in maternal diet effects birth weight (Doyle, 1992; Mathews et al., 1999).
There is also very little evidence that maternal diet alters body proportions at birth
(Langley-Evans and Langley-Evans, 2003). The Barker hypothesis has also been
strongly challenged by Bartley et al., (1994) who demonstrated that the cause of low
birth weight was more likely to be related to socio-economic status, and that these
socio-economic factors continued to influence the individual into adult life (Bartley
et al., 1994). Kramer and Joseph, (1996) have also pointed out inconsistencies within
Barker’s work and studies by Matthes et al., (1994) have found no link between
characteristics at birth and cardiovascular risk (Kramer and Joseph, 1996; Matthes et
al., 1994).
Major criticism of the Barker hypothesis also comes from Huxley et al.,
(2002) who performed a meta-analysis of over 100 studies that had previously
reported a regression coefficient of systolic blood pressure in relation to birth weight.
Huxley et al., found that the inverse association between birth weight and blood
pressure may simply have been due to random error and an inappropriate adjustment
for confounding factors such as current weight (Huxley et al., 2002).
1.7 Animal models as proof of the programming principle
Although there seems to be much controversy surrounding the idea that
maternal nutrition and prenatal undernutrition programmes human disease, since the
1960’s there has been a broad body of epidemiological evidence to add support to the
claim. However, most of the more robust evidence comes from animal models,
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especially studies of the pregnant rat and the sheep. Such studies show that exposing
the developing fetus to maternal food restriction or restriction of specific nutrients
results in changes to normal physiology and the initiation of disease processes
(Bertram and Hanson, 2001; Langley-Evans, 2004; Langley-Evans, 2001)
Animal studies have been extensively used to explore the programming
principle and a wide range of programmed endpoints have been identified. These
include obesity, (Breier et al., 2001; Jones, 1983), insulin resistance, (Simmons et
al., 2001), impaired glucose homeostasis (Taylor et al., 2005), hypertension (Dunn et
al., 2001; Khan et al., 2003; Langley and Jackson, 1994), susceptibility to oxidative
damage (Jennings et al., 2000), adiposity (Guo and Jen, 1995) and impaired
immunity (Chisari et al., 2001). These endpoints are observed after restriction of
food intake (Woodall et al., 1996a; Woodall et al., 1996b) or of specific nutrients
such as iron (Crowe et al., 1995; Gambling et al., 2003), calcium (Bergel and
Belizan, 2002) sodium (Battista et al., 2002), zinc (Beach, 1982) and protein
(Langley and Jackson, 1994) or via overnutrition by feeding a fat-rich diet (Khan et
al., 2004; Khan et al., 2003; Taylor et al., 2005). Programming by nutritional
manipulation has been observed in many different species such as sheep,
(Gopalakrishan, 2004) guinea pigs, (Kind, 1999) rats, (Langley-Evans, 2001) and
mice (Ozanne et al., 2004). This review will concentrate on the restriction of protein
in rodents, which is one of the most studied nutrients in fetal programming.
1.8 The maternal low protein diet model
Out of the many different nutrients protein is particularly relevant to global
nutrition because in humans protein intakes vary globally and even regionally.
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Intakes also vary in relation to socio-economic class. Data extracted from 2004 Food
and Agriculture Organisation of the United Nations (FAO) indicate that 65% of the
world population are likely to consume protein at less than the UK Reference
Nutrient Intake (51g/day), and therefore are at risk of low protein intake during
pregnancy (FAO, 2004). It is important to note that this information is derived from
food balance sheets which only determine the available protein (i.e. produced
through agriculture or imported) per head of population. Therefore actual
consumption will generally be lower and highly variable. Further to this in 2002 a
study of trimester 1 and 3 intakes of 300 British women was completed (Langley-
Evans, 2004). This study found that 6-8% of the women had first or third trimester
protein intakes below the UK Reference Nutrient Intake and that 55% of these
individuals were from lower socio-economic groups (Langley-Evans, 2004).
Low protein diets were first used to promote fetal growth retardation in rats
after Zeman and Stanbrough, (1969) found that feeding pregnant rats diets containing
40-60 g protein/kg, produced severe reductions in offspring birth weights (Zeman
and Stanbrough, 1969). Many early studies used diets that contained 4-5% protein
with controls containing up to 24% protein to examine this effect. This is not likely
to be physiologically relevant as the pregnant rat requires 12% protein (Clarke et al.,
1977). Langley and Jackson (1994) reported that feeding a 60, 90 or 120g protein/kg
diet to pregnant rats caused increased blood pressure in their offspring, compared to
that of control rats, despite all rats being transferred to the same standard diet at
littering (Langley and Jackson, 1994).
Langley-Evans and colleagues have since extensively characterised this low
protein diet model of programming in the rat. The control diet for these studies
contains 18% casein and various levels of protein restriction have been applied (12-
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6%) (Langley-Evans, 2004). Most work has concentrated on a 9% casein diet
(Langley-Evans, 2001), as this is the protein requirement for a non-pregnant rat and
therefore represents only a mild restriction (Langley-Evans, 2004). Langley-Evans
and colleagues matched the energy of the low protein diet with the control diet by
increasing carbohydrate content in proportion to the protein restriction (Langley-
Evans, 2004). The programming effects of this diet have been monitored
comprehensively and are explained below.
Rats that are fed a low protein diet throughout pregnancy (9% casein) have
fetuses that are larger than those of control specimens from day 14 through to day 20
of gestation, and this effect is amplified if low protein feeding continues for only the
first 7 days of gestation (Langley-Evans et al., 1996d; Langley-Evans and Nwagwu,
1998). Placental size is related to fetal growth and feeding of a low protein diet
produces an enlarged placenta by day 20 of gestation (Langley-Evans, 2001). During
rat gestation the rat fetus doubles in weight over the final 2 days (day 21 and 22).
The feeding of a low protein diet retards this major surge in growth and by full- term
the offspring tend to be of low- to- normal birth weight (Langley-Evans et al.,
1996d). This late gestation growth retardation appears to primarily affect the
development of the truncal organs, such as the liver and the lungs. Body length is
also reduced but the brain remains unaffected (Langley-Evans et al., 1996d). Adult
body composition does not appear to differ between low protein exposed rats and
control rats, however there is some evidence that low protein-exposed male rats
deposit more gonadal fat with aging (Bellinger et al., 2004; Bellinger et al., 2006).
Roach et al., (1999) also found that animals exposed to a low protein diet had
abnormalities in their bone morphology (Roach et al., 1999). Hales and colleagues
have also noted that fasting plasma glucose and insulin levels are lower in the
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offspring of rats fed a MLP diet in utero (Hales et al., 1996). This reduction is
associated with improved insulin sensitivity in early adulthood, however by 15
months of age, glucose tolerance in MLP offspring is noted to significantly decline
compared to controls and MLP exposure is associated with hypoinsulinaemia in
female animals and hyperinsulinaemia in male animals (Hales et al., 1996).
The major focus of research into the effects of MLP diet on fetal
development, is the effect the low protein diet has on blood pressure. By 4 weeks of
age rats consistently exhibit raised systolic blood pressure if exposed to maternal
protein restriction in utero (Langley-Evans, 2001). The increase in blood pressure
varies between 7 and 30 mmHg (Langley-Evans et al., 1994; Langley and Jackson,
1994) and appears to be permanent, with blood pressure remaining elevated in adult
life (Langley-Evans and Jackson, 1995). No differences between males and females
have been found and generally the elevated blood pressure is found to go hand in
hand with a reduced heart rate (Nwagwu et al., 2000). Similar experiments have also
been performed in mice with the same outcome (Dunn et al., 2001). The timing of
low protein feeding does not appear to be critical in programming raised blood
pressure. Feeding of a low protein diet for single weeks in pregnancy produces raised
blood pressure. However, low protein feeding over the final week of gestation was
found to be associated with greater elevation than earlier insults (Langley-Evans et
al., 1996b), but the greatest increase was found when feeding a low protein diet
throughout gestation (Langley-Evans, 2004).
In contrast to the low protein diet used by Langley-Evans and colleagues, the
low protein diet (Hope farms diet) used by Hales et al., (1996) for investigations in to
glucose metabolism and insulin resistance does not programme blood pressure
changes (Langley-Evans, 2000). The Langley-Evans low protein diet differs in
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several ways, it contains extra methionine (to avoid sulphur deficiency associated
with a casein based diet), fat and carbohydrate are provided as maize oil and sucrose-
starch respectively. The Hope farms diet provides less than half the amount of fat
(soyabean oil) and provides carbohydrate mostly in the form of glucose (Langley-
Evans, 2000). It is therefore very important that the composition of diets used in all
investigations are fully published, so that work can be compared and contrasted.
Similarly the low protein diet utilised by John Betram’s research group also fails to
program blood pressure (Hoppe et al., 2007a). However, it must be noted that
although the composition of the Hoppe diet differs very little from the diet utilised by
Langley-Evans and colleagues, the Hoppe diet was administered both pre- and
postnatally and therefore a direct comparison can not be made.
The method utilised to monitor blood pressure must also be carefully
described as there is much controversy over which is the most accurate method to
use in order to monitor blood pressure. Opinion within the scientific community
favours the use of radio telemetry systems. However, these are both invasive and
expensive. Indirect tail-cuff methods allow the analyses of blood pressure without
the use of invasive procedures which may themselves alter blood pressure. Modern
systems allow measurements to be taken without the use of heating, therefore
preventing heat-stress of the animals (Kubota et al., 2006). Analysis of the two
different methodologies have concluded that the tail-cuff method is a sensitive and
accurate technique for determining blood pressure in conscious rats (Ibrahim et al.,
2006) and it has demonstrated that similar measurements are obtain by both the radio
telemetry and the unheated tail-cuff methods (Kubota et al., 2006). Work within our
research group has previously utilised the tail-cuff method of monitoring blood
pressure. The programming effects of the low protein diet upon blood pressure have
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been verified by other research groups using the radio telemetry method (Woods et
al., 2004).
It has been suggested that low protein diet of Langley-Evans and colleagues
(1994) programmes blood pressure by altering the structure of the vasculature and
the kidney. Langley-Evans et al., (1999a; 2002) found that rats exposed to a low
protein diet had a reduced number of nephrons in the kidney at the time of birth,
similarly Hoppe and colleagues (2007a; 2007b) have also noted a reduced nephron
complement in both rats and mice following maternal protein restriction utilising a
different low protein diet (Hoppe et al., 2007a; Hoppe et al., 2007b). Mid-to-late
gestation is thought to be a critical period for the development of the kidney
(Langley-Evans et al., 2003; Langley-Evans et al., 1996b). Mackenzie and Brenner,
(1995) argued that in order to maintain the glomerular filtration rate (GFR), local
blood pressure inside the glomerulus is increased by the renin-angiotensin system
(RAS), maintaining glomerular perfusion (Mackenzie, 1995) which impacts on
systemic blood pressure. Martyn and Greenwald (2001) have argued that
programming of the vascular structure contributes to hypertension (Martyn and
Greenwald, 2001), and it has been demonstrated that low protein feeding in the rat
produces noticeable changes within the ascending aorta such as thinner-walled
vessels and differing elastin and collagen deposition from as early as 4 weeks’
postnatal age (Langley-Evans, 2004).
One of the major problems with using rodent models for cardiovascular
disease is that rats are resistant to atherosclerosis and CHD. Therefore there have
been very few rodent studies that examine CHD markers other than blood pressure,
(Langley-Evans, 2004). A recent study by Yates and colleagues (2008) however has
circumvented this problem by using ApoE*3-Leiden transgenic mice. ApoE*3-
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Leiden mice carry a mutation of human ApoE*3 rendering them prone to
atherosclerosis when fed a diet rich in cholesterol. Yates and colleagues found that
fetal exposure to a low protein diet in utero resulted in dyslipidaemia, elevated total
plasma cholesterol and triglyceride concentrations and the development of more
severe atherosclerotic lesions within the aortic arch compared to control animals
when fed an atherogenic postnatal diet (Yates et al., 2008). This model for the first
time effectively demonstrates the interaction of prenatal undernutrition with a
postnatal atherogenic diet increases the extent of atherosclerotic disease. Subsequent
studies and further investigation is needed in this area.
In conclusion, there is a wealth of experimental evidence that suggests that
fetal exposure to undernutrition (low protein diet) may be a factor capable of
programming cardiovascular disease. The mechanisms behind programming are not
fully understood, and more work must be done in order to understand completely the
nature of the risk associated with programming.
1.9 Mechanisms of programming
Research into the mechanisms behind the programming phenomenon is at a
very early stage and more investigation into the topic is needed. The exact
mechanism behind programming is not fully understood. An understanding of the
molecular machinery behind programming is essential in order to curb the rising
trend in non-communicable adult disease and in establishing therapeutic targets. The
key potential mechanisms thought to be involved in the nutritional programming of
disease are discussed below.
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1.9.1 Glucocorticoid hypothesis
Glucocorticoids are steroid hormones that are essential for normal physical
development of the fetus in utero. Exposure to glucocorticoids promotes the
maturation of fetal tissue in utero preparing the fetus for life outside the womb
(Edwards et al., 1993). In the lungs, glucocorticoids initiate the thinning of the
alveoli and production of surfactant (Ward, 1994). Glucocorticoids are routinely
given to women as they enter preterm labour in order to facilitate pulmonary
development. As well as their role in development, glucocorticoids are also
important mediators of stress responses and metabolic functions such as the
stimulation of fat breakdown in adipose tissue and are involved in many signalling
pathways (Cato et al., 2002; Rhen and Cidlowski, 2005). The binding of
glucocorticoids to their receptors enables transcription of gene targets (Newton,
2000). The development and maturation of the hypothalamic-pituitary adrenal (HPA)
axis is important in fetal development, occurring late in gestation. It is especially
sensitive to glucocorticoids (Edwards and McMillen, 2002). As a consequence of this
the placenta acts as a critical barrier, actively preventing glucocorticoids passing
from the mother to the fetus. Consequently there is a large concentration gradient of
active glucocorticoids between maternal and fetal circulation, which can be as high
as 1000:1 (Edwards et al., 1993). The gradient is maintained by the enzyme 11ȕ-
hydroxysteroid dehydrogenase 2 (11ȕ-HSD 2), which, in the placenta, catalyses the
conversion of active glucocorticoids to inactive metabolites (Drake and Seckl, 2004;
Edwards et al., 1996). This prevents the fetal tissues being overwhelmed by active
glucocorticoids that would perturb HPA axis development, ensuring that the HPA
axis is allowed to develop independently of maternal influences.
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The programming effects of glucocorticoids upon the development of chronic
disease states are well established. Animal studies in both sheep (Tangalakis et al.,
1992) and rodents (Nyirenda et al., 1998) suggest that fetal exposure to synthetic
glucocorticoids such as dexamethasone and betamethasone, which are poor
substrates for 11ȕ-HSD 2, have programming effects upon the development of
hypertension and renal disease (Benediktsson et al., 1993; Celsi et al., 1998; Dodic et
al., 2002). Indeed Benediktsson and colleagues found that the administration of
dexamethasone during pregnancy resulted in offspring with lower birth weights and
higher blood pressure than control animals (Benediktsson et al., 1993).
Due to the similarities between phenotypes exhibited by animals exposed
glucocorticoids and the nutritional insults during gestation, it has been proposed that
undernutrition during gestation may act as a stressor, altering the glucocorticoid
gradient between the mother and fetus (Langley-Evans, 2008). Indeed the feeding of
a low protein diet during gestation has been shown to reduce the placental activity
and expression of 11ȕ-HSD 2 (Langley-Evans et al., 1996c) resulting in over-
exposure of the fetus to maternal glucocorticoids. It has been proposed that it is this
over-exposure that initiates tissue remodelling resulting in the programmed
phenotype associated with the low protein diet (Langley-Evans, 1997). Studies in rats
support this hypothesis as when fed a low protein diet during gestation combined
with a treatment of metyrapone, a drug which blocks glucocorticoid synthesis in
early to mid gestation, offspring fail to develop the programmed phenotype of
hypertension and renal insufficiency associated with the low protein diet (McMullen
and Langley-Evans, 2005).
Even with the abundance of work within the field of glucocorticoids the
mechanisms through which over-exposure promotes programming are still unknown.
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It is established that glucocorticoids promote tissue maturation and this takes the
form of differentiation rather than proliferation. Current thinking is that during
development this may result in tissue remodelling, leading to the production of fewer
functional units within tissues (Langley-Evans, 2008). This is a process which has
previously been noted in the kidney of sheep (Dodic et al., 2002) and rodents
(Vehaskari et al., 2001).
1.9.2 Tissue remodelling
Normal tissue development involves both proliferation and differentiation.
All tissues and organs develop from progenitor (unipotent) cells in the embryo which
expand down the appropriate lineage during organogenesis. The timing of
organogenesis differs between tissues, for example the kidney develops late in
gestation, whereas the heart is formed early in development (Langley-Evans, 2004).
As previously stated organogenesis takes place as two specific stages proliferation
and differentiation. Current thinking is that a nutritional insult during a critical period
of development such as organogenesis could interfere with either process (Brameld
et al., 1998). This would result in either a reduced organ size, or a reduction in
functional units depending upon which phase of organogenesis was impeded. Several
animals models of nutritional programming exhibit evidence of tissue remodelling.
For example, rats exposed to a low protein diet in utero exhibit a 30-40% reduction
in nephron complement when on gross examination kidney sizes are similar
(Langley-Evans et al., 1999a; Vehaskari et al., 2001). Studies in sheep have yielded
similar results (Gopalakrishnan et al., 2005). Remodelling of the brain has also been
noted. The feeding of a low protein diet has been demonstrated to remodel neuronal
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density (Plagemann et al., 2000) and vasculature (Bennis-Taleb et al., 1999). It is
clear that tissue remodelling could be of paramount importance as a cause of disease
following fetal undernutrition, however it is still unclear what underlying processes
are involved in driving the remodelling of tissues.
1.9.3 Epigenetic mechanisms
The expression of key genes during development is thought to be regulated
by a number of epigenetic mechanisms. Whereby changes in gene expression are
mediated by changes in transcription by modulating access of the transcriptional
machinery to the DNA strands (Langley-Evans, 2008). DNA methylation and histone
acetylation, which control the super-coiling of DNA around the histone proteins
within each chromosome, can decrease and increase transcription of genes. The role
of acetylation in promoting transcription and methylation in promoting silencing, are
thought to be of prime importance in the disease process (Bird, 2002). This section of
the current literature will concentrate on the best characterised epigenetic
mechanisms, DNA methylation and histone modification.
1.9.3.1 History of epigenetics
The term epigenetic was coin by developmental biologist Conrad
Waddington (Van Speybroeck, 2002; Waddington, 1940) in the early 1940s to define
the way in which genes and the environment can influence the mature phenotype.
Waddingtons work stemmed from work on Drosophila melanogaster, showing that
alterations in wing vein patterns could be induced by heat-shock treatment of the
pupae. Breeding of the Drosophila that were particularly susceptible to the heat
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shock treatment resulted in Drosophila that exhibited the phenotype without the
environmental stimulus. This was termed genetic assimilation (Waddington, 1957)
and essentially showed that environmental stimuli may interact with the genome
during plastic stages of development, conveying phenotypical effects that may be
heritable (West-Eberhard, 2003).
Further to this, in 1975 Holliday and Pugh proposed that covalent chemical
DNA modifications at cytosine-guanine dinucleotides such as DNA methylation
were the mechanism behind Waddingtons hypothesis (Holliday and Pugh, 1975).
The discovery that X inactivation and genomic imprinting are also regulated by
epigenetic mechanisms has highlighted the importance of epigenetic mechanisms
within gene regulation (Monk, 1988; Willard et al., 1993).
1.9.3.2 DNA Methylation
DNA methylation (Figure 1.3) is the process by which cytosines are
methylated (addition of a methyl group) after DNA replication and is the best
characterised form of epigenetic marking. The methylation of DNA protects it from
endonuclease degradation and plays a critical role in regulating gene expression
(Waterland and Michels, 2007). The structure of the genome is established during
pre-implantation, in which specific DNA methylation patterns are established. Gene
expression is altered by the methylation of cytosine residues within CpG islands in
the promoter regions of genes (Waterland and Michels, 2007). An increase in CpG
methylation is associated with a decrease in the level of expression, and so is
associated with a restriction of transcriptional potential and silencing of the gene
(Jaenisch and Bird, 2003). DNA methylation is thought to work with other chromatin
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modifications to heritably maintain some areas of the genome in a transcriptionally
silent state (Bird, 2002).
As methyl donors and cofactors necessary for the synthesis of S-
adenosylmethionine, a prerequisite for DNA methylation, are derived from the diet
(Van den Veyver, 2002), it has been hypothesized that early nutrition may influence
adult diseases through modification of DNA methylation (Waterland and Garza,
1999). Interest in DNA methylation and its role within the field of nutritional
programming was stimulated when Waterland and Jirtle (2003) tested the hypothesis
that the methylation status of specific transposable element insertion sites (loci) are
able to be epigenetically programmed by early availability of methyl donors.
Waterland and Jirtle (2003) showed that dietary supplementation of the diets of
yellow agouti (Avy) mice with folic acid, choline, vitamin B12 and betaine, altered
the coat-colour phenotype of the heterozygous offspring via increased CpG
methylation at the Avy locus (Waterland and Jirtle, 2003). This effectively
demonstrated that nutritional factors during fetal development can modify gene
expression. Further to this Sinclair and colleagues (2007) showed differential
methylation of genes in fetal livers by feeding sheep a diet deficient in the methyl
donors, folic acid, vitamin B12 and methionine for 8 weeks prior to conception and
for the first 6 days of pregnancy. This resulted in male offspring exhibiting a
phenotype of elevated blood pressure and insulin resistance. Analysis by Restriction
landmark genome scanning (RLGS) revealed that 4% of the CpG islands within the
fetal liver were differentially methylated and the majority of these differentially
methylated CpG islands were hypomethylated (Sinclair et al., 2007).
Recent research by Lillycrop and colleagues (2005) has demonstrated that the
feeding of a low protein diet during rat gestation results in adult offspring over-
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expressing both peroxisome proliferator activated receptor Į (PPARĮ) and
glucocorticoid receptor (GR) (Lillycrop et al., 2005). The results from the studies by
Lillycrop et al., are comparable with the results of Sinclair and colleagues which
suggest that nutritional insults such as the low protein diet lead to hypomethylation
of DNA and therefore result in the overexpression of key genes in development
(Lillycrop et al., 2005; Lillycrop et al., 2008; Lillycrop et al., 2007).
The reason why nutrition in utero and, specifically the low protein diet, elicits
these effects upon DNA methylation is unknown. Current thinking is that the
expression of DNA methyltransferase 1 (DNMT-1) an enzyme involved in the
establishment and regulation of tissue-specific patterns of methylated cytosines is
down-regulated (Lillycrop et al., 2007). The availability of methyl donors such as
methionine and folic acid may also be of prime importance, as demonstrated by the
work of Sinclair et al., (2007). Supplementation of the low protein diet with folate
during rat pregnancy prevents the establisment of the physiological phenotypes
observed with the low protein diet. It has also been noted to normalize DNA
methylation patterns (Lillycrop et al., 2007; Torrens et al., 2006). Further to this
Rees et al., (1999) found that the feeding of a low protein diet reduced the threonine
concentration in fetal serum without affecting any other amino acid. It is thought that
threonine may be used in the generation of glycine, which is required in many
metabolic pathways during gestation. It is therefore thought to be a limiting nutrient
especially when protein intakes are low. The hypertensive effect of a low protein diet
can be reversed if the diet is supplemented with glycine (Jackson et al., 2002). Rees
et al., (1999) proposed that glycine was important because it was involved in the
metabolism of methionine and homocysteine (Rees et al., 1999). An absence of
38
glycine would cause an accumulation of homocysteine, having implications for DNA
methylation and possibly impacting on programming.
Figure 1.3 Overview of epigenetic mechanisms.
1.9.3.3 Histone modification
It is important to note that DNA methylation is not the only contributor to
epigenetic regulation of gene expression. Chromatin structure, the packing of
genomic DNA through association with proteins (Van Holde, 1998) is also of
importance (Figure 1.3). Indeed there is emerging evidence that both histone
modifications and DNA methylation are intrinsically linked (Cheung and Lau, 2005).
The organisation of chromatin has the ability to restrict the access of nuclear factors
to DNA and recent evidence has suggested that modification of histone proteins via
acetylation, phosphorylation, methylation and ubiquitination essentially alters
chromatin conformation and may play a direct role in the regulation of gene
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expression (Felsenfeld and Groudine, 2003). Indeed evidence from the field of fetal
programming (Lillycrop et al., 2007) demonstrated that hypomethylation and
increased expression of the GR110 promoter are associated with reduced DNMT-1
expression and altered histone modifications of the GR promoter, in the liver of
offspring from rats fed a protein restricted diet in utero. A review of the role histone
modifications play within the field of genetics/epigenetics is beyond the scope of this
thesis. For a comprehensive review of histone modifications please see (Berger,
2002; Iizuka and Smith, 2003; Zhang, 2003).
1.9.4 Epigenetic drift
Epigenetic drift is a process that promotes either DNA hypo- or hyper-
methylation with advancing age. Currently, research within the area of epigenetic
drift and the emergence of age-related phenotypes that develop with age is at a very
early stage. It is suggested that epigenetic drift occurs due to a decline in expression
of DNMT-1, which leads to a demethylation of the whole genome. Specific tissues
may up-regulate DNMT-3b as a result of this de-novo demethylation, causing
hypermethylation in certain gene promoters (Casillas et al., 2003; Fraga and Esteller,
2007). Research into the role epigenetic drift plays within disease development is at a
very early stage but it is clear that epigenetic drift can have severe consequences for
the process of disease through the alteration of gene expression. This mechanism has
been associated with the development of cancers (Casillas et al., 2003) and
Alzheimer's disease (Wang et al., 2008). Previous studies have indicated that gene
expression changes throughout the life course, for example in the rat model of
protein restriction the expression of genes involved in fatty acid synthesis such as
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SREBP-1c were up-regulated with aging, whereas genes associated with fatty acid
oxidation such as PPAR-Į were down regulated with aging. Both these shifts in
expression lead towards progression of the metabolic syndrome and the development
of disease (Erhuma et al., 2007a).
1.10 Transgenerational Programming
Epidemiological studies have indicated that suboptimal nutrition during fetal
development may permanently programme offspring’s susceptibility to chronic
diseases such as CHD and diabetes. However these effects of fetal programming may
not be limited to the first generation, as there is newly emerging evidence that
transgenerational effects may occur, whereby the consequences of deficits in
maternal nutrition are subsequently passed on to the grandchildren (James, 2002).
Pembrey (1996) suggested an intergenerational feed-forward control loop existed,
which linked the health and growth of an individual with the nutrition of their
grandparents (Pembrey, 1996).
1.10.1 Transgenerational programming in humans
Human studies in the field of transgenerational programming are very
limited, as it is unplausible and unethical to directly examine the relationship
between undernutrition in utero and the progression towards disease, time is also a
limiting factor. Therefore human data is generally restricted to retrospective studies
from both man made and natural disasters. Although there is much controversy
surrounding the use of such retrospective data, analysis has revealed some interesting
results.
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Historical records from Sweden show that individuals born in the early
twentieth century had increased mortality due to diabetes if the paternal grandfather
was exposed to excess nutrition during his prepubertal slow growth period (Kaati et
al., 2002). Similar effects were noted in females when the paternal grandmother had
access to abundant nutrition (Pembrey et al., 2006). Similarly studies of the Dutch
Hunger Winter have indicated that the offspring of females exposed to famine in the
first trimester of pregnancy had reduced birth weight (Stein and Lumey, 2000), an
effect which was independent of maternal birth weight. Increased neonatal adiposity
and poor health was noted in the second generation following famine exposure
(Painter et al., 2008).
1.10.2 Transgenerational programming in Animals
To date, several animal models have backed up data from human studies and
demonstrated that environmental factors in utero such as diet have far reaching
consequences for further generations. Beach et al., (1982) was one of the first studies
to report a transgenerational effect when feeding Swiss Webster mice a diet that was
moderately deficient in zinc from day 7 of gestation. It was noted that the offspring
of zinc-deficient mothers had depressed immune function. Furthermore when these
offspring were mated the second and third generation were found to have the same
depressed immune function as their parents, although not to the same degree as the
first generation (Beach, 1982). More recently intergenerational effects have been
noted by Drake et al., (2005) who found that reduced birth weight, glucose
intolerance and elevated hepatic phosphoenolpyruvate carboxykinase (PEPCK)
activity was passed on to the second generation via both the paternal and maternal
lines in the dexamethasone-programmed rat (Drake et al., 2005). Torrens and
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colleagues (2008) have also recently demonstrated that high blood pressure can be
transmitted to the F2 generation following maternal protein restricton during
pregnancy. Impaired vasodilatory response to acetylcholine was also noted in these
animals suggesting that endothelial dysfunction may contribute to the
transgenerational phenotype (Torrens et al., 2008). Transgenerational effects on
adiposity in later life (Zambrano et al., 2005), cardiovascular function (Torrens,
2002) and impaired glucose tolerance (Benyshek et al., 2006; Martin et al., 2000;
Zambrano et al., 2005) have also been noted in the F1 and F2 generations of rats.
Of prime importance is the report by Anyway and colleagues (2005) that
transgenerational effects of male infertility can be transmitted through the male
lineage in rats. Maternal exposure to endocrine disruptors such as vinclozolin during
the period of sex determination and testis development have been shown to induce
defects in offspring fertility due to effects on sperm formation. These effects have
been shown to be transferred down the male line to the fourth generation (Anway et
al., 2005). Differences in DNA methylation patterns have been noted in these
animals (Anway et al., 2005), suggesting epigenetic reprogramming of the germ line
has occurred. Increased susceptibility to kidney and prostate disease, tumour
development and immune system abnormalities have also been noted (Anway et al.,
2006a).
1.10.3 Implications of transgenerational programming
It is well established that maternal undernutrition can establish major effects
upon fetal development and risk of adult disease in the F1 generation. Emerging
evidence from both human and animal studies is providing evidence that the effects
of undernutrition may not be limited to the first generation and as a consequence the
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whole field of fetal programming and specifically transgenerational programming is
of a major concern to public health. In countries such as India and China where
maternal undernutrition has been commonplace for generations, recent economical
and nutritional transition towards a more westernised diet, could mean that such
countries are on the precipice of unavoidable metabolic disease.
1.11 Aims and hypotheses
The hypotheses to be explored in this thesis are:
x The feeding of a maternal low protein diet during gestation will result
in a F1 generation that is hypertensive, and that has a decreased
nephron complement and increased adiposity, as has been observed in
previous studies.
x The phenotype exhibited by the F1 generation will be passed to a
second (F2) and possibly third (F3) generation.
x The postnatal diet will play a critical role in the expression of an
obese, hypertensive and renal impaired phenotype and will be a key
factor in determining disease risk.
x Prenatal diet will programme adverse phenotypes by altering the
expression of key genes associated with tissue development.
x Epigenetic modification of the expression of genes will allow
intergenerational transmission of programmed phenotypes.
In order to fully investigate these hypotheses, a single longitudinal study of
animals exposed to differing levels of fetal nutrition was performed alongside
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behavioural, physiological and chemical analyses which are outlined within chapter
two of this thesis.
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2.0 Materials and Methods
All chemicals and reagents were of analytical grade or better and were
purchased from Sigma-Aldrich (UK), unless stated otherwise in the text. A full list of
suppliers is provided in the Appendix (Chapter 8).
2.1 Animal Procedures
The experiments described in this report were performed under license from
the Home Office in accordance with the 1986 Animals (Scientific Procedures) Act.
The study used rats of the Wistar strain purchased from Charles River (UK). All
animals were housed in plastic cages and subjected to a 12 hour light/dark cycle, at a
temperature of 20-22ÛC. The animals had ad libitum access to food and water at all
times. Animals were assigned to treatment groups and litters culled by using a
random number generator (http://www.graphpad.com/quickcalcs/randomN1.cfm).
Treatment groups and cross remained blind to the investigator during all analyses.
2.1.1 Maternal procedure
Figure 2.1 summarises the overall design of this experiment. Twenty virgin
female Wistar rats were mated with a single stud male at between 180 and 220g.
Upon confirmation of mating by the presence of a semen plug on the cage floor, the
rats were allocated to be fed either a 18% (w/w) casein (control) or a 9% (w/w)
casein (LP) diet throughout gestation, as described previously (Langley-Evans et al.,
1996d). The diets (Table 2.1) were isoenergetic, the difference in protein-derived
energy between the two diets being made up with the addition of carbohydrate
(starch-sucrose 2:1 w/w). During pregnancy animals were weighed and food intake
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was recorded daily. At the time of birth (day 22) animals were transferred to a
standard laboratory chow diet (B&K Universal Ltd, UK).
Figure 2.1: Schematic diagram of study design
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Table 2.1 Formulation of feed given to pregnant rats during pregnancy
Ingredients
CONTROL FEED
18% Casein
LOW PROTEIN FEED
9% Casein
Casein (g/Kg) 180 90
Cornstarch (g/Kg) 425 485
Solkafloc (g/Kg) 50 50
Sucrose (g/Kg) 213 243
Choline Chloride (g/Kg) 2 2
DL-Methionine (g/Kg) 5 5
AIN-76 Minerals (g/Kg) 20 20
AIN-76 Vitamins (g/Kg) 5 5
Corn Oil (g/Kg) 100 100
Energy MJ/Kg 16.76 16.84
Table 2.1 Diet composition presented as (g/Kg). Diets were prepared by mixing dry ingredients, then
binding using water to form a ball of approximately 60g. Diet was then dried at 60°C for 48 hours
prior to use (Langley-Evans et al., 1994). The energy content was determined by bomb calorimetry.
2.1.2 F1 offspring Procedure
At birth, individual pups were sexed by measurement of the ano-genital
distance and weighed. All litters were randomly culled to 8 pups (4 male and 4
female) to ensure a standard plane of nutrition during suckling. At approximately 3
weeks of age offspring were micro-chipped using the Avid micro-chipping system
and allocated into two sub-groups, breeders (B) and nutritional challenge (NC) (2
males and 2 females per group). Breeders and 1 male and 1 female from the NC
group were allocated to a standard chow diet (B&K Universal Ltd, UK, Table 2.2).
Remaining NC animals were allocated to be fed a high fat diet (Table 2.3), the
composition of this diet was identical to that used by Bellinger et al, (2004). All
animals were housed in single sex groups and had ad libitum access to food and
water at all times.
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At approximately 10 weeks of age, 2 randomly chosen males and 2 randomly
chosen females (B sub-group) from each F1 litter were utilised in a breeding
programme for production of the F2 generation. The four animals from each litter
allocated for breeding, were crossed with animals from another litter in order to
produce the four possible crosses from the F1 generation, (Control male x Control
female, LP male x LP female, Control male x LP female and LP male x Control
female, Figure 2.1). Upon confirmation of mating by the presence of a semen plug on
the cage floor the female rats were singly housed and fed standard chow diet until
delivery of the litter.
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Table 2.2 Formulation of B&K Universal standard chow diet
Ingredients Composition
Crude Oil (%) 4.73
Crude Protein (%) 18.68
Crude Fibre (%) 3.48
Ash (%) 5.38
NFE (%) 59.73
Digestible Crude Oil (%) 3.99
Digestible Crude Protein
(%)
16.53
Gross Energy (MJ/Kg) 16.39
Digestible Energy
(MJ/Kg)
14.00
Vitamin A (iu/Kg) 14609.4
Vitamin D3 (iu/Kg) 1504.1
Vitamin E (mg/Kg) 101.9
Thiamin (mg/Kg) 13.5
Riboflavin (mg/Kg) 11.8
Pyridoxine (mg/Kg) 14.4
Vitamin B12 (µg/Kg) 31.5
Vitamin K (mg/Kg) 16.0
Folic Acid (mg/Kg) 2.8
Nicotinic Acid (mg/Kg) 71.3
Pantothenic Acid (mg/Kg) 25.5
Choline (mg/Kg) 1390.2
Inositol (mg/Kg) 1714.0
Biotin (µg/Kg) 357.5
Calcium (%) 0.73
Total Phosphorus (%) 0.70
Magnesium (%) 0.18
Sodium (%) 0.22
Chloride (%) 0.44
Potassium (%) 0.69
Iron (mg/Kg) 87.0
Copper (mg/Kg) 18.3
Manganese (mg/Kg) 86.9
Zinc (mg/Kg) 92.5
Cobalt (µg/Kg) 456.8
Iodine (µg/Kg) 1840.8
Selenium (µg/Kg) 391.8
Lysine (%) 1.10
Methionine (%) 0.33
Linoleic Acid (%) 2.04
Linolenic Acid (%) 0.18
Table 2.2 B&K diet composition, Data obtained directly from B&K Universal Limited.
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Table 2.3 Formulation of diet given to high fat-fed animals
Ingredients HIGH FAT FEED
Casein (g/Kg) 200
Cornstarch (g/Kg) 220
Lard (g/Kg) 295
Sucrose (g/Kg) 100
Solkafloc (g/Kg) 50
DL-Methionine (g/Kg) 10
AIN-76 Minerals (g/Kg) 10
AIN-76 Vitamins (g/Kg) 5
Corn Oil (g/Kg) 100
Energy MJ/Kg 25.12
Table 2.3 Composition of diet used in high-fat feeding (Bellinger et al., 2004). The high fat diet
ingredients were mixed dry and stored at -40°C until needed. The energy content was determined by
bomb calorimetry.
2.1.3 F2 offspring Procedure
At birth, pups were sexed and weighed. All litters were randomised and then
culled to 8 pups (4 male and 4 female) to ensure a standard plane of nutrition during
suckling. At approximately 3 weeks of age offspring were micro-chipped and
randomly allocated into B and NC sub-groups as described above. Breeders and 1
male and 1 female from the NC group were allocated to a standard chow diet (B&K
Universal Ltd, UK). Remaining NC animals were allocated to be fed a high fat diet.
The animals were housed in single sex groups and had ad libitum access to food and
water at all times.
At approximately 10 weeks of age, 1 male and 1 female (B sub-group) from
each litter were crossed with animals from another litter in order to produce the
following crosses based upon the dietary exposures of their parents in the F1
generation: Control male x Control female and LP male x LP female (Figure 2.1).
Upon confirmation of mating by the presence of a semen plug on the cage floor the
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female rats were singly housed and fed standard chow until delivery of the litter.
Male rats were placed back into single-sexed housing with their littermates, until
studied later in life.
2.1.4 F3 offspring Procedure
At birth, pups were sexed and weighed. All litters were randomised and then
culled to 8 pups (4 male and 4 female) to ensure a standard plane of nutrition during
suckling. At approximately 3 weeks of age offspring were micro-chipped and
allocated to a standard chow diet (B&K Universal Ltd, UK). One male and one
female animal were randomly allocated to be fed a high fat diet. The animals were
housed in single sex groups and had ad libitum access to food and water at all times.
2.1.5 High Fat Feeding Procedure
Rats (where possible 1 male and 1 female offspring from each NC sub-group
per litter, in each generation) were randomised to a high-fat feeding protocol to
assess the impact of this nutritional challenge upon subsequent weight gain and body
composition, from approximately 4 weeks of age. The high-fat diet was identical to
that used in our previous work (Erhuma et al., 2007b) and contained 29.5% fat (w/w)
in the form of lard, and comprised 20% (w/w) protein (casein). The gross energy
content of the diet was 25.12 MJ/Kg (Table 2.3). A further group (consisting of 1
male and 1 female offspring from each NC group per litter, in each generation) were
fed a standard laboratory chow diet as a control (Table 2.2). This diet contained 19%
protein, 4.7% fat and had a gross energy content of 16.39 MJ/Kg. All animals from
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this group were housed in pairs and provided with ad libitum access to high fat diet
or standard laboratory chow. At 5, 7 and 9 weeks of age animals were singly housed
and food intake and body weight was monitored for a period of 3 days. Food intake
data is presented corrected for body weight, as in our previous studies of appetite in
this model (Bellinger et al., 2004). This corrects for any influence of body weight
upon food intake, and allows comparison between sexes.
2.2 Aging protocol
Male animals used in production of F2 and F3 generations were retained until
6 months old. Male and female F2 rats not used in the production of the F3
generation were retained until 1-year-old.
2.3 Culling of animals and sample collection
At approximately 10 weeks of age the NC group of animals was killed to
coincide with matings for the next generation. Animals were culled using a rising
concentration of CO2 and cervical dislocation. Liver, heart, kidneys, lungs, spleen,
thymus, hippocampus, hypothalamus, gonadal fat and perirenal fat were rapidly
removed and accurately weighed, then snap-frozen in liquid nitrogen and stored at -
80°C for up to 18 months until used for further analysis. The left kidney was fixed in
formalin for later determination of nephron number.
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2.4 Chemical Analyses
2.4.1 Coefficients of variation (COV)
For all chemical analyses the intra-assay coefficient of variation was
calculated to assess assay variation within each run/batch. The inter-assay coefficient
of variation was calculated to assess day-to-day variation between runs/batches.
COV = Standard Error of Mean × 100%
Mean
2.4.2 Preparation of plasma
Blood samples were collected and centrifuged at 13000rpm, 4°C for 10
minutes in order to separate plasma. The plasma was subsequently removed and
stored at -40°C for up to 6 months until used for analyses.
2.4.3 Determination of circulating metabolites
2.4.3.1 Cholesterol and Triglyceride Assays
Total circulating plasma cholesterol and triglycerides were assayed using
commercially available kits (ThermoTrace, Noble Park, Victoria, Australia),
according to the manufacturer's instructions. A standard curve was produced by
making serial dilutions of the cholesterol/ triglyceride standards contained within the
kit. 10µl of sample (plasma) or diluted standard was transferred in duplicate to a 96-
well plate, 200µl of cholesterol/triglyceride assay reagent was then pipetted into each
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well. The plate was then allowed to incubate at 37°C for 15 minutes. The 96-well
plate was then read at an absorbance of 550nm (reference wavelength 630nm) using
BIO-RAD 680XR Microplate Reader and BIO-RAD Microplate manager software
version 5.2.1, (BIO-RAD, UK). Assay linearity; Cholesterol (20 mmol/L),
WULJO\FHULGHV  PPRO/ $VVD\ VHQVLWLYLW\ &KROHVWHURO  ǻP$ SHU PPRO/
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variation were 4.4% and 3.1% respectively for the triglyceride assay and 2.2% and
3.2% respectively for the cholesterol assay.
2.4.3.2 Glucose Assay
Plasma glucose concentrations were determined in samples from non-fasted
animals, using an adaptation of the glucose oxidase method (Trinder, 1969). A
standard curve was produced by making serial dilutions of the glucose standard (0-
2mg/ml glucose). Samples were diluted 1:5 with phosphate buffer and loaded with
standards in duplicate onto a microtitre plate in 10µl quantities, 200µl of glucose
reagent (Section 8.2.1) was then added to each well. The plate was then incubated at
37°C for 15 minutes and then read at an absorbance of 620nm using Magellan,
Version 4.0 software and plate reader (Tecan, Sunrise). The inter- and intra-assay
coefficients of variation were 7.2% and 3.3% respectively.
2.4.3.3 Insulin (non-fasted)
Plasma insulin concentrations were determined in a 96-well plate using the
Ultra-Sensitive Rat Insulin ELISA kit (Crystal Chem Inc, USA). All reagents and
samples were allowed to reach room temperature prior to analysis. Each well was
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washed twice with 300µl of washing buffer, aspirated manually and blotted dry. 50µl
of Guinea Pig Anti-Insulin and 45µl of diluent was added to each well before 5µl of
sample or standard was added to each well in duplicate. The microplate was then
covered and allowed to incubate at 4°C overnight (16-20 hours). The plate was
aspirated and washed three times with 300 µl of washing buffer per wash and blotted
dry to remove any unbound materials. 100 µl of Anti-Guinea Pig Antibody Enzyme
Conjugate was added to each well. The microplate was then covered and allowed to
incubate at room temperature for 3 hours. Each well was then washed five times with
300 µl of washing buffer and blotted dry after each fresh addition of buffer to
remove any unbound materials. 100 µl of Enzyme substrate solution was added to
each well and allowed to react for 30 minutes at room temperature (avoiding
exposure to light). The reaction was then stopped with the addition of 50 µl of
Enzyme Reaction Stop Solution per well. The plate was then immediately read at a
wavelength of 492nm using the Magellan Version 4.0 computer package and plate
reader (Tecan, Sunrise). Mean concentrations were calculated from the duplicated
raw data quantified from the rat insulin standard curve (range 0-10ng/ml) which
used seven points derived from serial dilutions. The inter- and intra-assay
coefficients of variation for this assay were 9.5% and 8.2% respectively.
2.5 Physical and behavioural studies
2.5.1 Activity Monitoring
Locomotor activity was determined using a Linton AMIU53 Infrared Activity
Monitor (Linton Instruments, Diss, UK). The monitor consists of a grid of 48
infrared beams and sensors set on two levels. Beams may be broken by animal
movement in the X-Y plane or by rearing in the Z plane. Events were recorded by the
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AMlogger software for a total period of 90 minutes. The first 30 minutes were used
to assess the response to a novel environment since animals were transferred from
their home cage to the test cage. After 30 minutes they were regarded as habituated
to the test conditions. Locomotor activity was only assessed during the 12-hour light
phase. Within the test, three types of movement were recorded:
Activity = Breaking any beam on the lower level within 1 second.
Mobility = Breaking More than one beam (50mm apart) on the lower level, within 1
second.
Rearing = Breaking a beam on the upper level recorded in 1 second intervals.
2.5.2 Determination of Blood Pressure
Blood pressure was determined in all animals using an indirect tail cuff
method, as described previously (Sherman and Langley-Evans, 1998). Measurements
were made using an IITC Life Sciences Model 229 Blood Pressure amplifier/ pump
(IITC Inc, Woodlands CA, USA). This instrument allows measurements at a
temperature of 27°C, thereby avoiding heat-stress of the animals. The unheated
animal tail-cuff method has been previously shown to be an accurate and sensitive
technique for the non-invasive measurement of systolic blood pressure in the
conscious rat (Ibrahim et al., 2006; Kubota et al., 2006). All rats were housed at
27°C, in the room where the measurements were made for at least 2 hours prior to
testing. Measurements were made at the same time of day following standard
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procedures to minimise variation due to diurnal changes in blood pressure. Restraint
tubes and tail-cuff sizes were selected to be appropriate for the weight and size of the
animal and the tail-cuff was placed in the standard position at the base of the tail. In
order to minimise the impact of stress during the procedure (Tonkiss et al., 1998),
animals were restrained for no more than 5 minutes at any one time, after the
procedure, the animals were placed directly back in to the home cage with their litter
mates. No training of the rats to the restraint conditions was needed (Sherman and
Langley-Evans, 1998). Blood pressure was determined at 4, 6 and 8 weeks of age.
Measurements were taken in triplicate and an average value was derived for each
animal (Figure 2.2). The inter-assay coefficients of variation (Values obtained from
the same set of animals on different days) and intra-assay coefficients of variations
were 1.39% and 1.42% respectively.
Figure 2.2 Example blood pressure Trace.
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2.5.3 Nephron Number Determination
Nephron number was determined using an adaptation of the acid maceration
method of Welham et al.,(Welham et al., 2002). Although determination of nephron
complement via stereology (Bertram, 2001) is the gold standard method of analysis,
we used maceration in the current study due to the high throughput required (253
samples). Our results and overall effect matched those obtained via stereology in
previous studies of the LP diet in the F1 generation (Zimanyi, 2000). Formalin fixed
kidneys were weighed, cut in half and one portion was then incubated in 1 mol/L
hydrochloric acid at 37°C for 30 minutes. Acid was removed and replaced with 5 ml
of 50mM phosphate buffered saline (PBS; pH 7.4). The tissue was then homogenised
using a bench top homogeniser (Polytron) and a further 5ml of PBS was added to
give a final volume of 10ml. The sample was mixed thoroughly by inversion and a
20µl sample was taken and placed on a microscope slide and overlain with a cover
slip. A ×10 objective lens was used to count all glomeruli in the sample. This was
carried out in triplicate for each tissue sample. The values obtained were averaged
and used to calculate the total number of glomeruli per kidney using the following
equation.
Total Nephron number = Kidney weight× Average count × 500
Sample weight
The inter- and intra-assay coefficients of variations were 2.0% and 2.2%
respectively.
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2.6 Analyses of gene expression
2.6.1 RNA extraction and sample preparation
Rat kidneys were removed at the time of cull, snap-frozen in liquid nitrogen
and stored at -80°C until required for further analysis. Total RNA was isolated from
frozen kidney samples using the Trizol method (Invitrogen, UK). The RNA was
treated with DNase (Promega, UK) and subjected to phenol-chloroform extraction
and ethanol precipitation. RNA concentration was determined
spectrophotometrically (Nanodrop) and RNA integrity was confirmed on a 1%
agarose gel via electrophoresis.
2.6.1.1 Trizol extraction
Frozen rat kidneys stored at -80°C were transferred to a pestle and mortar.
Liquid nitrogen was poured over the kidney sample and it was ground into a fine
powder. Approximately 100mg of frozen crushed tissue was weighed into autoclaved
15ml glass tubes. 1ml of Trizol reagent (Invitrogen, UK) was added, and tissue
was then homogenised using a Polytron homogeniser, which was rinsed between
samples using ddH20. The homogenate was pipetted into autoclaved eppendorf tubes
and centrifuged at 12000 x g for 10 minutes at 4°C. Supernatant was then transferred
to a fresh eppendorf tube, to remove cell debris and incubated at room temperature
(18-30°C) for 5 minutes. 200µl chloroform (Fisher, UK) was added to each sample
and shaken vigorously for 15 seconds to ensure mixing of the contents. Each sample
was then incubated at room temperature for 3 minutes and centrifuged at 12000 x g
for 15 minutes at 4°C. The aqueous phase was transferred to a fresh eppendorf tube
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and 500 µl of isopropyl alcohol was added to precipitate the RNA. The samples were
vortexed and incubated at room temperature for 10 minutes. The samples were then
centrifuged at 12000 x g for 10 minutes at 4°C. The supernatant was then removed
and 1ml of 75% ethanol was added to the resulting RNA pellet and vortexed.
2.6.1.2 DNase Treatment
RNA was treated with DNase to ensure any remaining DNA contamination,
which could affect results during later analysis, was removed. Each sample (RNA
and ethanol) was centrifuged at 13000 x g for 15 minutes at 4°C to produce a pellet.
The ethanol was then removed and the pellet allowed to air-dry for 5 minutes, before
being redissolved in 40 µl RNase free water (Promega, UK), 5 µl DNase 10x buffer
(Promega, UK) and 5 µl DNase (Promega, UK). The samples were then vortexed to
ensure thorough mixing of components and spun down to collect the mixture at the
bottom of the eppendorf tube, and then incubated at 37°C for 30 minutes. 150 µl of
RNase free water and 200 µl of phenol/chloroform/isoamyl alcohol (25:24:1),
(Fisher, UK) were added to each sample, the mixture was again vortexed and
centrifuged at 13000 x g for 5 minutes at 4°C to allow phase separation. The
resulting aqueous layer containing RNA was pipetted into a fresh eppendorf and 15
µl of 3M sodium acetate pH 5.5 and 375 µl of 100% ethanol was added to each tube.
The resulting mixtures were allowed to precipitate overnight at -80°C. The following
morning samples were centrifuged at 13000 x g for 15 minutes at 4°C to pellet the
RNA The supernatant was removed and the RNA pellet was washed by the addition
of 1ml 75% ethanol. The samples were centrifuged for a further 5 minutes. The
ethanol was then removed and the RNA pellet was allowed to air-dry for 5 minutes,
61
before resuspending in 70 µl of RNase free water by passing through a pipette
several times.
2.6.1.3 RNA Quantification
RNA concentration was quantified using a Nanodrop® spectrophotometer
(Thermo, USA). 1 µl of each sample was placed onto the Nanodrop® pedestal and
quantified in duplicate using the Nanodrop® software provided with the
spectrophotometer. The pedestal was then wiped clean with a sterile laboratory
tissue, RNase free water was used as a blank. The Nanodrop® allows accurate and
reproducible quantification of nucleic acid samples upto 3700 ng/µl without dilution,
in samples as small as 1µl. The instrument determines concentration values as well
as 260/280 and 260/230 ratios. RNA samples were then diluted to 500ng/µl by the
addition of RNase-free water.
2.6.2 Pathway focussed DNA microarray:
Gene expression was analysed via DNA MicroArray analysis using the
pathway focussed Oligo GEArray® for rat endiothelial cell biology ORN-015.2
(SuperArray, USA). Microarray technology utilises RNA to determine the expression
levels of several hundred or thousand genes simultaneously. Microarrays are
composed of a number of gene-specific, nucleic acid probes that are immobilised on
a solid membrane. During the microarray procedure (Figure 2.3), RNA is converted
to labelled cDNA/cRNA and then hybridised to the immobilised nucleic acid probes
on the membrane, the labelled cDNA/cRNA bound to each gene-specific spot is
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detected using a chemiluminescent step. The resulting signal produced at each spot
on the membrane is representative of the amount of expression in the original RNA
sample.
Figure 2.3 Overview of Microarray process.
Chemiluminescent detection on
X-ray film
Hybridisation & washing
Target synthesis
and labelling
2.6.2.1 cDNA Synthesis
2.6.2.1.1 Preparation of Annealing Mixture
cDNA synthesis was completed using the recommended TrueLabeling-
AMP2.0 kit (SuperArray, USA). True-labelling primer, 5X cDNA synthesis buffer
and RNase-free water were allowed to thaw and were subsequently mixed and
collected at the bottom of the tube via a brief spin in a microcentrifuge. The reagents
were then placed on ice prior to beginning the procedure. 1 µg of RNA and 1 µl of
True-labelling primer were combined in a sterile PCR tube with the addition of
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RNase-free water to a final volume of 10 µl. Contents of the tubes were mixed by
passing through a pipette tip several times and then briefly centrifuged to collect the
mixture at the bottom of the tube. The tubes were then incubated at 70°C for 10
minutes followed by a brief centrifugation to collect mixture at the bottom of the
tube. The tubes were immediately placed on ice.
2.6.2.1.2 Preparation of cDNA Synthesis Master Mix
4 µl of RNase-free water, 4 µl of 5X cDNA synthesis buffer, 1 µl RNase
Inhibitor and 1 µl of cDNA Synthesis Enzyme Mix were combined in a sterile
eppendorf tube to achieve a final volume of 10 µl per reaction. The master mix was
mixed gently with a pipettor, followed by a brief centrifugation to collect the mixture
at the bottom of the tube. The cDNA Synthesis Master Mix was then placed on ice.
2.6.2.1.3 cDNA Synthesis Reaction
10 µl of cDNA Synthesis Master Mix was added to each tube containing 10
µl of Annealing Mixture and mixed gently with a pipettor followed by a brief
centrifugation to collect mixture at the bottom of the tube. The mixture was then
incubated at 42°C for 50 minutes followed by 75°C for 5 minutes, the mixture was
then cooled and held at 37°C. The mixture was then briefly centrifuged and returned
to 37°C until the addition of the Amplification Master Mix.
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2.6.2.2 cRNA Synthesis, Labeling, and Amplification
2.6.2.2.1 Preparation of Amplification Master Mix
2.5X RNA Polymerase buffer was warmed to room temperature and vortexed
to resuspend any precipitate. The buffer was then briefly centrifuged to collect
material at the bottom of the tube. RNA polymerase enzyme was removed from -
20°C storage and transferred to ice just before use.
16 µl of 2.5X RNA Polymerase buffer, 2 µl of biotinylated-UTP, 10mM
(Roche, UK) and 2 µl of RNA Polymerase were combined at room temperature in a
sterile eppendorf to a final volume of 20 µl per reaction. The master mix was mixed
gently with a pipettor to ensure a homogenous solution and then briefly centrifuged
to collect mixture at the bottom of the tube.
2.6.2.2.2 cRNA Synthesis Reaction
20 µl of Amplification Master Mix was added to each tube containing 20 µl
of cDNA Synthesis Reaction, then gently mixed with a pipettor, briefly centrifuged
and incubated in a PCR block at 37°C overnight.
2.6.2.3 cRNA Purification
2.6.2.3.1 Binding the cRNA to the Spin Column
60 µl of RNase-free water was added to each cRNA synthesis reaction tube to
give a final volume of 100 µl per reaction. Each reaction was then transferred to a
1.5ml RNase-free eppendorf and 350 µl of lysis & binding buffer was added to each
reaction mixture and mixed gently with a pipettor. 350 µl of ACS-Grade 100%
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ethanol (Fisher, UK) was then added to each reaction mixture, which was then mixed
with a pipettor and immediately transferred to the centre of a spin column. The spin
column was then centrifuged for 30 seconds at 8000 x g. The flow-through in the
collection tube was then discarded, and the spin column was placed in a fresh
collection tube.
2.6.2.3.2 Washing the Spin Column
600 µl of washing buffer (containing ethanol) was added to each spin
column, the spin column was then centrifuged at 8000 x g for 30 seconds. The flow-
through was discarded and the spin column was then put into a fresh collection tube.
200 µl of washing buffer was then added. The columns were then centrifuged at
11000 x g for 1 minute, the flow-through discarded and the spin column put back
into the collection tube and centrifuged at 180° from its original orientation for 2
minutes at 11000 x g.
2.6.2.3.3 Eluting the cRNA from the Spin Column
Each spin column was transferred to its own elution tube and 50 µl of room
temperature RNase-free 10mM Tris-HCl Buffer (pH 8.0) was added to the centre of
each spin column. The spin columns were then incubated at room temperature for 2
minutes and subsequently centrifuged at 8000 x g for 1 minute. The purified cRNA
was then stored on ice until quantification.
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2.6.2.3.4 cRNA Quantification and Quality Assesment
Quantification of cRNA was performed using a Nanodrop®
spectrophotometer, as previously described (Section 2.6.1.3). The yield was
determined using the following equation.
Yield = Concentration (µg/µl) × 50 µl
2.6.2.4 Array: Pre-hybridisation
5ml of deionised water was added to each hybridisation tube. The tubes were
then allowed to sit inverted for 5 minutes in order to pre-wet the array membrane.
The GEAhyb Hybridisation Solution was warmed to 60°C and the bottle inverted
several times to allow complete dissolution of the buffer components. The deionised
water was then discarded from the hybridisation tube and 2ml of pre-warmed
GEAhyb Hybridisation Solution was added to each tube. The tube was then vortexed
briefly. The hybridisation tubes were then placed in the hybridisation oven and pre-
hybridised at 60°C for 2 hours with continuous, but slow, agitation (5-10rpm).
2.6.2.5 Array: Hybridisation
To prepare the target hybridisation mixture, 2µg of biotin-labeled cRNA target
prepared using the True-Labeling-AMP 2.0 kit (section 2.6.2.1-2.6.2.3) was added to
an eppendorf containing 750µl of pre-warmed GEAhyb Hybridisation Solution,
mixed well via a pipettor and kept at 60°C. The pre-hybridisation solution was
discarded from the hybridisation tube and the Target Hybridisation Mix containing
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the labelled cRNA target was added to the tube. The hybridisation tube was then
allowed to hybridise overnight at 60°C in the hybridisation oven with continuous,
slow agitation (5-10rpm).
2.6.2.6 Array: Washing
The target hybridisation mix from the hybridisation tube was poured into a
sterile eppendorf. 5ml of Wash Solution 1 was added to each hybridisation tube. The
hybridisation tube was then vortexed and placed back into the hybridisation oven and
the array membrane was washed at 60°C for 15 minutes with fast agitation (28rpm).
The wash solution was then discarded and 5ml of Wash Solution 2 was added to each
hybridisation tube. The tube was then vortexed and placed back in the hybridisation
oven, the membrane was washed for exactly 15 minutes at 60°C, with fast agitation
(28rpm). Wash solution 2 was then discarded and the cap was placed back on the
hybidisation tube to prevent the membrane from drying out. The tube was allowed to
cool to room temperature.
2.6.2.7 Array: Chemiluminescent Detection
2ml of GEAblocking Solution Q was added to each hybridisation tube, the
tube was then vortex briefly and allowed to incubate at room temperature in the
hybridisation oven with fast agitation, for 40 minutes. The GEAblocking Solution Q
was then discarded and 2ml of dilute AP-SA Buffer was added. The tube was then
vortexed and incubated in the hybridisation oven at room temperature for exactly 10
minutes with gentle agitation. The membrane was then washed four times with 4ml
of 1X Buffer F, for 5 minutes, with gentle agitation. The last wash was then
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discarded and the membrane was then washed twice with 3ml of Buffer G. Once
complete, the second wash was discarded and 1ml of CDP-Star Chemiluminescent
substrate was added to each hybridisation tube. The tubes were then placed into the
hybridisation oven and allowed to incubate at room temperature for 5 minutes with
gentle agitation. The membrane was then removed from the hybridisation tube using
sterile forceps. The excess CDP-Star solution was removed from the membrane by
blotting on clean absorbent paper and the membrane was then placed into a re-
sealable plastic bag for image acquisition.
2.6.2.8 Array: Image Acquisition
Image acquisition was carried out by exposure to X-ray film (Amersham
Hyperfilm ECL, UK) within 5 minutes of CDP-Star treatment. Exposure times of 1,
2, and 5 minutes were imaged. Once dry the X-ray film images were photographed
using a CCD camera (BIO-RAD Fluor-S MultiImager and BIO-RAD Quantity
One software version 4.2.1, UK) and saved as a 16 bit TIFF image, the images were
then uploaded to the specially designed web-based GEArray Expression Analysis
Suite (http://geasuite.superarray.com, SuperArray, USA) for analysis. Any gene with
either a two-fold increase in expression or a 50% decrease in expression compared to
control samples was considered for further analysis.
2.7 DNA Methylation Assay
2.7.1 DNA Isolation (Qiagen, DNeasy: Animal Blood and Tissue kits)
25mg of crushed and frozen rat kidney was placed in a 1.5ml eppendorf, 180
µl of ATL Buffer and 30 µl of Proteinase K were then added, the mixture was then
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incubated at 56°C and vortexed every 30 minutes until completely lysed (4 hours).
After lysis each sample was vortexed for 15 seconds, then 200 µl of Buffer AL and
200 µl of 100% ethanol (Fisher, UK) was added to each sample. The sample was
then vortexed thoroughly. Each sample was then pipetted into a DNeasy Mini spin
column (Qiagen) in a 2ml collection tube and centrifuged at 6000 x g for 1 minute.
The flow-through was then discarded and the spin column was placed in a fresh
collection tube. 500 µl of Buffer AW1 was then added to the spin column, which was
then centrifuged at 6000 x g for 1 minute. The flow-through was discarded and the
spin column was placed in a fresh collection tube. 500 µl of Buffer AW2 was then
added to each spin column which was then centrifuged at 20000 x g for 3 minutes.
The flow-through was discarded and the spin column was carefully transferred to a
sterile 1.5ml elution tube. 200 µl of elution buffer AE was then added to each spin
column. The column was allowed to incubate at room temperature for 1 minute,
before being centrifuged at 6000 x g for 1 minute. DNA quality and quantity was
analysed using the Nanodrop® spectrophotometer as described in section 2.6.1.3.
DNA samples were then diluted to 50ng/µl.
2.7.2 Cytosine extension assay
The cytosine extension assay (Maloney et al., 2007; Pogribny et al., 1999) is
a method for analysing global DNA methylation The assay utilises a methylation
sensitive restriction endonuclease (HpaII) and its isochizomerMspI, combined with a
single nucleotide extension with radiolabeled [3H]dCTP. Both enzymes recognise
the restriction site 5‘-CCGG-3' , however HpaII is methylation sensitive and
therefore only cuts unmethylated DNA whereas MspI cuts DNA regardless of its
methylation status. The 5‘-CCGG-3' restriction site recognised by both HpaII and
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MspI occur randomly throughout the genome. Once radio-labelled the difference
between the two restriction endonucleases can be used to work out global
methylation.
1µg of genomic DNA was digested with the restriction enzymes MspI and
HpaII, DNA was also mock digested with water as an internal control. Each
digestion was done in triplicate in a mixture of 0.4µl bovine serum albumin
(BSA),(Promega, UK), 6µl of the appropriate restriction enzyme buffer (Promega,
UK), 3 µl of appropriate restriction enzyme (Promega, UK) or water and 0.6 µl of
ddH20 (Sigma, UK) to make a final volume of 30 µl per reaction. The reaction was
incubated overnight at 37°C. 15 µl of each digested DNA sample was then
transferred to a fresh eppendorf where 40µl of cytosine extension master mix
containing 10µl DNA polymerase buffer (Promega, UK), 4µl of 25mM magnesium
chloride (Promega, UK), 0.25µl DNA Polymerase (Promega, UK), 25.6744µl ddH20
and 0.0756µl of 250µCi [3H]dCTP, specific activity 59.0 Ci/mmol, (Amersham, UK)
per reaction. The mixture was then incubated at 56°C for 1 hour before being cooled
on ice for 5 minutes. 10µl of each reaction was then transferred to DE-81 ion
exchange filters (Whatman, UK) and washed three times with 300µl of 0.5M sodium
phosphate buffer, pH 7.0. The filters were then washed with 150µl of 75% ethanol
(Fisher, UK) and allowed to air dry for 30 minutes. The filters were then transferred
to scintillation vials where 4ml of scintillant (Perkin-Elmer, UK) was added. The
incorporation of [3H]dCTP was then counted using a TRI-CARB 2100TR liquid
scintillation analyzer (Perkin-Elmer, UK). The counts for the mock digestion were
considered as the background count for that DNA sample and were subtracted from
both the MspI and HpaII counts. In order to normalise the data for inconsistent
amounts of starting material, for each sample, the ratio between the HpaII and MspI
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counts were determined as an index of DNA methylation. The inter- and intra-assay
coefficients of variation for MspI and HpaII were 0.85%, 2.34%, 0.60% and 1.81%
respectively.
2.8 Quantitative Reverse Transcriptase polymerase chain reaction (RT-PCR)
RT-PCR was used to detect the expression of mRNA for Matrix
metallopeptidase 9 (MMP9), Granzyme B (GZMB), Interleukin 7 (IL-7),
Endothelial cell growth factor 1 (ECGF1) and Endothelin receptor type A (EDNRA)
mRNA in rat kidneys. This was done as a two step process therefore allowing both
the reverse transcriptase step and the polymerase chain reaction step to be optimised
independently. Rat Kidneys were removed at time of cull as described previously
(section 2.6.1) and stored at -80°C until further analysis was required. Total RNA
was isolated from frozen tissues via the Trizol method (section 2.6.1.1), RNA was
DNase treated (section 2.6.1.2) and quantified using the Nanodrop
spectrophotometer (section 2.6.1.3), RNA integrity was confirmed on a 1% agarose
gel via electrophoresis.
2.8.1 Annealing oligo primer to RNA (Reverse Transcriptase Reaction)
The reverse transcriptase reaction synthesises complementary strand DNA
(cDNA) from single stranded RNA. 5.33µl of 0.1µg/µl DNase treated total RNA,
1.06µl of Random Primers (Promega, UK) and 9.6µl of ddH20 (Sigma, UK) was
added to a Thermo-Fast® 96 well detection plate (ABgene) to make a total volume
of 16 µl per well, the detection plate was then sealed and placed in a PCR block
72
(Applied Biosystems, UK) and incubated at 70°C for 5 minutes followed by 4°C for
15 minutes. The detection plate was then put on ice and 1µl of each reaction on the
detection plate was transferred to a second detection plate which was then sealed and
stored on ice for –RT analysis (section 2.8.2.1), the remaining 15µl was used for
+RT analysis (section 2.8.3.1).
2.8.2 -RT Reaction (Contamination Control)
The –RT reaction was used to confirm there was no contamination of
genomic DNA within the RNA. 14µl of ddH20 (Sigma, UK) was added to each well
containing 1 µl of reaction mixture from the annealing of the oligo primer to RNA
(section 2.8.1). For multiple reactions a master mix (Table 2.4) was made and then
mixed and 10µl added to the diluted primer/RNA mix in each well of the detection
plate.
Table 2.4 –RT Mastermix (All reagents supplied from Promega, UK)
Reagent Volume Final concentration
MMLV Reverse
Transcriptase buffer (×5)
5 µl -
Nucleotides (dNTPs)
10mM of each
1.25 µl 0.5mM
RNase inhibitor 0.5 µl 25U
MMLV Reverse
Transcriptase
No Enzyme
ddH20 (RNase/DNase
free)
3.25 µl -
Total volume 10 µl -
The contents of each well (final volume 25 µl) were mixed gently with a
pipette, sealed and incubated at room temperature for 10 minutes before being placed
in a PCR block (Applied Biosystems, UK) and incubated at 42°C for 60 minutes.
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After incubation each well within the detection plate was diluted by adding 75 µl of
ddH20 (Sigma, UK), mixed with a pipette, labelled as “Stock -RT” and stored at -
20°C.
2.8.2.1 -RT Analysis
5µl of each –RT reaction was transferred to a separate well in a 384 well
plate detection plate. A probe mastermix (Table 2.6) containing ȕ-actin primers and
probes was made, vortexed and spun down. 10µl of the probe mastermix was then
added to each well containing 5µl of –RT reaction. The plate was then sealed and
spun down, and was then analysed using a standard probe run protocol on the
Lightcycler 480 and software version 1.5 (Roche, UK). Any samples showing
positive fluorescence were noted and omitted when pooling cDNA (section 2.8.4).
2.8.3 +RT Reaction
The annealed primers in the remaining 15 µl of reaction mixture (Section
2.8.1) are extended using the Moloney Murine Leukemia Virus (MMLV) reverse
transcriptase. For multiple reactions a master mix (Table 2.5) was made and 10µl
added to the primer/RNA mix in each well of the detection plate.
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Table 2.5 +RT Mastermix. (All reagents supplied from Promega, UK)
Reagent Volume Final concentration
MMLV Reverse
Transcriptase buffer (×5)
5 µl -
Nucleotides (dNTPs)
10mM of each
1.25 µl 0.5mM
RNase inhibitor 0.5 µl 25U
MMLV Reverse
Transcriptase
1 µl 200U
ddH20 (RNase/DNase
free)
2.25 µl -
Total volume 10 µl -
The contents of each well (final volume 25 µl) were mixed gently with a
pipette, sealed and incubated at room temperature for 10 minutes before being placed
in a PCR block (Applied Biosystems, UK) and incubated at 42°C for 60 minutes.
After incubation each well within the detection plate was diluted by adding 75 µl of
ddH20 (Sigma, UK), mixed with a pipette, labelled as “Stock +RT” and stored at -
20°C.
2.8.3.1 +RT Analysis
5µl of each cDNA sample synthesised during +RT step (section 2.8.3) was
transferred to a separate well in a 384 well detection plate. A probe mastermix (Table
2.6) containing ȕ-actin primers and probes was made, vortexed and spun down. 10µl
of the probe mastermix was then added to each well containing 5µl of +RT reaction.
The plate was then sealed and spun down and then analysed using a standard probe
run protocol on the Lightcycler 480 and software version 1.5 (Roche, UK). Any
samples which had a fluorescence value either two standard deviations higher or
lower than the mean fluorescence were noted and omitted when pooling cDNA
(section 2.8.4).
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2.8.4 Production of pooled cDNA
25µl of each sample that was not omitted during the –RT (section 2.8.2.1)
and +RT (Section 2.8.3.1) analysis was pooled together to from a Pooled cDNA
sample that was then used to generate a standard curve for each gene of interest
during qPCR analysis.
2.8.5 Sample dilution
The pooled cDNA produced in section 2.8.4, was diluted 1:2, 1:4, 1:8, 1:16,
1:32, 1:64 and 1:128, 5µl of each dilution was transferred in triplicate to a 384 well
detection plate, 10µl of ȕ-actin probe mastermix was then added to each well as
previously described (section 2.8.2.1). The plate was then sealed and spun down. The
plate was then analysed using a standard probe run protocol on the Lightcycler 480
and software version 1.5 (Roche, UK). The dilution factor of 1:8 was found to be the
optimum dilution for sample analysis. All + RT samples were then diluted 1:8 with
molecular grade ddH20 (Sigma, UK).
2.8.6 Quantitative Polymerase Chain Reaction (qPCR)
This reaction used the diluted cDNA from section 2.8.5. The Roche
lightcycler® 480 was used to amplify cDNA samples. The Lightcycler system is a
fluorophore-based real time PCR system which allows highly accurate qualitative
and quantitative detection of varying mRNA levels in samples via fluorescence. The
fluorescence is produced via a probe which is a single-stranded oligonucleotide
complementary to a segment of nucleotides within the cDNA template located
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between two primers. The probe has a fluorophore (eg 6-carboxyfluorescein (FAM))
on the 5’ end of the probe and a quencher (e.g. tetramethylrhodamine, (TAMRA)) on
the 3’ end. The close proximity of the quencher and fluorophore inhibits
fluorescence. However, during qPCR Taq polymerase degrades the probe releasing
the fluorophore which is then allowed to fluoresce. The amount of fluorescence is
therefore directly proportional to the amount of product formed during the course of
the qPCR reaction (Livak et al., 1995). All qPCR reactions were set up in 384
multiwell plates (Roche, UK). All samples and standards were run in triplicate. A
mastermix was prepared for each plate (Table 2.6).The master mix was vortexed and
centrifuged. 10 µl of mastermix was then added to 5 µl cDNA sample in a 384 well
plate format. A different mastermix was required for each gene of interest/ primer
and probe set. Each 384 well plate was then sealed, spun down and run on a standard
probe run protocol on the Lightcycler 480 and software version 1.5 (Roche, UK).
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Table 2.6 Probe Mastermix. (Lightcycler® 480 probes master mix was supplied by
Roche, UK, primer and probe sets were obtained from MWG, UK)
Reagents Volume
Lightcycler® 480 probes master mix 7.5 µl
Forward Primer 0.45 µl
Reverse Primer 0.45 µl
Probe 0.3 µl
ddH20 (Sigma, UK) 1.3 µl
Total volume 10 µl
2.8.6.1.1 Design of Primers and probes
Primer and probe sets were required for MMP9, GZMB, ECGF1 and
EDNRA. Gene sequences for these genes were found using Ensemble database
http://www.ensembl.org/index.html accession numbers can be found in Table 2.7
along with primer and probe sequences. Primer and probe sets were designed using
Primer Express software version 1.5 (Applied Biosystems, UK). mRNA
expression data was normalised via the use of the housekeeping gene 36B4.
Housekeeping genes are transcribed at a relatively constant level in several species
and across many or all known conditions. The housekeeping gene's products are
typically needed for maintenance of the cell. Their expression is unaffected by
experimental conditions.
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Table 2.7 Primer and probe sequences.
Gene Accession
number
Forward Primer
¶ĺ¶
Reverse Primer
¶ĺ¶
Probe
¶ĺ¶
MMP9 ENSRNOG000
00017539
TGGCACCATCATAACA
TCACCT
TM = 58, GC= 46%
GAGTCATCGATCACGT
CTCGC
TM = 61, GC= 57%
TGGATCCAAAGCTACAC
CGAAGACTTGC
TM = 66, GC= 50%
GZMB ENSRNOG000
00032868
TGTGCTGACTGCTGCT
CACTG
TM = 61, GC= 57%
TGTTCTTTGATGTTGT
GGGCC
TM = 58, GC= 48%
TCGGGAAGCAAAATAA
ATGTCACGTTGG
TM = 64, GC= 43%
ECGF1 ENSRNOG000
00032394
CTGCGGGACCTGGTCA
TT
TM = 58, GC= 61%
GGTCTTGGGTTTCTGC
CTGTC
TM = 61, GC= 57%
CTAGGAGGCGCCATTCT
TTGGCTTAGC
TM = 68, GC= 56%
EDNRA ENSRNOG000
00012721
TTGCCCTCAGCGAACA
CC
TM = 58, GC= 61%
CAACCAAGCAGAAGA
CGGTCT
TM = 60, GC= 52%
CAAGCAGCGTCGAGAG
GTGGCA
TM = 66, GC= 64%
IGF2 ENSRNOG000
00020369
CAAGCGGACCCGACC
T
TM = 59, GC= 75%
TGAGAAGCACCAACA
TCGACTT
TM = 58, GC= 45%
CGGCCTTGCGGTACCAA
TGGG
TM = 69, GC= 65%
36B4 -
GCTTCATTGTGGGAGC
AGACA
TM = 57, GC= 52%
CATGGTGTTCTTGCCC
ATCAG
TM = 56, GC= 52%
TCCAAGCAGATGCAGCA
GATCCGC
TM = 64, GC= 58%
2.9 Power Calculations
Statistical power was assessed if the hypothesis was rejected due to a non-
significant difference and the test group differed from the control group by 25% or
more. Power calculations were performed using the online researcher’s toolkit
sample size calculator http://www.dssresearch.com/toolkit/spcalc/power_a2.asp
(DSS Research). Means and standard deviations were calculated using SPSS (version
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14.0). The probability of a type I error (Į) was set at 0.05 and of a type II error (ȕ) set
at 0.10, to give a power (ȕ-1) of 0.90.
2.10 Statistical Analysis
All data was analysed using the Statistical Package for Social Sciences
(SPSS, Inc, Chicago, IL, Version 14.0). Differences between groups were assessed
using a mixed model ANOVA (fixed factors, maternal diet/ mating cross, sex and
age), unless otherwise indicated in the text. Values are expressed as mean ± S.E.M.
P<0.05 was considered as significant. Analysis of data arising from fetal
programming studies needs to be robust in order to avoid errors associated with
within-litter effects (Osmond et al., 2005; Walters and Edwards, 2003). As the
present study utilised multiple pups from the same dam, litter of origin was included
as a fixed nested factor in all analyses (Festing, 2006). Analyses were performed
within generations, with no consideration of influences between generations, except
for a comparison of blood pressure across the three generations. Within each
generation the 18% casein control diet (F1), or the Con x Con breeding cross (F2 and
F3) was used as the control group. In order to maintain litter of origin within the
analyses Post hoc testing was not possible.
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3.0 Maternal protein restriction during pregnancy and postnatal High Fat
Feeding- body composition
3.1 Introduction
As previously discussed (section 1.7), a range of animal models have been
used in order to study the basic physiological principles of the fetal programming
hypothesis. The sheer variety and complexity of experimental models has been a key
factor in the search for the mechanistic association between pre- and postnatal factors
and their physiological impact in later life (Langley-Evans et al., 1996b; Rajakumar
et al., 1998; Vickers et al., 2000; Woodall et al., 1996b). Most experimental work
undertaken has concentrated on a restriction of fetal growth (Rajakumar et al., 1998;
Woodall et al., 1996b), contrary to the fact that epidemiological studies suggest that
the phenomenon of fetal programming occurs within a normal distribution of birth
weights and sizes (Barker, 1994). The assumption has been that the stimuli which
impair growth will simultaneously induce fetal programming (Langley-Evans, 2004).
Alterations to maternal diet, particularly the feeding of a maternal low protein (MLP)
diet are commonly used to elicit intrauterine growth retardation (IUGR) in a
experimentally efficient and reproducible way (Langley-Evans, 2000, 2001;
Langley-Evans et al., 1996b). It is however important to note that offspring of
animals exposed to a 9% casein MLP diet during gestation are of similar
birthweights to controls (Langley-Evans et al., 1996b) emphasising the complexity
of the issue.
The feeding of a low protein diet during rat gestation has been shown to have
an extensive effect on fetal development (Langley-Evans, 2001; Langley-Evans et
al., 2003). The postnatal outcomes for offspring exposed to MLP diet during
gestation have been widely studied (section 1.8) and the timing of LP intervention
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has proved to be an essential determinant of programmed effects (Langley-Evans et
al., 1996b; Langley-Evans and Nwagwu, 1998).
Previous work on the MLP diet has demonstrated that MLP exposed
offspring of the F1 generation consume significantly less than controls when fed a
chow diet postnatally. However they have greater energy intake when placed on self
selection diets (Bellinger and Langley-Evans., 2005). Indeed previous studies have
indicated that MLP exposed animals exhibit altered appetite preferences, with a
preference for higher fat, more energy dense food types (Bellinger et al., 2004). HF
diets have been routinely used by several research groups in order to induce obesity
following maternal dietary change (Ortmann et al., 2003; Ozanne et al., 2004;
Vickers et al., 2000). Previously, Vickers and co-workers (2000) reported
hypertension, hyperphagia and obesity in F1 offspring following severe maternal
nutrient restriction (70% of ad libitum food intake) throughout gestation. Vickers et
al., (2000) noted differences in feeding behaviour and weight gain between
adequately nourished and undernourished groups of offspring (Vickers et al., 2000).
It was noted that weight gain and adiposity could be amplified by the manipulation
of the postnatal diet, and that symptoms associated with the development of the
metabolic syndrome were greatest in animals that were both nutrient restricted in
utero and then fed a hypercaloric or high fat diet postnatally (Vickers et al., 2000).
Bellinger and colleagues noted that F1 MLP-exposed animals were hypophagic,
however, when offered a self-selection diet they consumed more energy than control
offspring. This suggested that the animals had a hyperphagic tendency when offered
an energy dense diet (Bellinger, 2005; Bellinger et al., 2004) which is similar to the
observations noted by Vickers and colleagues (2000). Very little evidence exists with
relation to food intake and preferences in MLP restricted animals of the F2 and F3
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generations, Work by Zambrano and colleagues (2005) has indicated that there is no
difference in food intake within the F2 generation (Zambrano et al., 2005).
Body composition of the F1 generation following maternal protein restriction
is well documented. Previous studies have indicated that adult body composition
does not appear to differ between MLP exposed animals and control animals,
although there is some evidence that MLP exposed male rats deposit more gonadal
fat with aging (Bellinger et al., 2004). Currently no data exists on the body
composition of the F2 and F3 generations following maternal protein restriction
during gestation.
The work described within this chapter aimed to explore the potential impact
of a postnatal high fat (HF) diet (Western diet), against the background of prenatal
undernutrition. Dietary challenges in postnatal life have been used previously to
show their importance in the manifestation of programmed disease and obesity states
(Bellinger et al., 2004; Breier et al., 2001; Jones, 1983; Vickers et al., 2000). Similar
approaches were used in this study, as increased food intake may be important in the
development of obesity and onset of adult diseases such as CVD and type II diabetes.
It was hypothesised that a more palatable energy dense diet would unmask any
programmed hyperphagia in the MLP crosses of the F2 and F3 generations.
3.2 Objectives
Previous literature in this area has concentrated on the physiological and
metabolic profile of MLP-exposed F1 generation offspring, fed a high fat diet
postnatally. This study seeks to explore the effects the prenatal protein insult has for
83
further generations (F2 & F3), utilising a well-established and characterised animal
model of nutritional programming. The main aims of this chapter were to:
x Assess, using a variety of techniques, possible changes to body
composition of the F2 and F3 generations brought about by the
exposure to a MLP diet in the F0 generation.
x Utilise a postnatal HF diet to expose programmed hyperphagia in
MLP crosses of the F2 and F3 generations.
x Use a variety of physiological, biochemical and analytical techniques
to determine possible changes to body composition of the F2 and F3
generations brought about by the programmed hyperphagia.
3.3 Materials and methods
3.3.1 Animal Procedures
Virgin Wistar rats were mated and randomly allocated to be fed either a
control diet (n=10) or a LP diet (n=10) (as described in section 2.1.1) throughout
gestation. At birth, dams were returned to standard laboratory chow (section 2.1.1)
and resulting offspring were culled to 8 animals per litter (section 2.1.2). Upon
weaning (as described in section 2.1.2), rats were randomly allocated to either HF
(section 2.1.5) or standard chow diet (Table 2.2) until the time of cull (section 2.3).
F2 and F3 generations were produced as described in sections 2.1.3 & 2.1.4 and once
again randomly allocated to be fed either HF or standard chow diet postnatally. F2
and F3 generation offspring were also culled at 10 weeks of age (section 2.3).
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3.3.2 Food Intake and weight measurements
Food intake was monitored in all animals for a period of 3 consecutive days
at 5, 7 and 9 weeks of age, animals were singly housed during this time (section
2.1.5). Animals were also weighed at weekly intervals until the time of cull (10
weeks).
3.3.3 Biochemical endpoints
Glucose concentrations in plasma from non-fasted rats were analysed using
the Trinder method of enzymatic colorimetric analysis (section 2.4.3.2). Plasma
triglyceride and cholesterol concentrations were analysed using a commercially
available kit (section 2.4.3.1) and non-fasted insulin concentrations were analysed
using a commercial ELISA kit (section 2.4.3.3).
3.3.4 Statistical analysis
All data is presented as mean ± SEM, and was analysed using the Statistical
Package for Social Sciences (SPSS) version 14. Differences between groups were
assessed using a mixed model ANOVA (fixed factors, maternal diet, sex, diet and
age), unless otherwise indicated, P<0.05 was considered as significant.
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3.4 Birth Outcomes
The number of successful pregnancies, litter size, birth weight and the ratio of
male to female offspring was unaffected by maternal diet or mating cross in all 3
generations when compared to Con animals (data not shown). Average litter size was
fourteen, with a ratio of seven males to seven female offspring.
3.4.1 Growth Curves
Figure 3.1 Growth Curve of the F1 generation.
Figure 3.1 Data is shown as mean ± SEM, for Control diet male chow (n=10 male HF (n=10); female
chow (n=10 female HF (n=9). MLP diet male chow (n=8); male HF (n=10); female chow (n=9) and
female HF (n=11).
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Figure 3.2 Growth curves of the F2 generation.
Figure 3.2 Data is shown as mean ± SEM, Graph A represents F2 generation male growth curve. For
Con x Con chow (n=11); Con x Con HF (n=11); MLP x MLP chow (n=13); MLP x MLP HF (n=10);
MLP x Con chow (n=6); MLP x Con HF (n=7) Con x MLP chow (n=8) and Con x MLP HF (n=8).
Graph B represents F2 generation female growth curve. For Con x Con chow (n=11); Con x Con HF
(n=11); MLP x MLP chow (n=7); MLP x MLP HF (n=11); MLP x Con chow (n=10); MLP x Con HF
(n=8) Con x MLP chow (n=8) and Con x MLP HF (n=8).
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Figure 3.3 Growth curve of the F3 generation.
Figure 3.3 Data is shown as mean ± SEM. For male Con x Con chow (n=11); Con x Con HF (n=11);
MLP x MLP chow (n=7) MLP x MLP HF (n=8); female Con x Con chow (n=9); Con x Con HF
(n=9); MLP x MLP chow (n=8) and MLP x MLP HF (n=8).
3.5 Food Intake
3.5.1 F1 generation
Table 3.1 shows food intake (grams per day per kilogram body weight) of the
F1 generation offspring at 5, 7 and 9 weeks of age. Food intake was similar in
animals exposed to both control and MLP diets in utero at all time points monitored.
In both maternal dietary groups, food intake was similar in males and females at 5, 7
and 9 weeks of age. When maintained on a HF diet, 5 week-old animals, irrespective
of sex, substantially lowered their food intake by approximately (two-fold) 50%
(P<0.001) compared to chow fed animals. This trend continued at 7 (P<0.001) and 9
(P<0.001) weeks of age although the difference in food intake did become less
pronounced.
Table 3.3 shows energy intake (MJ per day per kilogram body weight) in the
F1 generation offspring at 5, 7 and 9 weeks of age. Energy intakes were similar in
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both maternal dietary groups at 5, 7 and 9 weeks of age. Energy intakes were also
similar in males and females at all time points monitored. When fed the HF diet, both
male and female animals initially lowered their energy intakes (P<0.05) by
approximately 10% at 5 weeks of age. However, by 7 weeks of age energy intakes
had returned to values comparable to that of animals fed a chow diet, at 9 weeks of
age no difference in energy intake between postnatal dietary groups was noted.
3.5.2 F2 generation
Table 3.2 shows food intake (grams per day per kilogram body weight) of the
F2 generation offspring at 5, 7 and 9 weeks of age. Food intake at 5 weeks of age in
the F2 generation was influenced by an interaction of mating cross and postnatal diet
(P<0.05). Food intake was greater (P<0.05) in the MLP x Con and MLP x MLP
mating cross male animals maintained on a chow diet, compared to controls (Con x
Con), However female animals exhibited a decrease in food intake in all MLP
mating crosses compared to controls. The feeding of the HF diet substantially
increased (P<0.05) food intake in the MLP x Con mating cross in both male and
female animals relative to all other mating crosses. At 7 weeks of age food intake
patterns were similar to that seen in 5 week old animals. Food intakes of male and
female animals fed a chow postnatal diet were similar to controls (Con x Con) in all
mating crosses. When fed the HF diet there was a marked increase (P<0.05) in food
intake (approximately 10%) in the MLP x Con mating cross compared to all other
mating crosses, in both male and female animals. At 9 weeks of age food intake was
similar among all mating crosses. Intake was also similar in male and female
animals. The feeding of a HF diet substantially reduced (P<0.001) grams intake per
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day per kilogram bodyweight in both male and female animals, compared to animals
fed a postnatal chow diet.
Table 3.4 shows the energy intakes (MJ per day per kilogram body weight) in
the F2 generation offspring at 5, 7 and 9 weeks of age. Energy intake at 5 weeks of
age was similar among male and female animals fed a chow diet irrespective of
mating cross. However, when fed the postnatal HF diet, energy intakes were reduced
(P<0.05) by approximately 20% in both male and female animals in all groups,
except the MLP x Con mating cross. At 7 weeks of age the trend was similar to that
seen at 5 weeks. Energy intakes were similar among male and female animals fed a
postnatal chow diet irrespective of mating cross. However, when fed the postnatal
HF diet energy intakes lowered (P<0.05). The decrease seen at 7 weeks of age was
less severe (approximately 10%) than was noted previously at 5 weeks of age. At 9
weeks of age, energy intakes were similar among all mating crosses irrespective of
sex and postnatal diet.
3.5.3 F3 generation
Table 3.5 shows food intake in the F3 generation offspring at 5, 7 and 9
weeks of age. At 5 weeks of age food intakes were similar in all animals regardless
of sex and mating cross when fed the postnatal chow diet. However, when fed the
postnatal HF diet, intakes were lower (P<0.05, approximately 35%) compared to
animals fed the postnatal chow diet. This decrease continued at 7 weeks of age, with
both male and female animals from the Con x Con mating cross exhibiting a lower
food intake of around 35%. However, the lower intake in the MLP x MLP mating
cross by this time had generally become less severe (approximately 25%). No
difference in intake related to mating cross or sex, was noted in 7-week-old animals
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fed on a postnatal chow diet. At 9 weeks of age, food intakes were similar in both
male and female animals irrespective of mating cross. Postnatal HF feeding lowered
(P<0.001) food intake in male and female animals by approximately 40% in both
Con x Con and MLP x MLP groups.
Table 3.6 shows energy intake (MJ per day per kilogram body weight) in the
F3 generation offspring at 5, 7 and 9 weeks of age. Energy intake at 5 weeks of age
was similar among both male and female animals regardless of mating cross and
postnatal diet. By 7 weeks of age energy intakes had reduced from values attained at
5 weeks. Energy intake was similar in both male and female animals and was
unaffected by mating cross and postnatal diet. At 9 weeks of age energy intakes
remained unaffected by mating cross. Postnatal HF feeding reduced (P<0.05) energy
intake in both male and female animals.
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Table 3.1 F1 generation food intake at 5, 7 and 9 weeks of age.
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Control Chow 11 183.2±11.4 129.9±9.1 107.6±11.7 9 180.7±6.9 130.3±4.0 117.9±8.8
Control HF 10 105.6±3.5 81.4±2.2 64.3±3.0 10 116.1±10.2 101.1±11.0 82.9±5.5
MLP Chow 8 195.9±11.9 132.9±6.2 98.4±2.9 9 202.7±13.6 145.4±7.4 118.7±4.9
F1
MLP HF 10 101.3±8.2 91.5±9.4 81.5±12.2 11 110.6±7.8 81.1±2.9 76.9±6.2
P for effect of maternal diet (F1) NS NS NS - NS NS NS
P for effect of postnatal diet (F1) P<0.001 P<0.001 P<0.001 - P<0.001 P<0.001 P<0.001
P for effect of sex (F1) NS NS NS - NS NS NS
P for interaction of maternal x postnatal
diets (F1)
NS NS NS - NS NS NS
Data shows mean ± SEM for n observations per group. Data are represented as grams per day per kilogram body weight. NS= not significant.
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Table 3.2 F2 generation food intake at 5, 7 and 9 weeks of age.
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Con x Con Chow 11 175.8±7.8 118.4±5.4 81.0±8.3 11 204.9±37.3 121.5±4.9 89.5±10.9
Con x Con HF 11 97.3±1.8 72.4±3.2 74.5±15.1 11 101.9±7.7 77.6±4.3 63.5±2.1
Con x MLP Chow 8 171.2±14.2 123.1±7.3 98.9±2.9 8 169.8±22.9 121.9±8.5 118.8±4.6
Con x MLP HF 8 94.6±5.9 82.0±5.4 68.7±14.2 8 91.9±7.1 78.7±5.7 67.6±3.9
MLP x Con Chow 6 182.5±14.6 132.8±11.9 97.4±6.3 10 195.8±40.4 118.7±4.8 112.5±6.8
MLP x Con HF 7 120.9±12.3 87.4±10.3 55.6±3.2 8 129.5±30.7 87.3±7.4 59.7±3.1
MLP x MLP Chow 13 194.9±7.0 122.6±4.1 89.6±1.8 7 197.3±9.4 118.3±6.9 100.4±4.8
F2
MLP x MLP HF 10 91.2±7.2 80.7±6.7 59.8±2.5 11 79.1±6.4 73.7±2.6 70.2±5.6
P for effect of mating cross (F2) P<0.05 P<0.05 NS - P<0.05 P<0.05 NS
P for effect of postnatal diet (F2) P<0.001 P<0.001 P<0.001 - P<0.001 P<0.001 P<0.001
P for interaction of mating cross x postnatal
diet (F2)
P<0.05 P<0.05 NS - P<0.05 P<0.05 NS
P for effect of sex (F2) P<0.05 NS NS - P<0.05 NS NS
Data shows mean ± SEM for n observations per group. Data are represented as grams per day per kilogram body weight. For F2 and F3 crosses the dietary origin of the male
parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not
significant.
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Table 3.3 F1 generation energy intake at 5, 7 and 9 weeks of age.
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Control Chow 11 3.0±0.2 2.1±0.1 1.8±0.2 9 3.0±0.1 2.1±0.1 1.9±0.1
Control HF 10 2.7±0.1 2.0±0.1 1.6±0.1 10 2.9±0.3 2.5±0.3 2.1±0.1
MLP Chow 8 3.2±0.2 2.2±0.1 1.6±0.1 9 3.3±0.2 2.4±0.1 2.0±0.1
F1
MLP HF 10 2.5±0.2 2.3±0.2 2.1±0.3 11 2.8±0.2 2.0±0.1 1.9±0.2
P for effect of maternal diet (F1) NS NS NS - NS NS NS
P for effect of postnatal diet (F1) P<0.05 NS NS - P<0.05 NS NS
P for effect of sex (F1) NS NS NS - NS NS NS
P for interaction of maternal x postnatal
diets (F1)
NS NS NS - NS NS NS
Data shows mean ± SEM for n observations per group. Data are represented as MJ per day per kilogram body weight. NS= not significant.
94
Table 3.4 F2 generation energy intake at 5, 7 and 9 weeks of age.
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Con x Con Chow 11 2.9±0.1 1.9±0.1 1.3±0.1 11 3.4±0.6 2.0±0.1 1.5±0.2
Con x Con HF 11 2.4±0.0 1.8±0.1 1.9±0.4 11 2.6±0.2 1.9±0.1 1.6±0.1
Con x MLP Chow 8 2.8±0.2 2.0±0.1 1.6±0.1 8 2.8±0.4 2.0±0.1 2.0±0.1
Con x MLP HF 8 2.4±0.1 2.1±0.1 1.7±0.4 8 2.3±0.2 2.0±0.1 1.7±0.1
MLP x Con Chow 6 3.0±0.2 2.2±0.2 1.6±0.1 10 3.2±0.7 1.9±0.1 1.8±0.1
MLP x Con HF 7 3.0±0.3 2.2±0.3 1.4±0.1 8 3.3±0.8 2.2±0.2 1.5±0.1
MLP x MLP Chow 13 3.2±0.1 2.0±0.1 1.5±0.0 7 3.2±0.2 2.4±0.1 1.7±0.1
F2
MLP x MLP HF 10 2.3±0.2 2.0±0.2 1.5±0.1 11 2.0±0.2 1.9±0.1 1.8±0.1
P for effect of mating cross (F2) NS NS NS - NS NS NS
P for effect of postnatal diet (F2) P<0.05 NS NS - P<0.05 NS NS
P for interaction of F2 or F3 mating cross x
postnatal diet (F2)
NS NS NS - NS NS NS
P for effect of sex (F2) NS NS NS - NS NS NS
Data shows mean ± SEM for n observations per group. Data are represented as MJ per day per kilogram body weight. For F2 and F3 crosses the dietary origin of the male
parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not
significant.
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Table 3.5 F3 generation food intake at 5, 7 and 9 weeks of age.
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Con x Con Chow 11 167.5±13.2 123.5±5.4 109.1±5.8 9 162.2±13.9 128.9±4.1 121.2±5.9
Con x Con HF 11 97.2±15.3 74.9±3.3 60.6±3.5 9 87.5±6.0 74.3±4.9 63.7±1.9
MLP x MLP Chow 7 172.9±7.6 102.2±4.3 103.7±3.4 8 146.8±13.1 116.6±5.1 122.8±4.4
F3
MLP x MLP HF 8 115.1±15.3 74.7±4.6 60.4±4.6 8 103.2±17.6 69.8±4.1 66.3±3.9
P for effect of mating cross (F3) NS NS NS - NS NS NS
P for effect of postnatal diet (F3) P<0.05 P<0.05 P<0.001 - P<0.05 P<0.05 P<0.001
P for interaction of mating cross x postnatal
diet (F3)
NS NS NS - NS NS NS
P for effect of sex (F3) P<0.05 NS NS - P<0.05 NS NS
Data shows mean ± SEM for n observations per group. Data are represented as grams per day per kilogram body weight. For F2 and F3 crosses the dietary origin of the male
parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not
significant
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Table 3.6 F3 generation energy intake at 5, 7 and 9 weeks of age.
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Con x Con Chow 11 2.7±0.2 2.0±0.1 1.8±0.1 9 2.7±0.2 2.1±0.1 2.0±0.1
Con x Con HF 11 2.4±0.4 1.9±0.1 1.5±0.1 9 2.2±0.2 1.9±0.1 1.6±0.1
MLP x MLP Chow 7 2.7±0.2 1.7±0.1 1.7±0.1 8 2.4±0.2 1.9±0.1 2.0±0.1
F3
MLP x MLP HF 8 2.9±0.4 1.9±0.1 1.5±0.1 8 2.6±0.4 1.8±0.1 1.7±0.1
P for effect of mating cross (F3) NS NS NS - NS NS NS
P for effect of postnatal diet (F3) NS NS P<0.05 - NS NS P<0.05
P for interaction of mating cross x postnatal
diet (F3)
NS NS NS - NS NS NS
P for effect of sex (F3) NS NS NS - NS NS NS
Data shows mean ± SEM for n observations per group. Data are represented as MJ per day per kilogram body weight. For F2 and F3 crosses the dietary origin of the male
parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not
significant
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3.6 Feed efficiency
3.6.1 F1 generation
Table 3.7 shows the feed efficiency (weight gained per unit of energy intake)
of the F1 generation offspring at 5, 7 and 9 weeks of age. Feed efficiency was similar
in animals exposed to control and MLP diets in utero, at all time points. In both
maternal dietary groups, efficiency in males was significantly (5 weeks P<0.001, 7 &
9 weeks P<0.05) higher than in females with approximately 20% greater weight gain
at any given level of food intake. When fed the HF diet, male animals increased
efficiency two-fold at 5 weeks of age (P<0.001). This trend continued at 7 and 9
weeks of age (P<0.001). Females exhibited the same response to high fat feeding, but
despite this their efficiency only attained levels noted in chow fed males. Throughout
the study, weight gain per unit food intake was greater with HF feeding than with
chow and males had greater efficiency than females. In F1 animals the prenatal diet
had no influence on feed efficiency.
3.6.2 F2 generation
Table 3.8 shows the feed efficiency of the F2 generation offspring at 5, 7 and
9 weeks of age. Feed efficiency in the F2 generation was similar in all mating crosses
at 5 and 7 weeks of age, however by 9 weeks, efficiency in all MLP mating crosses
was notably reduced (P<0.05) compared to the Con x Con group. Similar to the F1
generation, efficiency in males was significantly (P<0.001) higher than in females at
5 and 7 weeks of age. This trend intensified with increasing age and by 9 weeks of
age, male animals from the Con x Con mating cross had approximately 40% greater
weight gain per unit of food intake compared to females of the same group.
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However, efficiency in all three MLP mating crosses remained similar in males and
females. When fed the HF diet, male animals at 5 and 7 weeks of age, regardless of
mating cross, had greater efficiency approximately two-fold (P<0.001). By 9 weeks
of age, the feeding of the HF postnatal diet in all MLP mating crosses had greater
efficiency (approximately 40%). However efficiency levels with HF feeding in the
Con x Con group remained similar to values attained by chow fed animals. Females
exhibited the same response to HF feeding. Despite this their efficiency was still
lower than values attained by male animals. Throughout the study weight gain per
unit food intake in the F2 generation was greater with HF feeding than with chow
and males animals had greater efficiency than females. In F2 generation animals,
mating cross had no influence on feed efficiency at 5 and 7 weeks of age, however
by 9 weeks all MLP mating crosses exhibited greater efficiency compared to controls
(Con x Con), regardless of sex and postnatal diet.
3.6.3 F3 generation
Table 3.9 shows feed efficiency in the F3 generation offspring at 5, 7 and 9
weeks of age. At 5 and 7 weeks of age feed efficiency was similar regardless of
mating cross. By 9 weeks of age efficiency in animals from the MLP x MLP mating
cross was significantly reduced (P<0.05) compared to controls. This was, however
dependent upon postnatal diet. Efficiency in males was significantly (P<0.05) higher
than in females at 7 and 9 weeks of age, following the trend outlined in the F1 and F2
generations. There was no difference between sexes at 5 weeks. When fed a postnatal
HF diet, male animals regardless of mating cross, elevated their efficiency
approximately two-fold (7 weeks P<0.05 & 9 weeks P<0.001), another trait that was
noted in previous generations. Females of the F3 generation exhibited the same
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response to high fat feeding. However, their efficiency remained lower than their
male counterparts. Feed efficiency of the F3 generation was greater with HF feeding
than with chow diet. Male animals had greater efficiency than females. In the F3
generation animals, mating cross had no influence on feed efficiency at 5 and 7
weeks of age, however by 9 weeks the MLP x MLP mating cross exhibited reduced
efficiency compared to controls. An interaction of mating cross and postnatal diet
was noted (P<0.05).
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Table 3.7 F1 generation feed efficiency at 5, 7 & 9 weeks of age.
Males FemalesGeneration
Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Control Chow 11 25±2 22±2 14±2 9 16±2 12±2 6±1
Control HF 10 51±3 41±3 34±3 10 32±2 24±2 23±4
MLP Chow 8 24±3 19±2 17±5 9 17±1 11±1 9±1
F1
MLP HF 10 47±3 36±3 29±3 11 37±3 29±4 19±2
P for effect of maternal diet (F1) NS NS NS - NS NS NS
P for effect of postnatal diet (F1) P<0.001 P<0.001 P<0.001 - P<0.001 P<0.001 P<0.001
P for effect of sex (F1) P<0.001 P<0.05 P<0.05 - P<0.001 P<0.05 P<0.05
P for interaction of maternal x postnatal
diets (F1)
NS NS NS - NS NS NS
Data shows mean ± SEM for n observations per group. Data are represented as weight gained per unit food intake (%).NS= not significant.
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Table 3.8 F2 generation feed efficiency at 5, 7 & 9 weeks of age.
Males FemalesGeneration
Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Con x Con Chow 11 27±1 24±2 35±14 11 23±1 18±2 19±3
Con x Con HF 11 55±2 49±3 40±4 11 47±3 30±2 26±2
Con x MLP Chow 8 26±3 28±2 13±1 8 20±4 15±3 11±2
Con x MLP HF 8 52±4 57±4 35±5 8 47±5 34±5 24±4
MLP x Con Chow 6 32±7 29±0 12±2 10 19±3 20±2 12±3
MLP x Con HF 7 44±5 43±6 25±2 8 43±5 43±4 16±5
MLP x MLP Chow 13 26±2 18±2 18±2 7 20±2 11±2 16±4
F2
MLP x MLP HF 10 60±4 46±5 34±1 11 57±11 30±3 16±4
P for effect of mating cross (F2) NS NS P<0.05 - NS NS P<0.05
P for effect of postnatal diet (F2) P<0.001 P<0.001 P<0.001 - P<0.001 P<0.001 P<0.001
P for effect of sex (F2) P<0.05 P<0.001 P<0.001 - P<0.05 P<0.001 P<0.001
P for interaction of mating cross x postnatal
diet (F2)
NS NS P<0.05 - NS NS P<0.05
Data shows mean ± SEM for n observations per group. Data are represented as weight gained per unit food intake (%). For F2 and F3 crosses the dietary origin of the male
parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not
significant
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Table 3.9 F3 generation feed efficiency at 5, 7 & 9 weeks of age.
Males FemalesGeneration
Maternal
diet/cross
Postnatal
diet
n Week 5 Week 7 Week 9 n Week 5 Week 7 Week 9
Con x Con Chow 11 28±2 19±3 16±2 9 25±3 9±2 11±2
Con x Con HF 11 65±9 43±2 31±2 9 49±5 21±4 20±6
MLP x MLP Chow 7 28±1 18±1 9±2 8 23±3 14±3 9±1
F3
MLP x MLP HF 8 46±4 42±4 30±4 8 30±2 24±4 21±4
P for effect of mating cross (F3) NS NS P<0.05 - NS NS P<0.05
P for effect of postnatal diet (F3) NS P<0.05 P<0.001 - NS P<0.05 P<0.001
P for effect of sex (F3) NS P<0.05 P<0.05 - NS P<0.05 P<0.05
P for interaction of mating cross x postnatal
diet (F3)
NS NS P<0.05 - NS NS P<0.05
Data shows mean ± SEM for n observations per group. Data are represented as weight gained per unit food intake (%). For F2 and F3 crosses the dietary origin of the male
parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not
significant
103
3.7 Body composition 10 weeks
3.7.1 F1 generation
Table 3.10 shows the body composition of F1 generation male animals, when
culled at 10 weeks of age. Body weight at time of cull was similar in animals
exposed to control and MLP diets in utero. All organs and fat pads were of similar
size relative to body weight in chow fed male animals, irrespective of maternal
dietary exposure. The feeding of a HF diet postnatally had no effect on body weight
on males from the F1 generation (Table 3.10), however, liver and lung size relative
to bodyweight were greater (P<0.05) compared to chow fed rats, in both maternal
dietary groups, as were perirenal and gonadal fat (Figure 3.4) deposits (P<0.05). The
size of all other organs relative to body weight was similar irrespective of postnatal
diet.
Table 3.11 shows the body composition of F1 generation females at 10 weeks
of age. As noted in male animals, body weight at time of cull was unchanged by
MLP feeding and all organs and fat pads were of similar size relative to body weight
in chow fed female animals. Postnatal HF feeding in the F1 generation female
animals resulted in greater (P<0.05) liver size relative to body weight by
approximately 5-10%. Lung size was similarly affected showing an increase
(P<0.05) of approximately 7-15%. Gonadal and perirenal fat pads (Figure 3.4) were
also substantially greater (P<0.05) by approximately 40%, on postnatal HF feeding.
Tables 3.10 and 3.11 show that body weight and organ size relative to body
weight in both male and female animals of the F1 generation at 10 weeks of age were
unaffected by administration of control and MLP diets in utero. However, postnatal
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HF feeding did impact upon liver, lung, gonadal fat and perirenal fat deposition,
substantially increasing organ/fat pad size relative to body weight.
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Table 3.10 Male F1 generation body composition 10 weeks
Organ weight/body weight (%)Generation Maternal
diet/cross
Postnatal
diet
n Body wt (g)
Liver Left
kidney
Right
kidney
Heart Lung Brain Thymus Spleen Gonadal
fat pad
Perirenal fat
pad
Control Chow 11 383.7± 19.82 4.26±
0.20
0.37±
0.01
0.38±
0.02
0.38±
0.02
0.59±
0.03
0.47±
0.02
0.14±
0.01
0.23±
0.01
0.76±
0.07
0.71±
0.12
Control HF 10 381.7± 13.57 4.56±
0.18
0.39±
0.02
0.40±
0.02
0.36±
0.01
0.82±
0.09
0.47±
0.02
0.16±
0.02
0.22±
0.03
0.98±
0.1
0.97±
0.09
MLP Chow 8 380.8± 6.93 4.69±
0.14
0.39±
0.01
0.40±
0.01
0.39±
0.01
0.60±
0.04
0.46±
0.03
0.14±
0.01
0.22±
0.01
0.74±
0.04
0.66±
0.07
F1
MLP HF 10 356.9± 15.64 4.93±
0.19
0.40±
0.01
0.40±
0.01
0.37±
0.01
0.78±
0.05
0.48±
0.03
0.17±
0.02
0.27±
0.02
0.88±
0.11
0.87±
0.13
P for effect of maternal diet (F1) NS NS NS NS NS NS NS NS NS NS NS
P for effect of postnatal diet (F1) NS P<0.05 NS NS NS P<0.05 NS NS NS P<0.05 P<0.05
P for interaction of maternal x postnatal diets
(F1)
NS NS NS NS NS NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. Data represented as grams per 100 gram body weight. NS= not significant.
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Table 3.11 Female F1 generation body composition 10 weeks
Organ weight/body weight (%)Generation Maternal
diet/cross
Postnatal
diet
n Body wt (g)
Liver Left
kidney
Right
kidney
Heart Lung Brain Thymus Spleen Gonadal
fat pad
Perirenal fat
pad
Control Chow 9 246.9±8.37 4.30±
0.10
0.39±
0.01
0.41±
0.01
0.43±
0.01
0.71±
0.06
0.63±
0.02
0.19±
0.01
0.25±
0.00
0.81±
0.08
0.58±
0.06
Control HF 10 281.9 ±23.41 4.49±
0.19
0.41±
0.01
0.42±
0.01
0.38±
0.01
0.76±
0.05
0.63±
0.04
0.17±
0.02
0.27±
0.02
1.13±
0.10
0.84±
0.11
MLP Chow 9 243.8±4.56 4.22±
0.08
0.40±
0.01
0.41±
0.01
0.41±
0.01
0.69±
0.02
0.69±
0.02
0.20±
0.01
0.26±
0.02
0.74±
0.13
0.47±
0.05
F1
MLP HF 11 239.6 ±5.84 4.60±
0.10
0.43±
0.01
0.45±
0.01
0.44±
0.01
0.83±
0.04
0.67±
0.03
0.19±
0.01
0.33±
0.04
1.16±
0.08
0.89±
0.08
P for effect of maternal diet (F1) NS NS NS NS NS NS NS NS NS NS NS
P for effect of postnatal diet (F1) NS P<0.05 NS NS NS P<0.05 NS NS NS P<0.05 P<0.05
P for interaction of maternal x postnatal diets
(F1)
NS NS NS NS NS NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. Data represented as grams per 100 gram body weight. NS= not significant.
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Figure 3.4 Total abdominal Fat deposition in F1 generation
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Figure 3.4 Total fat represents combined gonadal and perirenal fat deposits. Data is shown as mean ±
SEM, for Control diet male chow (n=11); male HF (n=10); female chow (n=9) and female HF (n=10).
MLP diet male chow (n=8); male HF (n=10); female chow (n=9) and female HF (n=11). Significant
effects of postnatal diet (P<0.05) were noted, Data analysed using a mixed model ANOVA.
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3.7.2 F2 generation
Table 3.12 shows body composition of F2 generation male animals when
culled at 10 weeks of age. Body weight at time of cull was similar in animals from
all mating crosses and all organs were of similar size relative to body weight in chow
fed male animals of the F2 generation irrespective of mating cross. Abdominal fat
deposition (Figure 3.5) was significantly influenced by mating cross. Both perirenal
and gonadal fat deposits were smaller relative to body weight (P<0.05) in the MLP x
MLP cross compared to Con x Con group. The other MLP mating crosses had
similar amounts of fat to Con x Con group, male, chow fed animals. The feeding of
the HF postnatal diet to the F2 generation resulted in greater (P<0.001,
approximately 20%) lung size relative to body weight in all mating crosses. Brain
size was also larger (P<0.05) by around 13%, regardless of mating cross. In general,
HF feeding resulted in greater perirenal and gonadal fat deposition compared to
chow fed animals irrespective of mating cross. HF feeding exaggerated the
abdominal fat deposition phenotype observed in the chow fed animals. With HF
feeding, all MLP mating crosses showed reduced (P<0.001) perirenal and gonadal fat
deposition (approximately 18%) compared to the Con x Con mating cross fed a HF
postnatal diet.
Table 3.13 shows body composition (organ size relative to body weight) of
F2 generation female animals at 10 weeks of age. Body weight at time of cull was
similar among female animals of the F2 generation, regardless of mating cross and
all organs were of similar size relative to body weight in chow fed female animals.
Gonadal fat deposition was lower (P<0.05) in the MLP x MLP and MLP x Con
mating crosses by approximately 20% compared to their Con x Con counterparts.
Perirenal fat pad size relative to body weight was similar among all mating crosses.
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Feeding of the HF diet to the F2 generation females resulted in larger (P<0.001,
approximately 15%) lung size relative to body weight in all groups. Brain size was
also greater in most groups (P<0.05) by around 5%. However a decrease in brain
size, was noted in the Con x MLP mating cross. As in the F2 generation male
animals, HF feeding generally resulted in greater perirenal and gonadal fat deposition
(Figure 3.5) compared to chow fed animals irrespective of mating cross. HF feeding
exaggerated the abdominal fat deposition phenotype observed in the chow fed male
and female animals, and as with the postnatal HF male animals, HF feeding reduced
(P<0.001) perirenal and gonadal fat deposition (approximately 20%) in all MLP
mating crosses compared to the Con x Con mating cross animals fed a HF postnatal
diet.
Tables 3.12 and 3.13 show that body weight and organ size relative to body
weight in both male and female animals of the F2 generation at 10 weeks of age was
unaffected by mating cross. Abdominal fat deposition was lower in certain MLP
mating crosses compared to controls. Postnatal HF feeding enhanced this effect and
although abdominal fat deposition did increase in animals fed a HF diet compared to
chow controls, the fat gain was attenuated in all MLP mating crosses compared to
control animals (Con x Con) fed a HF postnatal diet (Figure 3.5).
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Table 3.12 Male F2 generation body composition 10 weeks
Organ weight/body weight (%)Generation Maternal
diet/cross
Postnatal
diet
n Body wt
(g) Liver Left
kidney
Right
kidney
Heart Lung Brain Thymus Spleen Gonadal
fat pad
Perirenal fat
pad
Con x Con Chow 11 381.3±
12.88
4.52±
0.08
0.39±
0.01
0.41±
0.01
0.37±
0.02
0.60±
0.03
0.48±
0.02
0.15±
0.01
0.24±
0.01
0.71±
0.04
0.68±
0.07
Con x Con HF 11 381.6 ±
17.64
4.78±
0.08
0.38±
0.01
0.39±
0.01
0.37±
0.01
0.76±
0.02
0.49±
0.02
0.16±
0.01
0.24±
0.01
1.09±
0.08
1.17±
0.12
Con x MLP Chow 8 412.9±
10.22
4.80±
0.05
0.39±
0.01
0.39±
0.01
0.36±
0.02
0.59±
0.02
0.45±
0.01
0.13±
0.01
0.22±
0.01
0.70±
0.05
0.59±
0.07
Con x MLP HF 8 349.3 ±
14.07
4.66±
0.26
0.39±
0.01
0.40±
0.01
0.41±
0.02
0.75±
0.02
0.52±
0.03
0.16±
0.01
0.24±
0.01
0.88±
0.07
0.77±
0.08
MLP x Con Chow 6 383.3±
18.70
4.95±
0.18
0.39±
0.02
0.41±
0.02
0.37±
0.03
0.61±
0.04
0.47±
0.03
0.17±
0.01
0.23±
0.02
0.72±
0.07
0.74±
0.10
MLP x Con HF 7 350.5 ±
10.89
4.83±
0.20
0.39±
0.02
0.41±
0.02
0.37±
0.01
0.75±
0.04
0.54±
0.02
0.16±
0.01
0.26±
0.02
0.91±
0.12
0.83±
0.16
MLP x MLP Chow 13 391.2±
14.95
4.62±
0.09
0.39±
0.01
0.41±
0.01
0.39±
0.02
0.63±
0.03
0.47±
0.02
0.14±
0.01
0.22±
0.01
0.66±
0.04
0.59±
0.08
F2
MLP x MLP HF 10 351.9 ±
10.51
4.82±
0.12
0.39±
0.01
0.41±
0.02
0.40±
0.02
0.80±
0.04
0.53±
0.02
0.14±
0.01
0.24±
0.01
0.90±
0.05
0.75±
0.10
P for effect of maternal cross (F2) NS NS NS NS NS NS NS NS NS P<0.05 P<0.05
P for effect of postnatal diet (F2) NS NS NS NS NS P<0.001 P<0.05 NS NS P<0.001 P<0.001
P for interaction of cross x postnatal diets (F2) NS NS NS NS NS NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. Data represented as grams per 100 gram body weight. For F2 and F3 crosses the dietary origin of the male parent is
shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not significant.
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Table 3.13 Female F2 generation body composition 10 weeks
Organ weight/body weight (%)Generation Maternal
diet/cross
Postnatal
diet
n Body
wt (g) Liver Left
kidney
Right
kidney
Heart Lung Brain Thymus Spleen Gonadal
fat pad
Perirenal fat
pad
Con x Con Chow 11 249.5±
5.66
4.27±
0.08
0.41±
0.01
0.43±
0.01
0.40±
0.01
0.71±
0.02
0.68±
0.02
0.18±
0.01
0.27±
0.01
0.73±
0.05
0.47±
0.05
Con x Con HF 11 244.8±
7.02
4.60±
0.09
0.41±
0.01
0.43±
0.01
0.41±
0.01
0.93±
0.05
0.71±
0.02
0.19±
0.01
0.28±
0.01
1.14±
0.11
0.80±
0.10
Con x MLP Chow 8 239.2±
8.29
4.15±
0.08
0.39±
0.01
0.41±
0.01
0.42±
0.01
0.69±
0.01
0.74±
0.02
0.18±
0.01
0.25±
0.01
0.76±
0.09
0.48±
0.05
Con x MLP HF 8 244.8±
4.96
4.84±
0.12
0.45±
0.01
0.46±
0.01
0.42±
0.02
0.84±
0.06
0.71±
0.02
0.19±
0.01
0.28±
0.01
0.83±
0.09
0.65±
0.09
MLP x Con Chow 10 259.0±
17.42
4.36±
0.06
0.40±
0.01
0.41±
0.01
0.41±
0.03
0.72±
0.03
0.71±
0.03
0.20±
0.01
0.25±
0.01
0.62±
0.07
0.43±
0.05
MLP x Con HF 8 236.9±
4.29
4.84±
0.04
0.41±
0.01
0.43±
0.00
0.43±
0.02
0.84±
0.04
0.72±
0.02
0.19±
0.02
0.30±
0.01
0.88±
0.08
0.64±
0.10
MLP x MLP Chow 7 250.6±
3.86
4.26±
0.08
0.41±
0.01
0.42±
0.01
0.43±
0.01
0.79±
0.03
0.68±
0.02
0.17±
0.01
0.25±
0.01
0.58±
0.09
0.48±
0.05
F2
MLP x MLP HF 11 228.3±
8.83
4.51±
0.14
0.43±
0.01
0.45±
0.01
0.44±
0.02
0.88±
0.04
0.77±
0.04
0.17±
0.01
0.28±
0.01
0.87±
0.10
0.69±
0.08
P for effect of maternal cross (F2) NS NS NS NS NS NS NS NS NS P<0.05 P<0.05
P for effect of postnatal diet (F2) NS NS NS NS NS P<0.001 P<0.05 NS NS P<0.001 P<0.001
P for interaction of cross x postnatal diets (F2) NS NS NS NS NS NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. Data represented as grams per 100 gram body weight. For F2 and F3 crosses the dietary origin of the male parent is
shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not significant.
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Figure 3.5 Total abdominal fat deposition F2 generation
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Figure 3.5 Total abdominal fat represents combined gonadal and perirenal fat deposits. Data is
shown as mean ± SEM, for Con x Con male chow (n=11); male HF (n=11); female chow (n=11) and
female HF (n=11), MLP x MLP male chow (n=13); male HF (n=10); female chow (n=7) and female
HF (n=11), Con x MLP male chow (n=8); male HF (n=8); female chow (n=8) and female HF (n=8),
MLP x Con male chow (n=6); male HF (n=7); female chow (n=10) and female HF (n=8). Significant
effects of sex (P<0.05), diet (P<0.001) and cross (P<0.05) were noted, Data analysed using a mixed
model ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the
female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female
exposed to LP diet in utero.
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3.7.3 F3 generation
Table 3.14 shows the body composition of F3 generation male animals when
culled at 10 weeks of age. Body weight at the time of cull was similar in male
animals from both mating crosses and all organs and abdominal fat pads were of
similar size relative to body weight in chow fed male animals. Postnatal HF feeding
significantly lowered (P<0.05) body weight at time of cull. Liver size relative to
body weight was substantially greater (P<0.05), and both left and right kidneys
(P<0.05), lung (P<0.05) and brain (P<0.05) size relative to body weight were
similarly affected. Abdominal fat deposition was also increased by postnatal HF
feeding as both gonadal (P<0.05) and perirenal (P<0.05) fat deposition was greater
(approximately 20%), irrespective of mating cross.
Table 3.15 shows body composition of F3 generation female animals at 10
weeks of age. As noted in male animals of the F3 generation, body weight at time of
cull was similar in female animals regardless of mating cross. (Table 3.14) Postnatal
HF feeding resulted in a smaller (P<0.05) body weight at the time of cull, and larger
liver size relative to body weight (P<0.05). Both left and right kidneys (P<0.05), lung
(P<0.05) and brain (P<0.05) size relative to body weight were also larger in HF fed
animals. Gonadal (P<0.05) and perirenal (P<0.05) fat deposition was greater
(approximately 33%) in animals on the HF diet compared to chow fed animals.
Tables 3.14 and 3.15 show that in the F3 generation, no differences in body
weight and organ or fat pad size relative to body weight were noted between mating
crosses. Postnatal HF feeding did, however, increase size of liver, kidneys, lung,
brain and abdominal fat depots relative to body weight. Unlike the F2 generation, no
programmed difference in fat deposition was observed in the F3 generation (Figure
3.6).
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Table 3.14 Male F3 generation body composition 10 weeks
Organ weight/body weight (%)Generation Maternal
diet/cross
Postnatal
diet
n Body
wt (g) Liver Left
kidney
Right
kidney
Heart Lung Brain Thymus Spleen Gonadal
fat pad
Perirenal fat
pad
Con x Con Chow 11 401.7±
8.59
4.77±
0.12
0.37±
0.01
0.39±
0.01
0.36±
0.02
0.64±
0.03
0.46±
0.01
0.15±
0.01
0.24±
0.01
0.77±
0.03
0.65±
0.06
Con x Con HF 9 376.1±
14.81
4.89±
0.11
0.40±
0.02
0.42±
0.02
0.38±
0.02
0.74±
0.04
0.51±
0.02
0.17±
0.01
0.30±
0.04
1.01±
0.05
0.95±
0.09
MLP x MLP Chow 6 411.2±
14.21
4.35±
0.10
0.39±
0.02
0.41±
0.02
0.36±
0.01
0.65±
0.04
0.46±
0.01
0.13±
0.01
0.23±
0.02
0.68±
0.05
0.58±
0.06
F3
MLP x MLP HF 8 377.8±
10.03
4.67±
0.17
0.40±
0.01
0.42±
0.01
0.38±
0.01
0.74±
0.02
0.49±
0.01
0.15±
0.02
0.25±
0.01
0.90±
0.08
0.84±
0.13
P for effect of maternal cross (F3) NS NS NS NS NS NS NS NS NS NS NS
P for effect of postnatal diet (F3) P<0.05 P<0.05 P<0.05 P<0.05 NS P<0.05 P<0.05 NS NS P<0.05 P<0.05
P for interaction of cross x postnatal diets (F3) NS NS NS NS NS NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. Data represented as grams per 100 gram body weight. For F2 and F3 crosses the dietary origin of the male parent is
shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not significant.
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Table 3.15 Female F3 generation body composition 10 weeks
Organ weight/body weight (%)Generation Maternal
diet/cross
Postnatal
diet
n Body
wt (g) Liver Left
kidney
Right
kidney
Heart Lung Brain Thymus Spleen Gonadal
fat pad
Perirenal fat
pad
Con x Con Chow 9 255.9
±9.71
4.77±
0.12
0.38±
0.01
0.40±
0.01
0.43±
0.02
0.71±
0.02
0.65±
0.05
0.17±
0.01
0.26±
0.01
0.69±
0.05
0.47±
0.07
Con x Con HF 9 236.1
±7.46
4.89±
0.11
0.43±
0.01
0.46±
0.01
0.44±
0.01
0.89±
0.04
0.73±
0.04
0.17±
0.01
0.28±
0.02
0.96±
0.10
0.65±
0.10
MLP x MLP Chow 8 266.8
±18.0
0
4.35±
0.10
0.38±
0.01
0.40±
0.01
0.41±
0.01
0.76±
0.03
0.64±
0.03
0.16±
0.01
0.25±
0.02
0.68±
0.08
0.56±
0.08
F3
MLP x MLP HF 8 238.7
±3.62
4.67±
0.17
0.40±
0.01
0.42±
0.01
0.42±
0.01
0.89±
0.04
0.69±
0.03
0.16±
0.01
0.28±
0.01
0.90±
0.08
0.71±
0.06
P for effect of maternal cross (F3) NS NS NS NS NS NS NS NS NS NS NS
P for effect of postnatal diet (F3) P<0.0
5
P<0.05 P<0.05 P<0.05 NS P<0.05 P<0.05 NS NS P<0.05 P<0.05
P for interaction of cross x postnatal diets (F3) NS NS NS NS NS NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. Data represented as grams per 100 gram body weight. For F2 and F3 crosses the dietary origin of the male parent is
shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not significant.
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Figure 3.6 Total abdominal fat deposition F3 generation
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Figure 3.6 Total abdominal fat represents combined gonadal and perirenal fat deposits. Data is
shown as mean ± SEM, for Con x Con male chow (n=11); male HF (n=9); female chow (n=9) and
female HF (n=9), MLP x MLP male chow (n=6); male HF (n=8); female chow (n=8) and female HF
(n=8). A significant effect of diet (P<0.05) was noted, Data analysed using a mixed model ANOVA.
For F2 and F3 crosses the dietary origin of the male parent is shown before the female parent, e.g.
Con x MLP indicates a cross between a male exposed to control diet and a female exposed to LP diet
in utero.
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3.8 Circulating metabolites
3.8.1 F1 generation
Table 3.16 shows circulating metabolite concentrations in the F1 generation
at 10 weeks of age. Non-fasted plasma glucose concentrations were similar in
animals exposed to both control and MLP diets in utero. Concentrations in female
animals were comparable to concentrations in male animals. Similarly triglyceride,
cholesterol and insulin concentrations were also unaffected by the maternal diet.
Concentrations of these metabolites remained comparable in males and females
regardless of the maternal diet in utero. Non-fasted insulin concentrations did not
differ between sexes and values remained around the 3000 pmol/L level.
Triglyceride and cholesterol concentrations in female offspring however were lower
than in males (P<0.05) by approximately 20-40%.
With postnatal HF feeding, glucose and triglyceride concentrations remained
similar to chow fed controls in both male and female animals. Cholesterol
concentrations showed an almost two-fold increase (P<0.05) in male HF animals
compared to chow controls, irrespective of the maternal diet. Female animals
exhibited the same response to HF. However, the increase was much less pronounced
than in males. The effect of postnatal HF feeding on plasma insulin concentrations
was not measured. Throughout this study all circulating metabolite levels monitored
were unaffected by the maternal diet. Triglyceride and cholesterol concentrations
were higher in male animals compared to female animals. Postnatal HF feeding
resulted in higher cholesterol levels. In F1 animals the prenatal diet had no effect on
the monitored circulating metabolites.
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Table 3.16 Circulating metabolites F1 generation 10 weeks
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
Glucose
mmol/L
Triglyceride
mmol/L
Cholesterol
mmol/L
Insulin
pmol/L
n
Glucose
mmol/L
Triglyceride
mmol/L
Cholesterol
mmol/L
Insulin
pmol/L
Control Chow 11 9.198±
1.749
0.651±
0.152
1.747±
0.111
3514±
579
9 8.854±
1.459
0.514±
0.142
1.621±
0.071
2699±
345
Control HF 9 12.307±
1.646
0.566±
0.129
2.431±
0.232
- 10 9.645±
1.193
0.111±
0.103
1.511±
0.138
-
MLP Chow 8 10.296±
1.636
0.527±
0.078
1.589±
0.210
2474±
273
9 9.857±
1.697
0.303±
0.092
1.580±
0.190
2340±
326
F1
MLP HF 9 8.929±
0.814
0.926±
0.198
2.647±
0.186
- 11 9.699±
0.894
0.288±
0.113
1.668±
0.089
-
P for effect of maternal diet (F1) NS NS NS NS - NS NS NS NS
P for effect of postnatal diet (F1) NS NS P<0.05 - - NS NS P<0.05 -
P for interaction of maternal x postnatal diets
(F1)
NS NS NS - - NS NS NS -
P for effect of sex (F1) NS P<0.05 P<0.05 NS - NS P<0.05 P<0.05 NS
Data shows mean ± SEM for n observations per group. NS= not significant.
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3.8.2 F2 generation
Table 3.17 shows circulating metabolite concentrations in the F2 generation
at 10 weeks of age. As in the F1 generation, non-fasted plasma glucose
concentrations were similar in all animals regardless of the mating cross. Similarly
cholesterol levels were also unaffected by mating cross. Concentrations of these two
metabolites were similar in male and female animals. Like glucose and cholesterol
concentrations, non-fasted insulin concentrations were similar in all mating crosses.
However concentrations in male animals were significantly higher (45%, P<0.05)
than in females. Triglyceride concentrations were significantly higher (P<0.05) in all
MLP mating crosses compared to Con x Con in both male and female animals.
With feeding of the HF postnatal diet, glucose and cholesterol concentrations
remained similar to those noted in chow fed animals (both sexes). Triglyceride levels
however were lower (P<0.05, approximately 50%) in HF fed male animals compared
to controls. The same trend was noted in the female animals (P<0.05) but the
decrease was much less pronounced (approximately 7%). As in the F1 generation,
the effect of postnatal HF feeding upon plasma insulin concentrations was not
measured. Throughout this study circulating non-fasted glucose, non-fasted insulin
and cholesterol concentrations were similar regardless of mating cross. Triglyceride
concentrations were higher in all MLP mating crosses. Triglyceride concentrations
were higher in males than in females and with postnatal HF feeding triglyceride
levels decreased in both male and female animals. In F2 animals, only triglyceride
concentrations were influenced by the fetal origins of the parents and therefore the
original MLP dietary intervention.
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Table 3.17 Circulating metabolites F2 generation 10 weeks
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
Glucose
mmol/L
Triglyceride
mmol/L
Cholesterol
mmol/L
Insulin
pmol/L
n
Glucose
mmol/L
Triglyceride
mmol/L
Cholesterol
mmol/L
Insulin
pmol/L
Con x Con Chow 11 11.184±
1.664
0.889±
0.123
1.344±
0.154
3927±
492
11 12.032±
1.048
0.377±
0.077
1.646±
0.176
2813±
379
Con x Con HF 11 12.877±
1.740
0.703±
0.096
2.070±
0.232
- 11 11.217±
1.086
0.237±
0.069
1.787±
0.127
-
Con x MLP Chow 8 10.458±
1.785
1.168±
0.152
1.464±
0.068
4625±
818
8 12.411±
2.020
0.282±
0.094
1.555±
0.187
2559±
302
Con x MLP HF 8 8.174±
1.807
0.697±
0.151
1.983±
0.172
- 8 12.199±
0.807
0.309±
0.078
1.502±
0.103
-
MLP x Con Chow 6 13.184±
2.001
1.287±
0.272
1.362±
0.179
4750±
1084
10 10.514±
2.315
0.600±
0.123
1.602±
0.173
3118±
288
MLP x Con HF 7 9.256±
2.399
0.544±
0.074
2.052±
0.145
- 8 10.783±
2.583
0.276±
0.094
1.723±
0.216
-
MLP x MLP Chow 13 11.522±
1.439
1.003±
0.201
2.055±
0.407
6182±
1102
7 13.666±
2.293
0.403±
0.174
1.912±
0.066
3552±
814
F2
MLP x MLP HF 10 10.115±
1.298
0.552±
0.484
1.499±
0.152
- 11 13.016±
1.447
0.374±
0.200
1.270±
0.404
-
P for effect of cross (F2) NS P<0.05 NS NS - NS P<0.05 NS NS
P for effect of postnatal diet (F2) NS P<0.05 NS - - NS P<0.05 NS -
P for interaction of cross x postnatal diets (F2) NS NS NS - - NS NS NS -
P for effect of sex (F2) NS P<0.05 NS P<0.05 - NS P<0.05 NS P<0.05
Data shows mean ± SEM for n observations per group. For F2 and F3 crosses the dietary origin of the male parent is shown before the female parent, e.g. Con x MLP
indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not significant.
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3.8.3 F3 generation
Table 3.18 shows the circulating metabolite concentrations in the F3
generation at 10 weeks of age. All monitored circulating metabolites including
glucose, insulin, triglyceride and cholesterol concentrations were unaffected by
mating cross and sex. Postnatal HF feeding had no effect on glucose and triglyceride
concentrations, but cholesterol concentrations were approximately 25% higher
(P<0.05) in HF-fed male animals. The effect of postnatal HF feeding upon plasma
insulin concentrations was not measured in the F3 generation. Similar to the F1
generation all rats, circulating metabolite concentrations monitored were unaffected
by mating cross and no effect of sex was noted. Postnatal HF feeding resulted in
higher cholesterol levels. In F3 animals, the prenatal diet had no effect on the
monitored circulating metabolites.
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Table 3.18 Circulating metabolites F3 generation 10 weeks
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
Glucose
mmol/L
Triglyceride
mmol/L
Cholesterol
mmol/L
Insulin
pmol/L
n
Glucose
mmol/L
Triglyceride
mmol/L
Cholesterol
mmol/L
Insulin
pmol/L
Con x Con Chow 11 11.847±
1.031
0.617±
0.138
1.533±
0.185
5679±
1029
9 10.525±
1.031
0.334±
0.103
1.605±
0.181
4082±
483
Con x Con HF 9 8.833±
1.599
0.917±
0.124
2.225±
0.191
- 9 10.031±
1.248
0.065±
0.046
1.570±
0.228
-
MLP x MLP Chow 6 9.028±
1.237
0.500±
0.138
1.650±
0.239
3875±
389
8 11.536±
4.035
0.485±
0.140
1.403±
0.102
3698±
436
F3
MLP x MLP HF 8 7.780±
1.099
0.732±
0.143
2.022±
0.184
- 8 9.491±
1.245
0.181±
0.073
1.508±
0.129
-
P for effect of cross (F3) NS NS NS NS - NS NS NS NS
P for effect of postnatal diet (F3) NS NS P<0.05 - - NS NS P<0.05 -
P for interaction of cross x postnatal diets (F3) NS NS NS - - NS NS NS -
P for effect of sex (F3) NS NS NS NS - NS NS NS NS
Data shows mean ± SEM for n observations per group. For F2 and F3 crosses the dietary origin of the male parent is shown before the female parent, e.g. Con x MLP
indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero. NS= not significant.
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3.9 Discussion
3.9.1 Summary of Findings
Studies of the feeding of a low protein diet throughout gestation and the
subsequent effects upon food intake, body composition and circulating
metabolites in the F1 generation are well documented (Bellinger, 2005; Bellinger
and Langley-Evans, 2005; Bellinger et al., 2004; Erhuma et al., 2007a; Erhuma
et al., 2007b; Vickers et al., 2000). The data in this chapter shows for the first
time the impact the original protein restriction has upon body composition and
feeding behaviour in the F2 and F3 generations (Table 3.19).
Table 3.19 Summary of findings from animals culled at 10 weeks.
Generation
F1 F2 F3
Body weight Unchanged by
maternal diet and
postnatal HF feeding
at 10 weeks.
Unchanged by mating
cross and postnatal
HF feeding at 10
weeks
Unchanged by mating
cross, decreased with
postnatal HF feeding
at 10 weeks
Food intake Unchanged by
maternal diet,
decreased with HF
feeding.
Unchanged by mating
cross, decreased with
HF feeding.
Unchanged by mating
cross, decreased with
HF feeding.
Brain size Unchanged by
maternal diet and
postnatal HF feeding
at 10 weeks.
Unchanged by mating
cross, increased with
postnatal HF feeding
at 10 weeks
Unchanged by mating
cross, increased with
postnatal HF feeding
at 10 weeks
Abdominal fat Unchanged by
maternal diet,
increased with
postnatal HF feeding
at 10 weeks
Decreased in all MLP
mating crosses,
increased with
postnatal HF feeding
at 10 weeks.
Unchanged by mating
cross, increased with
postnatal HF feeding
at 10 weeks
Glucose/ insulin Unchanged by
maternal diet and
postnatal HF feeding
at 10 weeks.
Unchanged by mating
cross and postnatal
HF feeding at 10
weeks.
Unchanged by mating
cross and postnatal
HF feeding at 10
weeks.
Cholesterol/ TAG Unchanged by
maternal diet,
cholesterol increased
with postnatal HF
feeding at 10 weeks.
Triglycerides
increased in male
MLP mating crosses,
decreased with
postnatal HF feeding
at 10 weeks.
Unchanged by mating
cross, cholesterol
increased with
postnatal HF feeding
at 10 weeks.
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Table 3.19 shows a brief summary of findings from animals from F1, F2 and F3 generations
culled at 10 weeks of age.
Table 3.19 shows a brief summary of the findings from the animals culled
at 10 weeks of age. The most striking finding from the analysis of body
composition and food intake data was, the emergence of a lean abdominal fat
phenotype within the F2 generation in all MLP mating crosses, which was not
present within either the F1 or F3 generations.
3.9.1.1 Effect of prenatal protein restriction and mating cross.
Both food (standard laboratory chow) and energy (MJ per kilogram
bodyweight) intakes were unaffected by MLP restriction during gestation at all
time points monitored. No difference between male and female animals was also
observed. These findings were unexpected as previous studies using exactly the
same MLP diet within our laboratory indicated that MLP exposed offspring
consumed significantly less than controls when fed chow, but have greater
energy intake when placed on a self selection diet (Bellinger and Langley-Evans,
2005). In these earlier studies food intake was monitored at 12 weeks of age, a
substantially later time point than monitored within this study. As such the
animals within the study by Bellinger and Langley-Evans (2005) were more
mature animals. This could explain the discrepancy with the current study.
Although previous work from our laboratory has shown MLP restricted
F1 generation animals exhibit reduced food intake levels compared to control
animals, work by Zambrano and colleagues (2006) noted no difference between
MLP and control groups at 14 weeks of age (Zambrano et al., 2006). Feed
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efficiency was also reduced in the study by Bellinger and colleagues (2005),
implying that the animals had an increased capacity for thermogenesis or other
forms of energy expenditure (Bellinger, 2005). There was no effect of maternal
protein restriction on feed efficiency in the F1 generation within the present
study. Studies by Vickers and colleagues showed that offspring from severely
undernourished mothers had significantly elevated food intake from an early
postnatal age. This phenotype continued with advancing age and was also
amplified by hypercaloric nutrition (Vickers et al., 2000). It is therefore not
entirely clear whether maternal protein restriction impacts on food intake within
the F1 generation as the literature is currently split. However it is apparent from
the data within this chapter that there was no effect of maternal protein restriction
on food intake, energy intake or feed efficiency in the F1 generation within the
current investigation.
This study has for the first time monitored feeding behaviour in 3
subsequent generations of animals, to analyse the potential for trangenerational
programming. F2 generation feed efficiency was unaffected by mating cross at 5
and 7 weeks of age, but by 9 weeks efficiency in all MLP mating crosses was
reduced compared to controls. This suggested that body weight gain may be
compromised, but results discussed later within this section show that this is not
the case.
Zambrano and colleagues (2005) have previously recorded food intake in
F2 generation offspring following protein restriction. They noted no difference in
MLP mating cross offspring, but did not report data on energy or feed efficiency
(Zambrano et al., 2005). Importantly, the study by Zambrano and colleages
differs in several ways to the work within this study. Firstly and most
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importantly, for breeding of the F2 generation their study utilised proven male
studs from outside the experiment. The experiment could only therefore analyse
transmission of phenotypes along the maternal line. Our study analysed both
paternal and maternal effects. We noted that food intake was only affected in the
offspring of mating crosses involving MLP exposed male offspring. Secondly the
compositions of the MLP diets within the two studies differ. The present study
includes methionine, whereas the Zambrano et al., (2005) diet contains cysteine.
Although both are sulphur containing amino acids, excess methionine is thought
to perturb metabolism of homocysteine, ultimately contributing to differential
methylation of DNA. This is a possible mechanism driving intergenerational
programming. Thirdly, animals within this study were singly housed at 5, 7 and 9
weeks of age while food intake was monitored. Animals within the Zambrano
study were housed in single sex caging at 14 weeks of age, the amount of food
consumed was averaged between the numbers of animals in each cage. This
method lacks accuracy.
F3 generation offspring exhibited no differences in energy intake between
any of the mating crosses, at any of the time points monitored. Feed efficiency at
9 weeks was reduced in the MLP x MLP mating cross compared to controls. As
previously stated, this is the first time in-depth analysis of feeding behaviour and
body composition has been monitored in the F2 and F3 generations following
maternal protein restriction. As such there is little evidence with which to
compare the results within this chapter. Perhaps most striking is the fact that
effects emerge in the F2 generation, for example reduced feed efficiency in all
MLP mating crosses, that are not seen within the F1 generation. This has
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possible implications for body composition, which is discussed later within this
chapter.
Body composition of the F1 generation following maternal protein
restriction has been well documented. Previous studies have suggested that adult
body composition does not appear to differ between MLP exposed animals and
control animals, although there is some evidence that MLP exposed male rats
deposit more gonadal fat with ageing (Bellinger et al., 2004). Roach et al., have
also reported abnormalities in bone morphology in MLP animals (Roach et al.,
1999). Similar to previous findings, body composition within this study did not
differ with exposure to MLP diet in utero. All organs and fat pads were of similar
size irrespective of maternal diet. It is important to note that the effect of aging
upon body composition was not investigated in the F1 generation within the
current study. There was no difference in circulating metabolites in the F1
generation confirming previous findings.
F2 generation body composition at 10 weeks of age was similar to F1
generation animals and all organs were of similar size relative to body weight.
Unexpectedly F2 generation animals exhibited a lower abdominal fat deposition
in all MLP groups. Although MLP groups by 9 weeks of age showed reduced
feed efficiency leading us to expect a smaller body due to slower growth, F2
MLP groups were of normal bodyweight at time of cull. This suggests F2
generation MLP groups may be programmed to avoid fat gain whilst retaining
lean mass (lean phenotype). This may be driven by mechanisms such as
increased physical activity or thermogenesis. By 1 year of age (data not shown),
the lean phenotype observed in the 10 week animals had disappeared, animals
from all MLP groups had comparable body weights and abdominal fat deposits
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to Con x Con group animals. Previous research in the F1 generation has indicated
that although initially, up to 1 year, MLP offspring appear to be resistant to
obesity, by 18 months there is an abrupt change in metabolic profile. Insulin
resistance and hypertriacylglycerolaemia result in the development of an age-
dependant metabolic syndrome-like phenotype (Erhuma et al., 2007a). It is
possible that this age-dependant process was operating in both the F1 and F2
generation within the current investigation. However the phenotype remained
unnoticed as the effect of aging was not monitored within the F1 generation.
Mating cross had no effect on body composition in the F3 generation, all
organs and fat pad sizes relative to body weight were similar in control and MLP
groups, this was unexpected as in the previous generation effects due to MLP
mating cross were noted. The F3 generation MLP group had lower feed
efficiency at 9 weeks of age than control animals and were of similar body
weight at time of cull. This suggests that the protective processes operating in the
F2 were still operating, but less effectively. There was no change in body
composition at 1 year of age.
3.9.1.2 Postnatal high fat feeding.
The primary aim of feeding a postnatal HF diet was to unmask any
programmed hyperphagia in MLP crosses of the F2 and F3 generations. Previous
studies have indicated that MLP exposed animals (F1) exhibit altered appetite
preferences, with a preference for higher fat, more energy dense food types
(Bellinger et al., 2004). HF diets have been routinely used by several research
groups in order to induce obesity following maternal dietary change (Ortmann et
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al., 2003; Ozanne et al., 2004; Vickers et al., 2000). In contrast to previous
research, the introduction of a HF diet at 4 weeks postnatal age to the F1
generation did not promote hyperphagia in MLP offspring, Food intake (grams
per day per kilogram body weight) was substantially reduced at all time points
monitored. Energy intakes initially reduced (5 weeks) with the introduction of
the novel HF diet. However, by 7 weeks of age, energy intakes were similar to
animals maintained on a standard laboratory chow postnatal diet irrespective of
prenatal exposure to MLP. The initial reduction in energy intake was probably
due to the palatability of the food - animals were only weaned onto the HF diet at
4 weeks of age, and therefore had possibly not fully become accustomed to the
new diet. Texture of the diet is another possibility - the HF diet utilised with this
study is very soft, possibly impacting upon energy intakes. It is also well known
that young rodents very effectively regulate food intake to maintain energy
balance (Woods and Strubbe, 1994). The observed lower intake probably reflects
this response. The reason as to why the feeding of a HF diet did not promote
hyperphagia in the MLP offspring after habituation to the HF diet is unknown.
However, it is likely that the palatability of the diet is the key issue. Although
Bellinger and colleagues (2005) used a HF diet with exactly the same
composition, it must be noted that access to the HF diet in this study was part of
a self- selection protocol whereby animals were offered free access to a HF diet,
a high carbohydrate diet and a high protein diet (Bellinger., 2005). Despite the
differences to previous research, the feed efficiency (weight gained per unit of
energy intake) of animals maintained on a HF postnatal diet in the F1 generation
roughly doubled. However, once again there was no interaction with maternal
diet.
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Unexpectedly, food intake of the F2 generation differed to that of the F1
generation, although food intakes similarly decreased in all groups when fed a
HF diet. , An interaction between maternal diet/ mating cross and postnatal diet
was noted at 5 and 7 weeks of age, which was absent in the F1 generation.
Animals from the MLP x Con cross were hyperphagic compared to other crosses
when maintained on a postnatal HF diet. Energy intakes however remained
similar at all time points monitored and, although as in the F1 generation feed
efficiency was higher in postnatal HF animals compared to chow, no interaction
with mating cross was noted at 5 and 7 weeks of age. However at 9 weeks of age
an interaction of maternal cross and postnatal diet was noted, with feed
efficiency substantially decreasing in males from the MLP x Con cross compared
to all the other F2 crosses.
F3 generation food intake was similar to the F1 generation, with no
interaction of maternal diet/ cross noted at any time point and the introduction of
a postnatal HF diet reduced food intakes in comparison to chow animals. Energy
intakes were similar at 5 and 7 weeks of age, whereas previous generations had
noted a consistent reduction in energy intakes at 5 weeks, suggesting that the
introduction of a novel diet with a different palatability was not an issue for the
F3 generation. However, at 9 weeks of age energy intakes in HF animals were
reduced regardless of maternal cross. The reason why the reduction in energy
intake was observed at a later time point in F3 animals is unknown, but this may
imply possible changes to the central nervous system and the hypothalamus. The
responses to the feeding of a HF diet postnatally differed across generations, but
the reason for these differences remains unknown. As there was no interaction
with maternal diet/ cross, these are essentially different batches of Wistar rats
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and it would therefore be expected that all three generations would have similar
responses to a postnatal HF challenge. There is, however, one concordant theme
running through each generation and that is that the HF diet utilised within this
study failed to induce hyperphagia.
As expected due to a higher feed efficiency, the subsequent effects of postnatal
HF feeding in the F1 generation mainly impacted upon abdominal fat deposition.
Gonadal and perirenal fat pad size was greater in animals on a HF postnatal diet
at 10 weeks of age. However animals were of similar body weight at time of cull,
suggesting that HF fed animals sacrificed lean tissue accretion for fat deposition
during growth.
As noted in the F1 generation, postnatal HF feeding in the F2 mainly
impacted upon abdominal fat deposition. Although body weight remained
similar, fat pad size was greater in all mating cross groups. The lean phenotype
observed in the MLP groups on postnatal chow diet remained even with HF
feeding. This further suggests that the F2 MLP groups possessed an adaptive
mechanism to cope with excessive energy in the diet. As suggested earlier this is
possibly due to enhanced physical activity or thermogenesis.
As in the previous generations, HF feeding in the F3 generation resulted
in greater abdominal fat deposition in combination with greater feed efficiency.
Body weight however was significantly reduced and all organ sizes relative to
body weight, except for the thymus, spleen and heart were greater than in chow
fed animals, suggesting growth was somehow restricted in lieu of fat deposition.
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3.9.1.3 Conclusion
The data within this chapter suggests that the HF diet failed to unmask
any programmed hyperphagia as previously observed within the work of
Bellinger and colleagues (2005). In contrast, animals demonstrated hypophagia
when offered a HF diet, perhaps due to the poor palatability of the diet or as an
attempt to regulate food intake to maintain energy balance.
The development of a lean phenotype within the F2 generation, which
remains evident regardless of a postnatal HF challenge, suggests that the F2 MLP
groups possessed an adaptive mechanism to cope with excessive energy in the
diet via either enhanced physical activity or thermogenesis. However, the reason
why responses varied across generations remains unknown. In order to follow up
data from this chapter, an investigation of energy expenditure is essential as
differences in energy intake and feed efficiency were absent and do not explain
the emergence of the F2 lean phenotype.
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4.0 Prenatal protein restriction, locomotor activity and behaviour
4.1 Introduction
The data described in chapter 3 suggested that F2 animals whose parents
were exposed to protein restriction in utero exhibit reduced feed efficiency and
appear to be resistant to abdominal fat deposition, even when consuming a HF diet.
As no difference in energy intake was observed between these groups, we postulated
that increased expenditure of energy through activity may be the underlying cause of
this difference in phenotype.
Previous studies in our laboratory have shown that mature, low protein
exposed animals actually deposit significantly more abdominal fat compared to
control animals (Bellinger et al., 2004). However, this is a phenotype that largely
develops with senescence (between 12 and 18 months of age) (Erhuma et al., 2007a).
MLP-exposed animals have also been shown to have an increased preference for
high fat, over high carbohydrate and high protein feed (Bellinger et al., 2004).
Previous experiments have examined the impact of timing of prenatal exposure to
MLP upon energy expenditure. MLP exposure during the first week of gestation was
found to be associated with the greatest reduction in energy expenditure when
oxygen consumption was measured by indirect calorimetry (Bellinger, 2005).
Providing a self-selection diet protocol at weaning to animals exposed to a MLP diet
during gestation increased their fat preference. However if the introduction of the
self-selection diet protocol is delayed until 6 months of age post-weaning, the effect
is diminished (Bellinger et al., 2004).
The effects of either a global or specific nutrient restriction during gestation
and their subsequent effects on behaviour have been monitored by various authors.
One of the first reports was by Jones and colleagues (1982) who studied the link
134
between restricted maternal nutrient supply and appetite and weight gain. They noted
hyperphagia and subsequent weight gain in animals exposed to global nutrient
restriction in utero and maintained on an energy dense diet postnatally (Jones and
Friedman, 1982). Since this initial observation there has been a wealth of interest in
how prenatal nutrition can impact upon later behaviour. One of the main areas of
research has been upon the effect of calorie restriction both pre- and postnatally on
indices of behaviour. Maternal calorie restriction during both gestation and /or
lactation can have permanent effects on resulting offspring’s responsiveness to
novelty (Levitsky and Barnes, 1972), and social behaviour (Whatson and Smart,
1978). Caloric restriction has also been shown to enhance anxiety-like behaviours in
rat offspring (Jaiswal et al., 1996).
Despite growing interest, the mechanisms that programme behaviour
associated with restricted maternal nutrition are poorly understood. Metabolic and
physiological changes have been noted in animals exposed to calorie restriction both
pre- and postnatally. Caloric restricted offspring have been shown to exhibit
hypothalamic-pituitary-adrenal (HPA) hyperactivity under stress conditions (Sebaai
et al., 2004; Sebaai et al., 2002). Most work on caloric restriction concentrates on a
severe restriction of around 50% of ad libitum food intake, impacting on critical
periods of brain development (Sebaai et al., 2004). To date, data on moderate caloric
restriction is unavailable. Differences in behaviour have also been noted in animals
exposed to restriction of specific nutrients. Spasov and colleagues (2008) noted that
rats fed a diet deficient in magnesium for 49 days developed anxiety-releated
behaviours and depression (Spasov et al., 2008). It is well-documented that stress
during gestation may impact upon the offspring (Gotz et al., 2008). Eseh and
colleagues (2005) noted that a maternal diet deficient in iron resulted in offspring
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with increased anxiety behaviours. This behaviour could be reversed with iron
repletion, but some behaviour modifications such as altered exploratory behaviours,
persisted (Eseh and Zimmerberg, 2005).
Several experimental situations are used in order to monitor animal behaviour
and activity including the elevated plus maze, open field test, emergence test and the
monitoring of locomotor activity. Previous studies with our laboratory have used
assessments of locomotor activity to give a basic assessment of behaviour and
physical activity (Bellinger et al., 2006). Within the previous chapter it was noted
that F2 animals whose parents were exposed to protein restriction in utero exhibit
reduced feed efficiency and appear to be resistant to abdominal fat deposition, even
when consuming a HF diet, possibly suggesting increased activity. The locomotor
activity test was used in this chapter to analyse if there were any alterations in
behaviour or locomotor activity between experimental groups that would explain this
phenotype. The main hypothesis of this chapter is that F2 MLP mating cross animals
have increased levels of activity (measured by analysis of locomotor activity)
compared to their control counterparts, which ultimately contributes to the lean
phenotype observed within the previous chapter.
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4.2 Objectives
The work described within this chapter will examine the effects of a prenatal
protein restriction upon locomotor activity in rats of the F1, F2 and F3 generations.
The specific aim of the chapter was:
x To assess whether MLP groups within the F2 generation exhibit
differing behaviour and levels of activity that might be related to the
lean phenotype observed in the previous chapter.
4.3 Materials and Methods
4.3.1 Locomotor Activity
Locomotor activity (section 2.5.1) was monitored in the NC sub-group in the
F1, F2 and F3 generations at both 4 and 10 weeks of age using a Linton AMIU53
Infrared Activity Monitor (Linton Instruments, Diss, UK). The first 30 minutes of a
90 minute test were used to assess the response to a novel environment, since
animals were transferred from their home cage to the test cage. After 30 minutes they
were regarded as habituated to the test conditions. Locomotor activity was only
assessed during the 12-hour light phase.
4.3.2 Statistical analysis
All data is presented as mean ± SEM. All data was analysed using the
statistical package for social sciences (SPSS) version 14. Differences between groups
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were assessed using a mixed model ANOVA (fixed factors, maternal diet, sex, diet
and age), P<0.05 was considered as significant.
4.4 Results
4.4.1 Week 4 Locomotor activity
4.4.1.1 F1 generation
Table 4.1 shows locomotor activity in the F1 generation animals at 4 weeks
of age. Novel activity (breaking any beam on the lower level within 1 second), novel
rearing (breaking a beam on the upper level recorded in 1 second intervals) and novel
mobility (breaking more than one beam on the lower level, within 1 second). Counts
were similar in animals exposed to control and MLP diets in utero. In both maternal
dietary groups counts were similar in both male and female animals. When fed a HF
diet novel activity, rearing and mobility counts all remained similar to values seen in
the chow controls, irrespective of maternal dietary group.
Habituated activity, rearing and mobility counts are also shown within Table
4.1. No effect of maternal dietary group was noted. Counts in male and female
animals were also comparable. When fed a HF diet, habituated activity counts were
greater (P<0.001) approximately two-fold in the animals compared to postnatal chow
animals, regardless of maternal diet in utero and sex. Habituated rearing counts
remained similar in both postnatal dietary groups irrespective of maternal diet or sex.
However, similar to activity levels, habituated mobility counts were greater
(P<0.001) approximately two-fold when comparing rats fed a postnatal HF diet with
thoase fed chow, irrespective of maternal diet and sex.
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Table 4.1 Locomotor activity F1 generation 4 weeks of age.
Locomotor Counts
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
NA NR NM HA HR HM
n
NA NR NM HA HR HM
Control Chow 31 1037.8
±43.4
510.8
±59.3
383.0
±23.7
281.0
±49.2
183.1
±83.8
32.2
±9.8
29 1104.4
±47.3
491.9
±30.7
394.8
±19.6
236.0
±47.5
26.5
±11.8
19.3
±4.7
Control HF 10 949.8
±76.4
472.6
±125.4
335.8
±37.4
431.1
±105.6
214.1
±138.3
69.9
±16.3
10 1049.3
±44.9
797.4
±189.0
394.6
±29.3
346.7
±60.4
493.3
±158.6
70.6
±25.2
MLP Chow 28 1025.8
±43.5
498.8
±55.1
361.4
±23.4
251.6
±11.0
196.3
±66.7
32.1
±11.6
29 998.7
±49.5
502.1
±48.2
360.9
±25.0
313.4
±49.9
200.2
±73.3
40.5
±8.8
F1
MLP HF 10 991.6
±77.5
486.7
±104.9
334.6
±23.3
599.7
±149.8
254.0
±114.0
103.0
±27.9
11 979.6
±55.3
458.6
±78.7
346.5
±23.9
464.4
±77.6
99.9
±30.1
85.3
±16.9
P for effect of maternal diet (F1) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of postnatal diet (F1) NS NS NS P<0.001 NS P<0.001 - NS NS NS P<0.001 NS P<0.001
P for interaction of maternal x postnatal
diet (F1)
NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex (F1) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x maternal diet (F1) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x postnatal diet (F1) NS NS NS NS NS NS - NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. Data are represented as number of infra-red beams broken within 1 second. NA= novel activity, NR = novel rearing,
NM = novel mobility, HA = habituated activity, HR = habituated rearing, HM = habituated mobility and NS= not significant.
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4.4.1.2 F2 generation
Locomotor activity for the F2 generation at 4 weeks of age is displayed
within Table 4.2. In the novel period, activity, rearing and mobility counts were
unaffected by mating cross. Counts in male and female animals were also similar,
regardless of mating cross. When fed a HF diet, novel activity and rearing levels
remained similar to postnatal chow animal levels irrespective of mating cross. Novel
mobility levels however, were (P<0.05) approximately 5% lower in all mating
crosses regardless of sex, except the Con x Con male animals which had 15% greater
mobility when fed HF relative to chow.
Habituated activity, rearing and mobility (Table 4.2) were also unaffected by
mating cross. Counts were similar in male and female animals. When fed the
postnatal HF diet, habituated activity and rearing levels remained similar to postnatal
chow animals, however habituated mobility counts were (P<0.05) approximately
45% higher in comparison to postnatal chow fed animals. This was evident in both
male and female animals irrespective of mating cross.
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Table 4.2 Locomotor activity F2 generation 4 weeks of age.
Locomotor Counts
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
NA NR NM HA HR HM
n
NA NR NM HA HR HM
Con x
Con
Chow 33 1001
±77.11
347.5
±79.3
318.7
±48.1
407.9
±115.2
80.8
±22.9
50.4
±13.1
33 1001.8
±64.1
420.9
±59.9
354.6
±39.6
281.6
±54.6
33.3
±20.6
31.2
±15.3
Con x
Con
HF 11 1042.5
±104.6
336.6
±55.9
364.6
±52.7
654.4
±147.9
71.6
±26.2
60
±11.4
11 1085.1
±39.6
391.8
±40.8
338.6
±29.9
477.2
±114.9
88.8
±52.4
47.1
±13.7
Con x
MLP
Chow 24 1039
±85.6
520.8
±95.4
362.3
±38.2
479.4
±150.3
209.9
±136.5
33.8
±11.4
24 1133.7
±76.4
708.8
±137.1
396.8
±47.7
443.5
±128.8
190
±141.5
51
±18.7
Con x
MLP
HF 8 960.1
±42.1
623
±147.7
330.9
±22.4
417.6
±126.4
342
±176.5
81.63
±31.7
8 887.3
±89.9
447.5
±99.5
290.2
±48
353.7
±80.4
367.2
±286.3
67.2
±22.7
MLP x
Con
Chow 23 1063.8
±54.8
483.1
±44.8
409.6
±28.1
177.9
±15.9
6.1
±2.5
13.7
±3.4
26 1054.4
±71.8
528.9
±105.7
379.1
±26.6
313.8
±114.8
179.1
±126.9
46.1
±21.4
MLP x
Con
HF 7 900.3
±61.5
319
±50.5
299.3
±33
351.9
±105.4
129
±68.8
74.3
±31.2
8 1010.1
±61.9
444.1
±82.1
338
±30.3
288
±92
132.4
±63.7
50.4
±25.3
MLP x
MLP
Chow 35 1002.5
±39.5
465.9
±72.4
351.7
±24.3
286.5
±45.5
92.1
±43.6
37.3
±10.6
29 1015.5
±63.5
506.3
±86.1
366
±34
298.8
±92.7
47.5
±16.6
53.4
±24.9
F2
MLP x
MLP
HF 10 1022
±81.3
437.6
±142.1
334.3
±29.2
550.4
±147.7
264.8
±157.9
99.8
±30.2
11 920.6
±49.8
635.5
±128.8
316.1
±26.8
382.1
±78.4
387.5
±154.5
77.3
±21.9
P for effect of mating cross (F2) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of postnatal diet (F2) NS NS P<0.05 NS NS P<0.05 - NS NS P<0.05 NS NS P<0.05
P for interaction of mating cross x postnatal
diet (F2)
NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex (F2) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x mating cross (F2) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x postnatal diet (F2) NS NS NS NS NS NS - NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. . Data are represented as number of infra-red beams broken within 1 second. For F2 and F3 crosses the dietary origin
of the male parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero.
NA= novel activity, NR = novel rearing, NM = novel mobility, HA = habituated activity, HR = habituated rearing, HM = habituated mobility and NS= not significant.
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4.4.1.3 F3 generation
Table 4.3 depicts the locomotor activity of F3 generation animals at 4 weeks
of age. As with the F1 and F2 rats, in the novel period activity, rearing and mobility
counts were similar in both groups (Con x Con & MLP x MLP). Counts in male and
female animals were also comparable. Postnatal HF feeding had no effects upon
locomotor activity.
Once habituated the activity, rearing and mobility of the rats (Table 4.3) were
also unaffected by mating cross, and sex. Postnatal HF feeding however did impact
upon habituated rearing and mobility levels. Rearing behaviour was considerably
more common (P<0.05) approximately 280% higher, and mobility was greater
(approximately two-fold higher P<0.05) in animals fed the postnatal HF diet,
compared to animals maintained on chow diet, irrespective of mating cross or sex.
Habituated activity levels remained similar in all groups.
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Table 4.3 Locomotor activity F3 generation 4 weeks of age.
Locomotor Counts
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
NA NR NM HA HR HM
n
NA NR NM HA HR HM
Con x
Con
Chow 31 1140.6
±72.1
510.3
±56.6
407.8
±41.7
339.2
±166.8
18.4
±9.7
21.1
±9.8
29 1021.9
±37.7
456.6
±61
394.7
±24.1
293.7
±54.7
45.1
±25.5
29.6
±13.5
Con x
Con
HF 11 1124.8
±61.4
489.5
±73.5
432.8
±34.8
360.8
±91.5
108.7
±42.1
80.1
±32.5
9 1040.8
±67.3
491.9
±61.4
399.1
±49.7
439.4
±115.5
278.3
±92.1
104.9
±42.4
MLP x
MLP
Chow 23 1031.1
±51.7
511.6
±43.8
387.1
±45.6
500.4
±149.1
54.5
±27.0
101.6
±58.5
24 1069.6
±120.4
454.1
±51.7
421.8
±50.5
356.4
±168.1
37.4
±9.4
36.1
±6.9
F3
MLP x
MLP
HF 8 1131.9
±100.8
387.3
±48.7
381.6
±45.6
498.3
±119.9
136.6
±60.1
103.4
±30.2
8 953.3
±59.4
373.8
±39.6
343.4
±29.9
374.5
±87.9
144.5
±51.8
88.5
±27.3
P for effect of mating cross (F3) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of postnatal diet (F3) NS NS NS NS P<0.05 P<0.05 - NS NS NS NS P<0.05 P<0.05
P for interaction of mating cross x
postnatal diet (F3)
NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex (F3) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x mating cross (F3) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x postnatal diet (F3) NS NS NS NS NS NS - NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. . Data are represented as number of infra-red beams broken within 1 second. For F2 and F3 crosses the dietary origin
of the male parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero.
NA= novel activity, NR = novel rearing, NM = novel mobility, HA = habituated activity, HR = habituated rearing, HM = habituated mobility and NS= not significant.
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4.4.2 10 week Locomotor Activity
4.4.2.1 F1 generation
Table 4.4 shows the locomotor activity of the F1 generation at 10 weeks of
age. In the novel period, activity rearing and mobility counts were similar in animals
exposed to control and MLP diets in utero. Novel activity (P<0.001) and mobility
(P<0.001) values were higher by approximately 16% in females than in males.
Postnatal HF feeding had no effect on novel activity, rearing or mobility counts,
where values remained similar to chow fed animals. Once habituated, activity,
rearing and mobility counts (Table 4.4) remained similar. Thus, as in 4 week old rats,
at 10 weeks of age there was no effect of maternal diet in utero on locomotor activity
in the F1 generation.
4.4.2.2 F2 generation
Locomotor activity of the F2 generation at 10 weeks of age is shown in Table
4.5. Novel activity, rearing and mobility counts were similar in animals from all
mating crosses. Novel activity values were generally similar among male and female
animals. However novel rearing levels were (P<0.05) approximately 20% lower in
females compared to males on a chow postnatal diet, irrespective of mating cross.
Novel mobility counts however were (P<0.05) approximately 25% higher in females
compared to their male counterparts. Postnatal HF feeding had no effect on novel
activity, rearing or mobility in the F2 generation, in either sex.
Table 4.5 also shows the habituated activity, rearing and mobility counts for
the F2 generation animals. Similar to the novel period habituated activity rearing and
mobility counts were unaffected by mating cross. There was also no difference
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between male and female animals for habituated activity and rearing, but habituated
mobility was greater (P<0.001) in females compared to male animals. There was no
effect of postnatal HF feeding on habituated activity, but habituated rearing values
were substantially higher (approximately three-fold, P<0.001) compared to levels
observed in chow fed animals. Similarly, habituated mobility levels were also greater
(2-3-fold, P<0.001) irrespective of sex and mating cross.
4.4.2.3 F3 generation
Table 4.6 shows locomotor activity of the F3 generation at 10 weeks of age.
Novel activity and rearing were unaffected by mating cross. Novel mobility levels
were (P<0.05) approximately 18% lower in the MLP x MLP mating cross, compared
to the Con x Con controls. Novel activity, rearing and mobility levels were similar in
male and females. Postnatal HF feeding also had no effect on novel activity, rearing
or mobility levels.
In the habituated state, activity, rearing and mobility (Table 4.6) counts were
all unaffected by mating cross. There was also no effect of sex. Postnatal HF feeding
had no impact on habituated activity or mobility, but rearing was (P<0.05)
approximately three-fold more prevalent in animals fed a postnatal HF diet compared
to those fed a postnatal chow diet, irrespective of sex and mating cross.
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Table 4.4 Locomotor activity F1 generation 10 weeks of age.
Locomotor Counts
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
NA NR NM HA HR HM
n
NA NR NM HA HR HM
Control Chow 31 1096.2
±37.6
894.6
±47.3
507.7
±23.3
390.3
±59.2
262.7
±62.9
96
±18.2
29 1280.3
±35.7
798.4
±36.7
586.9
±22.4
472.9
±69.9
285.1
±60.6
122
±25.5
Control HF 10 1035.1
±52.8
740.4
±159.4
398.6
±41.6
600.8
±146.8
516.1
±157.2
151.7
±34.4
10 1220
±40.2
864.9
±111.8
566.4
±32.5
505.4
±132.9
612.9
±184.1
128.3
±49.1
MLP Chow 28 1148.5
±40.6
971.9
±55.2
516.4
±21.9
383.5
±79.5
530.5
±128.8
73.8
±15.5
29 1263.6
±35.1
865.2
±51.2
594.3
±23.5
525.8
±71.5
389.8
±84.3
149.6
±25.6
F1
MLP HF 10 1071.1
±41.8
784.8
±119.7
460.4
±28.4
532.1
±79.1
443.6
±125.4
143.9
±38.1
11 1347.9
±42.5
813.5
±108.1
626.6
±27.3
548.3
±128.7
427.1
±143.3
128.5
±43.1
P for effect of maternal diet (F1) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of postnatal diet (F1) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex (F1) P<0.001 NS P<0.001 NS NS NS - P<0.001 NS P<0.001 NS NS NS
P for interaction of maternal x postnatal
diet (F1)
NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x maternal diet (F1) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x postnatal diet (F1) NS NS P<0.05 NS NS NS - NS NS P<0.05 NS NS NS
Data shows mean ± SEM for n observations per group. Data are represented as number of infra-red beams broken within 1 second. NA= novel activity, NR = novel rearing,
NM = novel mobility, HA = habituated activity, HR = habituated rearing, HM = habituated mobility and NS= not significant.
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Table 4.5 Locomotor activity F2 generation 10 weeks of age.
Locomotor Counts
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
NA NR NM HA HR HM
n
NA NR NM HA HR HM
Con x
Con
Chow 33 1102.6
±75.6
894
±98.1
454.2
±50.4
325
±54.8
334.4
±140.2
53.2
±13.9
33 1199
±41.3
789
±70.1
529.5
±22.3
436.5
±197.4
186.9
±96.4
42.9
±27
Con x
Con
HF 11 1051.3
±37.2
945.2
±138.3
387.4
±37.4
432.5
±102.2
602.8
±230
48.2
±15.2
11 1188.8
±75.6
846.9
±73.9
534.3
±38.6
348.6
±81.6
319.1
±120.2
91.4
±25.5
Con x
MLP
Chow 24 994.1
±53.5
816.6
±83.1
379.5
±26.8
220.4
±48.3
24.1
±6.9
13.4
±4.4
24 1226.4
±33.5
678
±52.7
568.6
±25.8
401.7
±99.2
141.4
±59
99.4
±39.3
Con x
MLP
HF 8 1065
±128.9
666.5
±116.3
380.6
±52.5
581.5
±219.4
293.8
±167.6
99.5
±51.7
8 1012.6
±71.7
611.4
±66.6
423.9
±33.5
369.3
±139.9
197.1
±70.4
59.6
±19.6
MLP x
Con
Chow 23 896.4
±86.3
718
±97.8
381.8
±45.1
113.2
±56.8
194.4
±176.1
20.8
±13.9
26 996.6
±74
580.9
±69.8
426.9
±38.1
162.4
±33
117.8
±65.9
23.8
±8.3
MLP x
Con
HF 7 1002.7
±41.6
860.2
±67.6
424.5
±26.5
264.7
±71.2
609.8
±218.9
57
±22.7
8 1101.1
±104.6
819.4
±128.1
467.7
±55.5
349.7
±138.7
368.1
±151.9
61.3
±27.4
MLP x
MLP
Chow 35 1040.4
±48.2
774.2
±90.3
413.7
±25.7
417
±133.7
152
±121.8
31.6
±6.9
29 1138.6
±97.4
613.7
±74.9
520.7
±50.2
353.3
±109.1
302
±224.8
83.4
±40.1
F2
MLP x
MLP
HF 10 1044.7
±55.8
1010
±132.5
393.7
±26.9
392.8
±100.9
660.4
±202.9
51
±23.9
11 1132.8
±66.6
796.9
±126.2
463.1
±39.1
496.4
±122.4
556.8
±147.4
146.9
±53.7
P for effect of mating cross (F2) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of postnatal diet (F2) NS NS NS NS P<0.00
1
P<0.00
1
- NS NS NS NS P<0.00
1
P<0.00
1
P for effect of sex (F2) NS P<0.05 P<0.05 NS NS P<0.00
1
- NS P<0.05 P<0.05 NS NS P<0.00
1
P for interaction of mating cross x postnatal
diet (F2)
NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x mating cross (F2) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x postnatal diet (F2) NS NS NS NS NS NS - NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. . Data are represented as number of infra-red beams broken within 1 second. For F2 and F3 crosses the dietary origin
of the male parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero.
NA= novel activity, NR = novel rearing, NM = novel mobility, HA = habituated activity, HR = habituated rearing, HM = habituated mobility and NS= not significant.
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Table 4.6 Locomotor activity F3 generation 10 weeks of age.
Locomotor Counts
Males FemalesGeneration Maternal
diet/cross
Postnatal
diet
n
NA NR NM HA HR HM
n
NA NR NM HA HR HM
Con x
Con
Chow 31 1132.4
±46.7
738.9
±53.5
489.8
±26.6
261.8
±52.9
101.3
±40.5
51.2
±20.5
29 1121
±60.5
738.2
±57.6
558.2
±38.7
367.3
±105.6
134.1
±58.6
78.2
±32.3
Con x
Con
HF 11 1155.9
±24.2
861.7
±118.9
502.3
±21.2
648.6
±146.1
385.7
±150.1
119.7
±27.8
9 1225.7
±45.8
1085.8
±161.5
565.1
±52.9
347.4
±96.8
775
±249.4
107.7
±40.5
MLP x
MLP
Chow 23 1075.3
±103.1
441.8
±82
398.8
±60.5
149.5
±35.4
15.3
±12.9
9.7
±3.3
24 953.4
±56.6
496
±78.5
395.9
±46.3
181.9
±53.3
52.5
±30.8
34.3
±15.8
F3
MLP x
MLP
HF 8 1053
±90.5
762.5
±110.9
437.8
±61.5
378
±134.3
414.6
±142.9
104.3
±50.5
8 1039.6
±37.5
523.5
±78.6
376.6
±23.3
216.4
±74.1
217.1
±108.2
42.5
±21.3
P for effect of mating cross (F3) NS NS P<0.05 NS NS NS - NS NS P<0.05 NS NS NS
P for effect of postnatal diet (F3) NS NS NS NS P<0.05 NS - NS NS NS NS P<0.05 NS
P for effect of sex (F3) NS NS NS NS NS NS - NS NS NS NS NS NS
P for interaction of mating cross x
postnatal diet (F3)
NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x mating cross (F3) NS NS NS NS NS NS - NS NS NS NS NS NS
P for effect of sex x postnatal diet (F3) NS NS NS NS NS NS - NS NS NS NS NS NS
Data shows mean ± SEM for n observations per group. . Data are represented as number of infra-red beams broken within 1 second. For F2 and F3 crosses the dietary origin
of the male parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP diet in utero.
NA= novel activity, NR = novel rearing, NM = novel mobility, HA = habituated activity, HR = habituated rearing, HM = habituated mobility and NS= not significant.
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4.5 Discussion
4.5.1 Summary of findings
Investigations of the effects of caloric restriction and the feeding of a
MLP diet in utero upon locomotor activity in the F1 generation have been
previously documented (Bellinger et al., 2006; Vickers et al., 2003). The data
presented in this chapter uniquely considers whether this original dietary insult
has an effect on locomotor activity and behaviour in subsequent generations.
4.5.1.1 Summary of findings 4 week locomotor activity.
Table 4.7 Summary of findings at 4 weeks of age.
Generation
F1 F2 F3
Novel activity No change with
maternal diet or
with postnatal diet
No change with
maternal diet or with
postnatal diet
No change with
maternal diet or with
postnatal diet
Novel rearing No change with
maternal diet or
with postnatal diet
No change with
maternal diet or with
postnatal diet
No change with
maternal diet or with
postnatal diet
Novel mobility No change with
maternal diet or
with postnatal diet
No change with
maternal diet,
decreased with HF
postnatal feeding
No change with
maternal diet or with
postnatal diet
Habituated activity No change with
maternal diet,
increased with HF
postnatal feeding
No change with
maternal diet or with
postnatal diet
No change with
maternal diet or with
postnatal diet
Habituated rearing No change with
maternal diet or
with postnatal diet
No change with
maternal diet or with
postnatal diet
No change with
maternal diet,
increased with HF
postnatal feeding
Habituated mobility No change with
maternal diet,
increased with HF
postnatal feeding
No change with
maternal diet,
increased with HF
postnatal feeding
No change with
maternal diet,
increased with HF
postnatal feeding
Table 4.7 shows a brief summary of findings from the assessment of locomotor activity at 4
weeks of age in the F1, F2 and F3 generations.
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Table 4.7 shows a summary of findings from the 4 week locomotor analysis.
There was no effect of maternal diet/ mating cross on locomotor activity in either
novel or habituated periods at 4 weeks of age, in any generation. Postnatal high
fat feeding resulted in greater habituated activity and mobility in the F1
generation. However in the F2 generation HF feeding decreased novel and
habituated mobility. In the F3 generation postnatal HF feeding resulted in higher
habituated rearing and mobility counts. This data suggest that rats alter
locomotor activity when challenged with a HF diet, but despite variation in the
nature of this response between generations, there was no evidence of
programming by protein restriction.
4.5.1.2 Summary of findings 10 weeks locomotor activity.
Table 4.8 Summary of findings at 10 weeks of age.
Generation
F1 F2 F3
Novel activity No change with
maternal diet or
with postnatal diet
No change with
maternal diet or with
postnatal diet
No change with
maternal diet or with
postnatal diet
Novel rearing No change with
maternal diet or
with postnatal diet
No change with
maternal diet or with
postnatal diet
No change with
maternal diet or with
postnatal diet
Novel mobility No change with
maternal diet or
with postnatal diet
No change with
maternal diet or with
postnatal diet
Decreased in MLP x
MLP mating cross, no
effect of postnatal diet
Habituated activity No change with
maternal diet or
with postnatal diet
No change with
maternal diet or with
postnatal diet
No change with
maternal diet or with
postnatal diet
Habituated rearing No change with
maternal diet or
with postnatal diet
No change with
maternal diet,
increased with HF
postnatal feeding
No change with
maternal diet,
increased with HF
postnatal feeding
Habituated mobility No change with
maternal diet or
with postnatal diet
No change with
maternal diet,
increased with HF
postnatal feeding
No change with
maternal diet or with
postnatal diet
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Table 4.8 shows a brief summary of findings from the assessment of locomotor activity at 4
weeks of age in the F1, F2 and F3 generations.
Table 4.8 shows a summary of the findings from the locomotor analysis
of 10 week old animals. There was no effect of maternal diet/ mating cross on
locomotor activity in either novel or habituated states, at 10 weeks of age, in the
F1 or F2 generation. In the F3 generation novel mobility was decreased in the
MLP x MLP group. Postnatal HF feeding had no impact upon the behaviour of
the F1 generation at 10 weeks of age. The F2 generation exhibited higher
habituated rearing and mobility. Postnatal HF diet resulted in greater habituated
rearing counts in the F3 generation. These findings largely confirm those in
younger animals, as there were few programmed changes in behaviour.
Interestingly in the older rats the response to HF feeding seen in weanlings was
largely absent.
4.5.2 Effect of prenatal protein restriction and mating cross on locomotor
activity.
Over the last few decades there has been considerable interest in
environmental stressors and the development of behavioural disorders. The most
striking of these was the association between schizophrenia (Susser, 1996; Susser
et al., 1996) and affective disorder (Brown et al., 2000) following early life
exposure to the Dutch Hunger Winter. Maternal stress and lower socio-economic
status in gestation have also been associated with attention deficit disorder and
developmental delays in childhood (Biederman et al., 1995; Milberger et al.,
1997; Stott, 1973). Indeed many variables have the potential to impact upon fetal
development including, stress, malnutrition, disease susceptibility, drug use and
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delivery complications, (Faraone and Biederman, 1998; Milberger et al., 1997;
Sprich-Buckminster et al., 1993). The current study utilised analysis locomotor
activity to investigate behaviour and activity within the F1, F2 and F3
generations.
The analysis of locomotor activity is used as an indication of spontaneous
behaviour over a 90 minute period that is split into three stages (each 30
minutes), firstly, the novel period (first 30 minutes). Locomotor activity during
this time is analysed in order to assess behaviour in a novel environment.
Secondly, the habituated period, which is an average of the counts observed in
the second and third stages. Locomotor activity during this time is used to assess
habituated locomotor activity, for example how the animals behaves in the home
cage.
Previous work within our laboratory has indicated that, at 13 months of
age, female animals were more active than males in novel periods, and that
rearing behaviours were significantly influenced by maternal diet. MLP exposed
animals exhibited lower levels of rearing than controls (Bellinger et al., 2006).
Similarly Vickers and colleagues noted decreased activity in animals exposed to
maternal undernutrition (Vickers et al., 2003). As previously stated, rearing
behaviour is often referred to as emotional behaviour, and is associated with
stressful situations, such as being in a novel environment (Borta and Schwarting,
2005). This therefore suggests that animals exposed to protein restriction in utero
are less likely to become stressed in novel situations, or that they have a reduced
exploratory behaviour. Opinions about the effects of prenatal malnutrition are
clearly split as Almeida and co-workers indicate that prenatal malnutrition
enhances exploratory behaviour (Almeida et al., 1996). Interestingly, recent
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studies examining the impact of maternal cafeteria feeding to induce obesity
during the pre-mating, pregnancy or suckling periods, has suggested offspring
exposed to highly palatable diet during suckling show less anxiety when on a
plus-maze or in an open field (Wright et al., unpublished data).
Unlike previous studies, data from the current investigation indicated no
effect of maternal diet or mating cross on F1 or F2 generation locomotor activity
levels at either 4 or 10 weeks of age in either novel or habituated periods. Similar
to the F2 generation, the F3 generation exhibited no maternal diet-related
difference in locomotor activity in novel or habituated periods at 4 weeks of age,
but by 10 weeks of age animals from the MLP x MLP mating cross were less
mobile in the novel period than the Con x Con group. Although the results were
unexpected, it is important to note that the present study differs in several ways
to studies that have previously reported reductions in activity and rearing levels
(Bellinger et al., 2006; Vickers et al., 2003). Firstly in the study by Vickers et al.,
(2003) a global restriction of 30% was applied in pregnancy, compared to the 9%
protein restriction used within the present study. Also timing and type of
locomotor assessment was different, locomotor activity was measured at 5, 20
and 60 weeks of age using less sophisticated methodology than in the present
study where assessments were made at 4 and 10 weeks of age. Similarly in the
work by Bellinger and colleagues (2006), only animals subjected to a (9%
casein) MLP diet during the final week of gestation exhibited decreased rearing
counts. Animals were also assessed at 13 months of age so there is the possibility
that MLP animal groups could develop differences in behaviour with aging.
Another possible alternative is that differences in behaviour manifest at night
(during darkness). During this investigation locomotor activity was only
153
monitored during daylight and this could possibly account for the differences
between the studies.
One of the aims of the work presented in this chapter, was to assess
whether differences in body composition noted in chapter 3 could be related to
differences in locomotor activity and hence energy expenditure through physical
activity. We had noted that F2 animals derived from parents originally exposed
to a MLP diet in utero, exhibited a leaner body composition and a relative
resistance to fat gain when fed a HF diet. This suggests that mechanisms are in
place to expend energy without fat accretion, since food and energy intakes
showed no evidence of programmed differences. The analysis of locomotor
activity showed no difference in components of behaviour that might contribute
to energy expenditure (activity & mobility). This indicates that other
mechanisms, such as increased thermogenesis or BMR maintain the leaner body
composition seen in these animals.
To date, there is very little literature about BMR in relation to fetal
programming. Daenzer and coworkers (2002) considered the effect of increased
maternal protein in utero on resting metabolic rate (RMR) in F1 generation
animals and found that maternal protein exposure had no effect. However this
study did report a decrease in both total and weight specific total energy
expenditure (TEE), suggesting the cause may be due to thermogenesis or
physical activity (Daenzer et al., 2002). Similarly, studies within our laboratory
have found no difference in RMR in MLP exposed animals (Bellinger, 2005;
Ware, 2008). Unfortunately due to the complex study design and time limits we
were unable to monitor RMR within the present study. Our data in the context of
other work suggests that differences in body composition seen within the F2
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generation must be due to some other mechanism such as non-exercise activity
thermogenesis (Levine et al., 2006).
Uncoupling protein 1 (UCP1) expression is associated with thermogenic
activity. Expression of UCP1 is most abundant in brown adipose tissue (BAT)
(Power, 1989). It has been proposed that overall BAT mass may be related to
UCP1 availability. Recent observations suggest that UCP1 expression in brown
adipocytes within inguinal fat deposits are very sensitive to the nutritional
environment, as global undernutrition during gestation severely suppresses UCP1
expression in the fat depots of mice (Kozak and Anunciado-Koza, 2008).
Previous work within our laboratory has indicated that animals exposed to MLP
have altered ratios of brown to white fat in the intrascapular depot and have
significantly increased UCP1 expression in BAT (Bellinger, 2005). Scarpace and
colleagues (1997) noted that increased UCP1 expression is associated with
increased energy expenditure (Scarpace et al., 1997). Recent studies in mice
however, cast doubt on UCP1 as a mechanism protecting against fat gain, as
UCP1 deficient mice have been shown to be resistant to diet induced obesity (Liu
et al., 2003). Although current opinion is split, these results suggest that within
the present study, the “lean phenotype” observed within the F2 generation could
be due to increased UCP1 expression. This mechanism enables animals to
process excess energy less efficiently, reducing fat deposition.
4.5.3 Effect of postnatal HF feeding on locomotor activity and behaviour.
In the present study the postnatal feeding of a HF diet to rats of the F1
generation had no effect on activity, rearing or mobility in the novel period at
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either 4 or 10 weeks of age. However, in the habituated state, activity and
mobility levels were elevated in 4 week old animals. Previous data suggests that
postnatal hypercaloric nutrition exacerbates sedentary behaviour (Vickers et al.,
2003), this was however data from prenatal globally restricted (30%) animals. In
a recent study, mice selectively bred for a high level of wheel running were
maintained on a HF diet (60%). Male animals were observed to reduce their food
intake but still increased body fat, whereas females increased their ingested
calories without any effects on body mass. Females increased daily energy
expenditure, spontaneous activity (700%) and had a higher BMR (Vaanholt et
al., 2008). This data suggests that on feeding HF to rodents, both BMR and
locomotor activity are altered in a sex specific manner in order to facilitate fat
utilization.
To my knowledge no data currently exist with the wider body of literature
regarding locomotor activity in programmed animals in the F2 and F3
generations. Our results show that at 4 weeks of age F2 animals on a HF
postnatal diet exhibited increased mobility levels in both novel and habituated
periods. However by 10 weeks of age both habituated rearing and mobility were
increased. Similarly habituated rearing (4 & 10 weeks) and mobility (4 weeks)
levels were higher in the F3 generation. This suggests that the activity was
increased in animals on postnatal HF diet in order to shed excess energy imposed
by the postnatal diet.
4.5.4 Conclusions.
Data from the previous chapter suggested an intergenerational effect of a
MLP diet during gestation, impacting upon fat deposition in the F2 generation in
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the absence of changes to energy intake between groups. Although the
mechanism driving the observed lean phenotype remains unknown, we can
exclude differences in activity, and so it is likely to involve thermogenesis and
possibly UCP1 expression. Work presented in this thesis will now focus on the
well-documented raised systolic blood pressure associated with the MLP diet.
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5.0 Prenatal protein restriction and blood pressure.
5.1 Introduction
Findings from epidemiological associations between weight at birth and CVD
(Barker et al., 2002b; Barker et al., 1993; Langley-Evans, 2006) are supported by
animal experiments showing that nutrition in utero can programme adult blood
pressure (Bergel and Belizan, 2002; Crowe et al., 1995; Gambling et al., 2003;
Langley and Jackson, 1994). The feeding of MLP in rat pregnancy as reported within
this investigation, has previously been shown to programme a lifelong elevation of
systolic blood pressure (Langley-Evans et al., 1996b; Langley-Evans et al., 1996c;
Langley-Evans et al., 1994; Langley and Jackson, 1994). It is well documented that
animals exposed to MLP diet in utero consistently exhibit raised systolic blood
pressure by 4 weeks of age (Langley-Evans, 2001). The magnitude of the increase
varies between 7 and 30 mmHg (Langley-Evans et al., 1994; Langley and Jackson,
1994) and appears to be permanent, remaining elevated well into adulthood, in both
male and female animals (Langley-Evans and Jackson, 1995; Nwagwu et al., 2000).
High blood pressure associated with the MLP diet is also found to coincide with a
reduced heart rate (Nwagwu et al., 2000). Previous studies within our laboratory
have suggested that the timing of the MLP insult during gestation is not critical in the
programming of blood pressure. Feeding MLP for single weeks of gestation, for
example days 0-7, increased blood pressure to a similar level as that noted in animals
restricted between days 8-14 (Langley-Evans et al., 1996d). The final week of
gestation (days 15-22), has been shown to be associated with a greater elevation of
blood pressure. However, the greatest increase is seen when feeding a MLP diet
throughout the whole of gestation (Langley-Evans, 2004). The effects of a MLP diet
during gestation on blood pressure are not limited to rats. Studies in mice have
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demonstrated that MLP diet throughout pregnancy also induces hypertension in the
offspring (Dunn et al., 2001). Current thinking is that protein restriction elicits an
effect on blood pressure, at least in part, by altering the structure and vasculature of
the kidney. Indeed, work within our laboratory has shown that rats exposed to a MLP
diet in utero have a reduced nephron complement at the time of birth (Langley-Evans
et al., 2003; Langley-Evans et al., 1999a). Martyn and Greenwald (2001) also
hypothesised that programming of the vascular structure contributes to high blood
pressure (Martyn and Greenwald, 2001). MLP feeding in gestation has been shown
to induce noticeable changes within the ascending aorta such as altered elastin and
collagen deposition from 4 weeks of age (Langley-Evans, 2004). The analysis of
blood pressure was used in this investigation to asses if the hypertensive phenotype
programmed by protein restriction was apparent in the F2 and F3 generations.
5.2 Objectives
The work described within this chapter will examine the effects of prenatal
protein restriction upon systolic blood pressure in rats of the F1, F2 and F3
generations. The specific aims of the chapter are:
x To confirm previous findings on the effects of exposure to a MLP diet
in utero, on the blood pressure and nephron complement of the F1
generation.
x To assess whether elevated blood pressure and perturbations in
nephron complement in the F1 generation are transmitted to
subsequent generations (F2 and F3).
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5.3 Materials and Methods
5.3.1 Determination of Blood Pressure
As described in (section 2.5.2), blood pressure was determined in all animals
using an indirect tail cuff method (Sherman and Langley-Evans, 1998). All rats were
housed at 27°C, in the room where the measurements were made for at least 2 hours
prior to testing. Blood pressure was determined at 4, 6 and 8 weeks of age.
Measurements were taken in triplicate and a mean value was derived for each
animal.
5.3.2 Nephron Number Determination
Nephron number (section 2.5.3), was determined using an adaptation of the
acid maceration method (Welham et al., 2002).
5.3.3 Statistical analysis
All data is presented as mean ± SEM. All data was analysed using the
Statistical Package for Social Sciences (SPSS) version 14. Differences between
groups were assessed using a mixed model ANOVA (fixed factors, maternal diet,
sex, diet and age), P<0.05 was considered as significant.
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5.4 Results
5.4.1 Blood pressure
5.4.1.1 F1 generation
Systolic blood pressure at 4 weeks of age in F1 generation offspring (Figure
5.1) was approximately 9% lower (P<0.05) in MLP exposed animals than in
controls. Blood pressure was also similar in both male and female animals. However,
by 6 weeks of age (Figure 5.1) this significant difference in blood pressure had
disappeared and systolic blood pressure was similar in both maternal dietary groups.
Male and female animals also remained comparable. At 8 weeks of age (Figure 5.1)
blood pressure in the MLP group was significantly (P<0.05) higher (approximately
9mmHg) than in the control group (Con).
At 4 weeks of age (Figure 5.1) postnatal HF feeding significantly (P<0.05)
lowered systolic blood pressure by approximately 10mmHg compared to chow fed
animals. This occurred independent of sex. By 6 weeks of age (Figure 5.1) the effect
of the HF diet was diminished and pressures in Chow and HF animals were similar.
By 8 weeks of age postnatal HF feeding resulted in significantly higher (P<0.05)
systolic blood pressure in MLP exposed animals regardless of sex (Figure 5.1).
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Figure 5.1 F1 generation systolic blood pressure at 4, 6 and 8 weeks of age.
Figure 5.1 Data is shown as mean ± SEM. Graph A represents male systolic blood pressure at 4, 6 &
8 weeks of age. For Control chow (n = 31); Control HF (n = 10); MLP chow (n = 28); MLP HF (n =
10). Graph B represents female systolic blood pressure at 4, 6 & 8 weeks of age. For Control chow (n
= 29); Control HF (n = 10); MLP chow (n = 29); MLP HF (n = 11). Significant effects of maternal
diet (P<0.05) were noted at 4 and 8 weeks of age. Significant effects of postnatal diet (P<0.05) were
noted at 4 weeks of age. Data analysed using a mixed model ANOVA.
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5.4.1.2 F2 generation
Figure 5.2 shows the systolic blood pressure at 4 weeks of age in the F2
generation. Blood pressure was similar in all mating cross groups (approximately
130 mmHg). Blood pressure in male animals was comparable to that observed in
female animals. At 6 weeks of age, (Figure 5.2) there was a significant influence of
mating cross. All MLP mating crosses were approximately 4 mmHg higher (P<0.05)
than the Con x Con mating cross. Pressures in male and female animals were similar.
At 8 weeks of age (Figure 5.2) the trend of elevated blood pressure in the MLP
mating crosses continued (P<0.001), MLP animals were approximately 5-10 mmHg
higher than the Control mating cross (Con x Con). The feeding of a postnatal HF diet
had no effect upon systolic blood pressure in the F2 generation at any of the time
points in which systolic blood pressure was monitored.
163
Figure 5.2 F2 generation systolic blood pressures at 4, 6 and 8 weeks of age.
†
†
†
†
†
† †
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Figure 5.2 Data is shown as mean ± SEM. Graph A represents the systolic blood pressure at 4, 6 & 8 weeks of age of male animals maintained on a chow postnatal
diet. For Con x Con (n = 33); Con x MLP (n = 24); MLP x Con (n = 23); MLP x MLP (n = 35). Graph B represents the systolic blood pressure at 4, 6 & 8 weeks of
age of male animals maintained on a HF postnatal diet. For Con x Con (n = 11); Con x MLP (n = 8); MLP x Con (n = 7); MLP x MLP (n = 10). Graph C represents
the systolic blood pressure at 4, 6 & 8 weeks of age of female animals maintained on a chow postnatal diet. For Con x Con (n = 33); Con x MLP (n = 24); MLP x
Con (n = 26); MLP x MLP (n = 29). Graph D represents the systolic blood pressure at 4, 6 & 8 weeks of age of female animals maintained on a HF postnatal diet.
For Con x Con (n = 11); Con x MLP (n = 8); MLP x Con (n = 8); MLP x MLP (n = 11). † indicates a significant effect of mating cross. Significant effects of
mating cross (P<0.05) were noted at 6 and 8 weeks of age. Data analysed using a mixed model ANOVA. For F2 and F3 crosses the dietary origin of the male
parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to a MLP diet in utero.
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5.4.1.3 F3 generation
There was no effect of mating cross on systolic blood pressure at 4 weeks of
age in the F3 generation (Figure 5.3). This continued at 6 weeks of age (Figure
5.3).Values between mating cross groups were similar, as were blood pressure values
between male and female animals. At 8 weeks of age (Figure 5.3) there remained no
difference in blood pressure between mating crosses of the F3 generation, likewise
blood pressure values between male and female animals was also similar.
Animals that were maintained on a postnatal HF diet had lower (P<0.05)
systolic blood pressure at 4 weeks of age (approximately 10%) in comparison to
animals maintained on a postnatal chow diet, irrespective of sex. By 6 weeks of age
this effect was no longer present.
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Figure 5.3 F3 generation systolic blood pressures at 4, 6 and 8 weeks of age.
Figure 5.3 Data is shown as mean ± SEM. Graph A represents male systolic blood pressure at 4, 6 & 8 weeks
of age. For Con x Con chow (n = 31); Con x Con HF (n = 11); MLP x MLP chow (n = 23); MLP x MLP HF
(n = 8). Graph B represents female systolic blood pressure at 4, 6 & 8 weeks of age. For Con x Con chow (n =
29); Con x Con HF (n = 9); MLP x MLP chow (n = 24); MLP x MLP HF (n = 8). Significant effects of sex
(P<0.05) and postnatal diet (P<0.05) were noted at 4 weeks of age. Data analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female parent, e.g.
Con x MLP indicates a cross between a male exposed to control diet and a female exposed to a MLP diet in
utero.
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Figure 5.4 8 week systolic blood pressures
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Figure 5.4 Data is shown as mean ± SEM. Graph A represents the systolic blood pressure at 8 weeks of age of male animals maintained on a chow postnatal diet. For F1
Con (n=31); MLP (n=28). F2 Con x Con (n=33); MLP x MLP (n=35); Con x MLP (n=24) and MLP x Con (n=23). F3 Con x Con (n=31) and MLP x MLP (n=23). Graph
B represents the systolic blood pressure at 8 weeks of age of male animals maintained on a HF postnatal diet. For F1 Con (n=10); MLP (n=10). F2 Con x Con (n=11);
MLP x MLP (n=10); Con x MLP (n=8) and MLP x Con (n=7). F3 Con x Con (n=11) and MLP x MLP (n=8). Graph C represents the systolic blood pressure at 8 weeks of
age of female animals maintained on a chow postnatal diet. For F1 Con (n=29); MLP (n=29). F2 Con x Con (n=33); MLP x MLP (n=29); Con x MLP (n=24) and MLP x
Con (n=26). F3 Con x Con (n=29) and MLP x MLP (n=24). Graph D represents the systolic blood pressure at 8 weeks of age of female animals maintained on a HF
postnatal diet. For F1 Con (n=10); MLP (n=11). F2 Con x Con (n=11); MLP x MLP (n=11); Con x MLP (n=8) and MLP x Con (n=8). F3 Con x Con (n=9) and MLP x
MLP (n=8). Significant effects of mating cross (P<0.001) were noted in the F1 and F2 generations. Data analysed using a mixed model ANOVA. For F2 and F3 crosses
the dietary origin of the male parent is shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to a
MLP diet in utero.
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5.4.2 Nephron Number
Nephron number in the left kidney was determined after cull at 10 weeks of
age. F1 generation nephron complement (Figure 5.5) was lower (P<0.001) by
approximately 35% in animals exposed to a MLP diet in utero, compared to control
animals. Nephron numbers in male and female animals were similar. In the F2
generation (Figure 5.5), nephron complement followed the same trend as the F1
generation. Nephron numbers were approximately 40% lower (P<0.001) in all MLP
mating crosses compared to controls (Con x Con). Nephron numbers in male and
female animals remained similar. In the F3 generation (Figure 5.5) nephron
complement was similar in the two groups. No difference in male and female
animals was detected. Due to time constraints, the possible effects of postnatal HF
feeding were not analysed within this investigation.
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Figure 5.5 Nephron complement at 10 weeks of age.
Figure 5.5 Data is shown as mean ± SEM, For F1 Con male (n=8); female (n=9), MLP male (n=11);
female (n=9). F2 Con x Con male (n=22); female (n=22), MLP x MLP male (n=23); female (n=18),
Con x MLP male (n=16); female (n=16), MLP x Con male (n=13); female (n=18). F3 Con x Con male
(n=20); female (n=18), MLP x MLP male (n=14); female (n=16). Significant effects of maternal diet
(F1: P<0.001) and mating cross (F2: P<0.001) were noted. Data analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to MLP diet in utero.
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5.5 Discussion
5.5.1 Summary of findings
The links between prenatal exposure to maternal protein restriction and
elevations in systolic blood pressure in the F1 generation are well established
(Langley-Evans, 1996, 1997; Langley-Evans et al., 1996b; Langley-Evans et al.,
2003; Langley-Evans et al., 1994; Langley-Evans et al., 1999a; Langley-Evans et al.,
1999b; Langley-Evans et al., 1996d). The results within this chapter show that there
is clear transgenerational transmission of this effect to the F2 generation.
Table 5.1 Summary of findings.
Generation
F1 F2 F3
4 Week blood
pressure
Decreased in MLP
maternal diet
group, decreased
with HF postnatal
feeding
No change with
mating cross or
postnatal diet
No change with
mating cross,
decreased with HF
postnatal feeding
6 Week blood
pressure
No change with
maternal diet or
postnatal diet
Increased in all
MLP mating cross
groups, no change
with postnatal diet
No change with
mating cross or
postnatal diet
8 Week blood
pressure
Increased in MLP
maternal diet
group, no change
with postnatal diet
Increased in all
MLP mating cross
groups, no change
with postnatal diet
No change with
mating cross or
postnatal diet
Nephron
complement
Decreased in MLP
maternal diet group
Decreased in MLP
mating cross
groups
No change with
mating cross
Table 5.1 shows a brief summary of the findings from the assessment of systolic blood pressure and
nephron complement in the F1, F2 and F3 generations.
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Table 5.1 shows a brief summary of the findings from the blood pressure and
nephron number analyses of the animals within this investigation. Blood pressure
within the F1 and F2 generations by 8 weeks of age was higher in animals exposed to
MLP diet, either in utero or by mating cross. This increased blood pressure went
hand in hand with a reduction in nephron number in the MLP groups of both
generations. There was no effect of maternal diet/ mating cross on the blood pressure
or nephron complement of the F3 generation. There was no correlation between
blood pressure at 4, 6 or 8 weeks of age with nephron number at 10 weeks of age in
any generation.
5.5.2 Effect of prenatal protein restriction and mating cross
Data within the present chapter considered the impact of prenatal protein
restriction upon blood pressure and renal development. Previous work within our
laboratory has characterised the programming effects of a MLP diet during rat
pregnancy upon blood pressure (Langley-Evans, 1996; Langley-Evans et al., 1996b;
Langley-Evans et al., 1994; Langley-Evans et al., 1999b; Langley-Evans et al.,
1996d) and renal development and function (Langley-Evans et al., 2003; Langley-
Evans et al., 1999a) in the F1 generation. Data from the current investigation has for
the first time shown that the effects of protein restriction in utero may not be limited
to the first generation. The present investigation combines measurements of blood
pressure with analysis of nephron complement to show that a relatively mild protein
restriction during gestation has far-reaching implications for future generations.
Much of the work previously undertaken on transgenerational programming has
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focussed purely on a mechanistic viewpoint, without extensive effort to demonstrate
that there is intergenerational transmission of any phenotype (Anway et al., 2008).
The method utilised within this investigation to analyse blood pressure was
the indirect tail cuff method (Sherman and Langley-Evans, 1998). Currently there is
much debate over which is the most appropriate method to use in order to monitor
blood pressure. Kurtz and colleagues (2005) recently published a review containing a
list of recommendations for blood pressure measurement in animals; this review lists
both the advantages and disadvantages of both direct and indirect methods of blood
pressure monitoring and concluded that the method utilised depends upon the
objectives of the investigation (Kurtz et al., 2005). Although current opinion within
the scientific community is leaning towards the use of radio-telemetry systems
similar to the equipment used in the study by Tonkiss and colleagues (1998), this
procedure was unfeasible in this investigation due to the large number of animals that
needed monitoring, in addition the review by Kurtz and colleagues (2005)
specifically states that tail cuff is appropriate for large studies in which the aim is to
identify large differences in blood pressure between groups.
It should be noted that a host of other external factors are able to affect blood
pressure including ambient room temperature, light cycle, noise levels, duration of
human contact, number of animals per caging unit, proximity to other animals
undergoing experimental procedures, cage unit size and design, and access to
supplemental items such as toys, treadmills, and hiding spaces within the cage unit.
Therefore, it is important to keep in mind that many environmental factors can have
substantial effects on cardiovascular function and blood pressure monitoring,
therefore all factors should also be considered when using either indirect or direct
methods for measuring blood pressure (Kurtz et al., 2005).
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The tail-cuff method used within this study analyses blood pressure without
the use of heating, therefore preventing heat-stress of the animals that is usually
associated with the tail cuff procedure (Kubota et al., 2006; Tonkiss et al., 1998).
The tail cuff method has been expertly utilised in several previous studies within our
own and other research groups (Langley-Evans et al., 1996b; Langley-Evans and
Jackson, 1995, 1996). Recent research has indicated that the rise in blood pressure
associated with restraint stress (measured by telemetry) is similar in control and MLP
offspring (Swali et al., unpublished data) conflicting with evidence reported by
Tonkiss and colleagues (1998). Previous studies have concluded that the tail-cuff
method is a sensitive and accurate technique for determining blood pressure in
conscious rats (Ibrahim et al., 2006) and it has demonstrated that similar
measurements are obtained by both the radio telemetry and the unheated tail-cuff
methods (Kubota et al., 2006).
The MLP diet protocol used within this investigation is the best characterised
and most widely studied model of nutritional programming. As previously stated, the
exposure to a MLP diet in utero has been shown to consistently induce persistent
high blood pressure in the offspring (Langley and Jackson, 1994). Earlier studies
have indicated that MLP-exposed offspring may be hypertensive from as early as
weaning (Langley-Evans et al., 1994) and that this persists throughout adult life
(Langley-Evans and Jackson, 1995). As expected, systolic blood pressure was higher
in MLP exposed animals of the F1 generation. However, within this study, no
evidence of raised blood pressure was observed until 8 weeks of age. In fact a lower
blood pressure was noted in MLP offspring of the F1 generation at 4 weeks of age.
Although atypical of previous research on the MLP diet, similar outcomes have been
observed following the maternal restriction of iron (Crowe et al., 1995; Gambling et
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al., 2003), where high blood pressure follows a period of lower blood pressure
around the time of weaning. The current investigation is the first study to examine
the interplay between blood pressure and renal structure across 3 successive
generations. It has demonstrated that the effects of a mild protein restriction and its
resultant phenotype are passed from the F1 generation to the F2 generation via both
the paternal and maternal lines (as all F2 crosses involving low protein resulted in
raised systolic blood pressure). The transmission of this phenotype must therefore
involve epigenetic modifications, specifically in the gametes.
The kidney plays a major role in homeostatic regulation of blood pressure
and, in rats, fetal exposure to the low protein diet has been shown to reduce nephron
complement by up to 30% (Langley-Evans et al., 1999a; Welham et al., 2002). The
present study shows that this reduction in nephron number is passed to a second
generation via both parental lines. It is hypothesised that to compensate for nephron
deficits at birth and to maintain renal haemodynamic functions, blood pressure
within the nephrons is increased to maintain glomerular perfusion. Thus a cycle of
progressive nephron loss begins whereby increasing blood pressure results in the loss
of more nephrons eventually resulting in hypertension (Mackenzie, 1995). There is,
however, emerging evidence that the nutritional programming nephron number and
of blood pressure are independent processes occuring in a sex specific manner
(McMullen and Langley-Evans, 2005). The relationship between nephron number
and subsequent blood pressure is not clear-cut as there is evidence that hypertension
can occur without a reduction in nephron number (Jackson et al., 2002). Live human
kidney donation studies support this, as they show that uninephrectomy in adult renal
transplant donors carries a very low risk of hypertension (Gossmann et al., 2005). It
has been hypothesised that this difference maybe due primarily to age, for example
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the effect of fewer nephrons from birth may be different from the loss of nephrons in
the mature individual. Data from animal studies support this age-dependence
hypothesis (Moritz et al., 2002; Woods, 1999). It is thought that the differing
intensity of the renal adaption to reduced nephron number may be key to this
phenomenon. The hyperfiltration response to reduced nephron number is more
effective in the young kidney (Chou and Hsu, 1991). A more effective response to
preserve GFR in the short-term may therefore enhance hypertension in the long term.
Although there is much debate over the relationship between nephron number and
blood pressure it is clear from previous studies and the data within this chapter that
the restriction of protein during gestation has the potential to generate a phenotype
that features both reduced nephron complement and hypertension. It is apparent that
this phenotype is subsequently passed on to a second generation via both parental
lines.
Torrens et al., (2008) have also recently shown that high blood pressure can
be transmitted to the F2 generation following maternal protein restriction, however
this study was only powered to assess maternal transmission. Within the study by
Torrens and colleagues, there was evidence of an impaired vasodilatory response to
acetylcholine, suggesting that in addition to renal programming, endothelial
dysfunction may contribute to the transgenerational phenomena.
An interesting and unexpected result to arise from the current investigation
was that the blood pressures of control animals in F3 were elevated, and nephron
counts decreased, compared to the F1 groups. The reason for this is unknown. It is
however possible that these intergenerational differences may effectively be due to
in-breeding of a small colony in the F2 and F3 generations. Furthermore, the fact that
the present study shows that the experience of the mother and grandmother of each
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animal determines blood pressure, and nephron complement may be of relevance.
The grandmaternal influence on the F1 generation will have been different to the
grandmaternal influence on the F3 generation, and it is this difference which could
explain the changes.
It is evident from the data on blood pressure and nephron number presented
in this chapter, that the offspring (F2) of either male or female rats exposed to MLP
diets in utero (F1) develop the same traits as their parents. Other research groups
have also found evidence of transgenerational programming (Beach, 1982;
Waterland et al., 2007; Zambrano et al., 2005), however, like the study by Torrens
and colleagues, they have only considered the maternal transmission of phenotypes.
These studies used stud males that were unexposed to dietary and hormonal
challenges in utero to breed from programmed females. One of the main problems
with such studies is that they cannot conclusively demonstrate that maternal traits are
transmitted to the next generation via programmed influences on the ovum, as
changes to the maternal environment and the composition of proteins in the embryo
may play a key role. Metabolic traits such as glucose intolerance or cardiovascular
traits such as raised blood pressure could be programmed as a response to the
prevailing maternal environment during F1 pregnancy. For example, it has been
previously shown that MLP diets in rat pregnancy and lactation lead to glucose
intolerance. F2 offspring derived from glucose intolerant females also show this trait,
which is acquired through glucose spill-over across the placenta (Reusens and
Remacle, 2001).
A major strength of the research design of the present study was the use of
males from the F1 and F2 generations in the mating crosses to produce the
successive generations. This allows us to assess the potential contribution of the
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paternal, as well as maternal factors, in transgenerational programming. In the
present study we can at least conclude that male animals must transmit a
programming signal to their offspring via alterations to the sperm genome.
Arguments suggesting that maternal blood pressure tracking (familial aggregation)
may produce these effects (Feng et al., 2008; Hunt et al., 2000; Liese et al., 1997),
fall short of the mark as high blood pressure was passed down both the maternal and
paternal lines. This argument also cannot explain the decrease in nephron number
found in both the F1 and F2 populations. It could be hypothesised that there may be
the potential for some form of selection, whereby only fetuses with elevated blood
pressures survive the pregnancy insult. This would potentially select for a
hypertensive genotype. This “survivor” effect is not plausible, however, within this
study as pregnancy outcomes were similar in rats fed to control and MLP diets.
5.5.3 Postnatal high fat feeding
There was little impact of postnatal HF feeding upon systolic blood pressure
at any of the time points monitored. Reductions in blood pressure were indicated at 4
weeks of age in the F1 and F3 generations. Lard is comprised of 38 - 43% saturated
fats and 56 - 62% unsaturated fats, of which around 50% are monounsaturated fatty
acids (MUFA). Previous research has indicated that the feeding of lard-based high fat
diet both pre- and postnatally significantly increase systolic blood pressure (Kaufman
et al., 1991; Khan et al., 2003; Yoshioka et al., 2000). The reason why there was no
observed change in systolic blood pressure in the animals maintained on a high fat
postnatal diet within the current investigation is unknown. In a comparison of the
diets utilised by both the current investigation and the study by Yoshioka and
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colleagues (2000) both diets contained the same amount of lard (29%). One possible
explanation is that the standard chow diet utilised within the current investigation is
masking any effects of the lard based diet. The standard chow diet used within this
study has higher concentrations of polyunsaturated fatty acids (PUFA), especially n-
6, than are present in lard. Previous studies have indicated that n-6 fatty acids have a
hypertensive effect (Langley-Evans et al., 1996a). Therefore, effectively both
standard chow and high fat animals could have higher systolic blood pressure
relative to a low n-6, low saturated fat diet.
5.5.4 Conclusions
The data presented within this chapter demonstrates that the feeding of a
MLP diet in utero resulted in a phenotype comprising raised systolic blood pressure
and reduced nephron complement. This was transmitted to a second generation via
both the maternal and paternal lines. Although there is much debate over the link
between nephron number and blood pressure it is important to note that nephron
number is an important determinant of hypertension and renal disease (Hoy et al.,
2008). Further work will take a mechanistic viewpoint and attempt to identify
possible gene targets involved in endothelial cell biology. Possible epigenetic modes
of inheritance will be analysed in order to understand the molecular basis of the
observed phenotype.
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6.0 Prenatal protein restriction and the molecular basis of hypertension
6.1 Introduction
As described previously (section 1.2), it is clear that the risk of developing
CVD and diabetes emerges as a consequence of interplay between genetic and
environmental factors. Studies reported earlier in this thesis have indicated that the
feeding of a MLP diet throughout gestation programmes a phenotype that consists of
high systolic blood pressure combined with a lower complement of nephrons, which
is passed from the F1 generation to the F2 generation. It has been postulated that
undernutrition during gestation programmes long-term changes in gene expression,
which alter metabolism in the developing fetus and result in cardiovascular
abnormalities in later life (Barker et al., 1993). Indeed the expression of genes that
either protect against, or predispose to these conditions will be further modified by
interactions between the genotype, early life nutrition, and the postnatal environment
(Langley-Evans, 2006). A number of studies have indicated that prenatal
undernutrition has the capacity to modulate the epigenetic regulation of gene
expression (Burdge et al., 2007a; Jaenisch and Bird, 2003). This raises the prospect
that undernutrition can establish heritable changes to the epigenome and, as such, the
disease programming effects of undernutrition in the fetal period may not be limited
to the first generation. Data from within this thesis and emerging evidence from
human and animal studies suggests that transgenerational effects may occur, whereby
the consequences of deficits in maternal nutrition are subsequently passed on to the
grand children (Beach, 1982; James, 2002; Pembrey, 1996). Indeed epigenetic
changes within tissues and especially gametes could play a vital role in the
transgenerational effect.
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6.2 Objectives
The primary aim of the studies within this chapter was to assess changes in
renal gene expression. Targeted microarray technology was used in order to assess
potential gene targets, alongside real time PCR to determine the magnitude of the
programmed changes between control and MLP exposed animals. The specific aims
of this chapter were;
x To identify potential gene targets for qRT-PCR analysis using a
microarray approach.
x To assess the impact of prenatal MLP exposure upon renal gene
expression.
x Examine potential differences in the extent of DNA methylation
between control and MLP exposed offspring.
6.3 Materials and methods
6.3.1 Microarray: determination of gene expression
A pathway focussed DNA microarray study was used in order to compare the
expression of 113 genes in the kidney associated with endothelial cell biology,
including genes involved in permissibility and vessel tone, angiogenesis, endothelial
cell activation and endothelial cell injury. This technique was used as a hypothesis
generating tool to assess appropriate gene targets to follow up in more detail via
qRT-PCR (Zhang et al., 2002).
Kidneys (n = 4 per group, selected for extremes of blood pressure) were
removed at time of cull (10 weeks of age), snap frozen in liquid nitrogen and stored
at -80°C prior to analysis (section 2.3). Total RNA was isolated using the Trizol
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method (section 2.6.1.1) and integrity was determined using the Nanodrop®
spectrophotometer (section 2.6.1.3). Microarray assays were performed as described
in section 2.6. Images were analysed using a specially designed web-based analysis
suite. Upon analysis of microarray data, a selection criterion of a two-fold increase or
decrease in gene expression was applied.
6.3.2 qRT-PCR
RT-PCR (section 2.8) was used to detect the expression of mRNA for Matrix
metallopeptidase 9 (MMP9), Granzyme B (GZMB), Endothelial cell growth factor 1
(ECGF1), Endothelin receptor type A (EDNRA) and Insulin-like growth factor 2
(IGF2) mRNA in rat kidneys (n = 6 per group). Expression was determined as
described in section 2.8.
6.3.3 Cytosine extension assay
The cytosine extension assay was used as a method for analysing global DNA
methylation (n = 6 per group). The assay was performed as described in section
2.7.2.
6.3.4 Statistical Analysis
All data was analysed using the Statistical Package for Social Sciences
(SPSS, Inc, Chicago, IL, Version 14.0). Differences between groups were assessed
using a mixed model ANOVA (fixed factors, maternal diet, sex and age). Values are
expressed as mean ± S.E.M. P<0.05 was considered as significant.
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6.4 Results
6.4.1 Gene expression
6.4.1.1 DNA Microarray Studies
In the F1 generation a total of 38 genes out of 113 were up-regulated two-fold
or greater, and 12 genes were down-regulated by at least 50% (Table 6.1). However,
none of these changes were significant when subjected to statistical analysis using a
mixed model ANOVA. A total of 7 genes were two-fold up-regulated and 30 genes
were 50% down-regulated (Table 6.2) within the F2 generation. Similar to the F1
generation, none of these changes were statistically significant. Within the F3
generation, 3 genes were up-regulated two-fold or more, and 30 genes were more
than 50% down-regulated (Table 6.3). Although some significant changes in gene
expression were seen within the F3 generation, these genes were considered to be
irrelevant to the hypothesis, as they were unchanged within the F1 and F2
generations.
The microarray data suggested that there was a relatively narrow profile of
genes that were programmed by fetal exposure to MLP diet in utero that were
comparable across all the generations. Using the selection criteria described in
section 2.6.2.8, a total of 11 genes were highlighted as being differently expressed in
rat kidneys of MLP-exposed animals compared to control animals. Out of the 113
genes analysed 4 common genes were found to be up-regulated two-fold or more
within the F1 and F2 generation (Figure 6.1). These were Cxcl2, Cxcl11, Ecgf1 and
Gzmb. Both Cxcl2 and Cxcl11 were disregarded as these are chemokines secreted by
macrophages in response to stress or injury and therefore were not thought to be key
in the programming of the kidneys in utero but were elevated due to postnatal
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stimuli. 2 common genes were found to be down-regulated 50% or more within the
F1 and F2 generations (Figure 6.2), these were Ednra and Il7, both were selected for
further study. A further 5 genes were found to be down-regulated by 50% or more in
all 3 generations (Figure 6.2). From these five genes Mmp9 was selected for further
analysis as previous research has suggested it has a role within uteric bud branching
in the kidneys (Lelongt and Ronco, 2002).
Due to expense and time constraints a decision was made to analyse five of
the genes identified by the microarray analysis by real time PCR (2 genes up-
regulated and 3 genes down-regulated), these genes were Matrix metallopeptidase 9
(MMP9), Granzyme B (GZMB), Endothelial cell growth factor 1 (ECGF1),
Endothelin receptor type A (EDNRA) and Interlukin 7 (Il7).
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Table 6.1 Comparrison of gene expression in kidneys of control and MLP male animals
of the F1 generation.
Maternal DietGene
Control MLP
Fold Change P Value
Ifnb1 .0050 .0367 7.3400 .4795
Edn1 .0075 .0433 5.7733 .4965
Il11 .0050 .0267 5.3400 .5035
Itgav_predicted .0050 .0267 5.3400 .5035
Agtr2 .0125 .0667 5.3360 .4427
Il3 .0025 .0133 5.3200 .5035
Pdgfra .0025 .0133 5.3200 .5035
Bcl2l1 .0125 .0633 5.0640 .3747
Edn2 .0075 .0367 4.8933 .5118
Angpt2 .0150 .0733 4.8867 .3976
Agt .0150 .0733 4.8867 .2468
Birc4 .0150 .0700 4.6667 .4592
Angpt1 .0175 .0800 4.5714 .4426
Bcl2 .0150 .0667 4.4467 .2795
Ace2 .0200 .0867 4.3350 .4301
Birc1b .0125 .0500 4.0000 .4951
Edn3_mapped .0075 .0300 4.0000 .5350
Fgf2 .0100 .0400 4.0000 .5350
Flt1 .0075 .0300 4.0000 .5350
Mmp1a_predicted .0050 .0200 4.0000 .5350
Ccl20 .0150 .0567 3.7800 .5079
Chga .0125 .0433 3.4640 .3576
Ccl2 .0200 .0667 3.3350 .5009
Blr1 .0175 .0567 3.2400 .3528
Cxcl1 .0150 .0433 2.8867 .3006
Cxcl11 .0100 .0267 2.6700 .6004
Cxcl2 .0100 .0267 2.6700 .6004
Flt3 .0100 .0267 2.6700 .5385
Ecgf1 .0075 .0200 2.6667 .5994
Ccl5 .0200 .0533 2.6650 .4450
Cpb2 .0125 .0333 2.6640 .6011
Alox5 .0350 .0900 2.5714 .3630
Agtr1b .0325 .0767 2.3600 .5279
Csf3 .0200 .0467 2.3350 .4838
Flt4 .0100 .0233 2.3300 .5845
Vwf .0325 .0733 2.2554 .3510
Gzmb .0075 .0167 2.2267 .6431
Fgf1 .0150 .0300 2.0000 .5580
Bcl2a1 .0350 .0667 1.9057 .4590
Birc3 .1000 .1900 1.9000 .1386
Birc5 .0450 .0833 1.8511 .4096
Csf2 .0275 .0500 1.8182 .6730
Casp8 .0250 .0433 1.7320 .5871
Cdh5_predicted .0250 .0433 1.7320 .5913
AS1R2 .0175 .0300 1.7143 .3844
Enpep .0125 .0200 1.6000 .7085
Itgb3 .0125 .0200 1.6000 .7506
Cflar .0350 .0533 1.5229 .5993
Mmp2 .0100 .0133 1.3300 .8457
Tgfb1 .0025 .0033 1.3200 .8457
BAS2C .8925 1.1600 1.2997 .3390
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BAS2C .9825 1.2233 1.2451 .4105
Casp3 .0625 .0767 1.2272 .7544
Itgb1 .0800 .0900 1.1250 .8155
Gapdh .9775 1.0600 1.0844 .3863
Gapdh .9800 1.0600 1.0816 .3981
Casp6 .0550 .0567 1.0309 .9701
Ace .2150 .2133 .9921 .9836
Tek .0750 .0733 .9773 .9743
Cx3cl1 .6300 .5667 .8995 .7983
Casp1 .1300 .1167 .8977 .8404
Plg .0600 .0533 .8883 .8648
Icam2 .1800 .1567 .8706 .7995
Nos3 .4575 .3933 .8597 .7500
Sod1 1.0050 .8633 .8590 .3946
Ppia 1.0400 .8800 .8462 .3981
Adam17 .2400 .1933 .8054 .6841
Rpl32 .9600 .7633 .7951 .4418
Npr1 .4675 .3700 .7914 .5740
Anxa5 .2200 .1700 .7727 .6899
Ldha .7825 .6000 .7668 .5939
Tnfsf10 .5950 .4533 .7618 .6010
Itga5 .3925 .2967 .7559 .5901
Mmp14 .7175 .5400 .7526 .5723
Plau .5825 .4333 .7439 .5923
Kdr .8100 .5800 .7160 .4330
Ednrb .1075 .0767 .7135 .5993
Aldoa .9350 .6600 .7059 .4626
Aldoa .9475 .6633 .7001 .4521
Cradd .1975 .1367 .6922 .6310
Timp1 .4025 .2700 .6708 .4700
Col18a1 .3200 .2133 .6666 .4621
Tfpi2 .0050 .0033 .6600 .8090
Bax .2325 .1433 .6163 .5342
Xdh .0225 .0133 .5911 .7010
Icam1 .0750 .0433 .5773 .4827
Il6 .0125 .0067 .5360 .6018
Tfpi .0925 .0467 .5049 .2978
Fn1 .4100 .1933 .4715 .2996
Il15 .2250 .1000 .4444 .3199
Pla2g4c .0450 .0167 .3711 .3782
Il1b .0475 .0167 .3516 .3786
F3 .1075 .0367 .3414 .1902
Plat .3325 .1133 .3408 .2043
Ednra .0800 .0267 .3338 .4190
Pdgfrb .0300 .0100 .3333 .5599
Il7 .0250 .0067 .2680 .2963
Mmp9 .1075 .0233 .2167 .2124
Nos2 .0725 .0133 .1834 .1364
Table 6.1 shows gene expression in the F1 generation. Fold difference indicates a ratio of expression for
MLP Vs Control. Genes exhibiting a two-fold up-regulation are highlighted in blue and genes exhibiting
less than 50% of control expression are shown in red. For a full list of gene names please see appendix.
No significant effects were noted. Data analysed using a mixed model ANOVA.
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Table 6.2 Comparrison of gene expression in kidneys of control and MLP mating cross
male animals of the F2 generation.
Breeding Cross Cross CrossGene
Con X
Con
MLP X
MLP
Fold
Change MLP X
Con
Fold
Change Con X
MLP
Fold
Change
P
Value
Gzmb .0025 .0125 5.0000 .0050 2.0000 .0100 4.0000 .6236
Il6 .0025 .0100 4.0000 .0025 1.0000 .0150 6.0000 .3904
Ecgf1 .0050 .0100 2.0000 .0075 1.5000 .0200 4.0000 .7196
AS1R1 .0025 .0050 2.0000 .0000 .0000 .0100 4.0000 .3763
Cxcl11 .0100 .0175 1.7500 .0125 1.2500 .0150 1.5000 .9512
Cxcl2 .0075 .0125 1.6667 .0100 1.3333 .0175 2.3333 .8895
Enpep .0075 .0125 1.6667 .0075 1.0000 .0150 2.0000 .8477
Chga .0175 .0275 1.5714 .0175 1.0000 .0200 1.1429 .9471
Flt3 .0050 .0075 1.5000 .0075 1.5000 .0075 1.5000 .9873
Bcl2 .0325 .0375 1.1538 .0350 1.0769 .0200 .6154 .8814
Cflar .0350 .0400 1.1429 .0350 1.0000 .0250 .7143 .8999
Cxcl1 .0200 .0225 1.1250 .0150 .7500 .0150 .7500 .9226
Bcl2l1 .0250 .0275 1.1000 .0250 1.0000 .0225 .9000 .9965
Blr1 .0300 .0325 1.0833 .0250 .8333 .0250 .8333 .9834
Gapdh .9875 1.0600 1.0734 .9875 1.0000 1.0050 1.0177 .3885
Gapdh .9900 1.0625 1.0732 .9900 1.0000 1.0050 1.0152 .3700
BAS2C 1.0000 1.0600 1.0600 .9925 .9925 1.0200 1.0200 .5132
Rpl32 .9675 1.0050 1.0388 .9700 1.0026 .9675 1.0000 .6331
Sod1 1.0000 1.0350 1.0350 .9950 .9950 1.0025 1.0025 .5798
Nppb .0025 .0025 1.0000 .0000 .0000 .0050 2.0000 .7256
Vcam1 .0050 .0050 1.0000 .0000 .0000 .0075 1.5000 .6621
BAS2C .9550 .9500 .9948 .9500 .9948 .9475 .9921 .9997
Birc1b .0225 .0200 .8889 .0175 .7778 .0225 1.0000 .9937
Serpine1 .0225 .0200 .8889 .0150 .6667 .0075 .3333 .8566
Angpt2 .0375 .0325 .8667 .0350 .9333 .0225 .6000 .9119
Ppia 1.0225 .8775 .8582 1.0225 1.0000 .9925 .9707 .3785
Aldoa .9375 .7925 .8453 .9575 1.0213 .8700 .9280 .2100
Nos3 .5725 .4825 .8428 .5550 .9694 .4575 .7991 .8752
Ccl5 .0300 .0250 .8333 .0200 .6667 .0250 .8333 .9599
Agtr2 .0250 .0200 .8000 .0175 .7000 .0225 .9000 .9850
Edn3_map .0125 .0100 .8000 .0125 1.0000 .0100 .8000 .9933
Ednrb .0700 .0550 .7857 .0775 1.1071 .0275 .3929 .6812
Aldoa .9250 .7200 .7784 .9500 1.0270 .8300 .8973 .2787
Cdh5_pre .0425 .0325 .7647 .0275 .6471 .0300 .7059 .9024
Flt4 .0100 .0075 .7500 .0125 1.2500 .0075 .7500 .9637
Agtr1b .0400 .0300 .7500 .0675 1.6875 .0250 .6250 .2729
Csf3 .0300 .0225 .7500 .0200 .6667 .0175 .5833 .8803
Col18a1 .2450 .1750 .7143 .2175 .8878 .2375 .9694 .9621
Bcl2a1 .0600 .0425 .7083 .0500 .8333 .0250 .4167 .4946
Agt .0500 .0350 .7000 .0400 .8000 .0225 .4500 .6740
Ccl20 .0325 .0225 .6923 .0200 .6154 .0200 .6154 .8952
Birc4 .0400 .0275 .6875 .0250 .6250 .0225 .5625 .8287
Mmp14 .5425 .3650 .6728 .3450 .6359 .7575 1.3963 .3203
Alox5 .0650 .0425 .6538 .0550 .8462 .0550 .8462 .8277
Ccl2 .0350 .0225 .6429 .0325 .9286 .0250 .7143 .9092
Pla2g4c .0625 .0400 .6400 .0375 .6000 .0175 .2800 .8285
Ldha .6200 .3900 .6290 .5625 .9073 .6350 1.0242 .7668
AS1 .0200 .0125 .6250 .0325 1.6250 .0475 2.3750 .4017
Birc5 .0600 .0375 .6250 .0500 .8333 .0425 .7083 .6311
AS1R2 .0450 .0275 .6111 .0525 1.1667 .0550 1.2222 .8746
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Cx3cl1 .6400 .3850 .6016 .4775 .7461 .4675 .7305 .7570
Angpt1 .0625 .0375 .6000 .0550 .8800 .0250 .4000 .2942
Plau .5275 .3150 .5972 .2425 .4597 .3950 .7488 .7620
F3 .0675 .0400 .5926 .1200 1.7778 .0300 .4444 .7250
Casp1 .1500 .0875 .5833 .1375 .9167 .0675 .4500 .6061
Casp3 .0825 .0475 .5758 .0650 .7879 .0300 .3636 .3600
Casp8 .0525 .0300 .5714 .0275 .5238 .0275 .5238 .7693
Birc3 .1400 .0775 .5536 .1075 .7679 .1350 .9643 .5459
Fn1 .2825 .1525 .5398 .1625 .5752 .1375 .4867 .7917
Icam2 .2625 .1400 .5333 .2375 .9048 .1850 .7048 .6929
Timp1 .4100 .2150 .5244 .2600 .6341 .1725 .4207 .4812
Kdr .8325 .4225 .5075 .7225 .8679 .5550 .6667 .2617
Tnfsf10 .4700 .2375 .5053 .4800 1.0213 .5125 1.0904 .4600
Fgf2 .0100 .0050 .5000 .0075 .7500 .0075 .7500 .9537
Ace2 .0550 .0275 .5000 .0325 .5909 .0250 .4545 .5785
Anxa5 .2025 .1000 .4938 .1700 .8395 .1525 .7531 .8661
Npr1 .5425 .2650 .4885 .4175 .7696 .3375 .6221 .5110
Ace .3075 .1450 .4715 .2150 .6992 .2725 .8862 .5816
Tek .1150 .0525 .4565 .0550 .4783 .1100 .9565 .7523
Csf2 .0275 .0125 .4545 .0225 .8182 .0225 .8182 .8475
Edn2 .0125 .0050 .4000 .0100 .8000 .0100 .8000 .9138
Il7 .0375 .0150 .4000 .0150 .4000 .0200 .5333 .5725
Plat .2875 .1125 .3913 .2025 .7043 .1650 .5739 .8460
Cpb2 .0325 .0125 .3846 .0125 .3846 .0225 .6923 .7315
Fgf1 .0325 .0125 .3846 .0125 .3846 .0225 .6923 .6619
Icam1 .1125 .0425 .3778 .0500 .4444 .0225 .2000 .3504
Casp6 .0700 .0250 .3571 .0650 .9286 .0300 .4286 .5491
Il15 .1525 .0525 .3443 .0975 .6393 .0875 .5738 .6945
Adam17 .2700 .0925 .3426 .2125 .7870 .1850 .6852 .6081
Itgb3 .0075 .0025 .3333 .0050 .6667 .0075 1.0000 .8892
Nos2 .0775 .0225 .2903 .0700 .9032 .0250 .3226 .6957
Ednra .0700 .0200 .2857 .0250 .3571 .0175 .2500 .5033
Itgb1 .1225 .0350 .2857 .0500 .4082 .0200 .1633 .0941
Tfpi .1025 .0275 .2683 .0600 .5854 .0300 .2927 .5938
Tnf .0100 .0025 .2500 .0000 .0000 .0075 .7500 .6007
Il1b .0350 .0075 .2143 .0250 .7143 .0100 .2857 .2145
Itga5 .3250 .0675 .2077 .2400 .7385 .4250 1.3077 .2266
Edn1 .0125 .0025 .2000 .0100 .8000 .0100 .8000 .8057
Bax .2750 .0550 .2000 .1575 .5727 .1750 .6364 .6437
Plg .1025 .0200 .1951 .0650 .6341 .0200 .1951 .3600
Mmp9 .2600 .0475 .1827 .0775 .2981 .0975 .3750 .1221
Cradd .2475 .0175 .0707 .1150 .4646 .1475 .5960 .5397
Vwf .0925 .0050 .0541 .0450 .4865 .0600 .6486 .6111
Flt1 .0050 .0000 .0000 .0075 1.5000 .0075 1.5000 .7462
Xdh .0475 .0000 .0000 .0300 .6316 .0150 .3158 .5586
Table 6.2 shows gene expression in the F2 generation. Fold difference indicates a ratio of expression for
MLP Vs Control. Genes exhibiting a two-fold up-regulation are highlighted in blue and genes exhibiting
less than 50% of control expression are shown in red. For a full list of gene names please see appendix.
No significant effects were noted. Data analysed using a mixed model ANOVA. For F2 and F3 crosses
the dietary origin of the male parent is shown before the female parent, eg. Con x MLP indicates a cross
between a male exposed to control diet and a female exposed to MLP diet in utero.
189
Table 6.3 Comparrison of gene expression in kidneys of control and MLP mating cross
male animals of the F3 generation.
CrossGene
Con X Con MLP X MLP
Fold Change P Value
AS1 .0075 .0333 4.4400 .1120
Plg .0125 .0400 3.2000 .4655
Fgf1 .0150 .0333 2.2200 .3201
Gzmb .0075 .0133 1.7733 .6018
Ace2 .0325 .0567 1.7446 .4632
Alox5 .0475 .0800 1.6842 .5062
Angpt1 .0325 .0533 1.6400 .5138
Birc3 .1125 .1733 1.5404 .5844
Ccl2 .0300 .0433 1.4433 .6137
Kit .0050 .0067 1.3400 .8090
Ocln .0050 .0067 1.3400 .8090
Birc4 .0300 .0400 1.3333 .7370
Il6 .0075 .0100 1.3333 .8144
Angpt2 .0325 .0433 1.3323 .7069
Ecgf1 .0100 .0133 1.3300 .8206
Agt .0325 .0400 1.2308 .7824
Blr1 .0300 .0367 1.2233 .8121
Cxcl1 .0225 .0267 1.1867 .8536
Icam2 .1200 .1400 1.1667 .7152
Cxcl2 .0175 .0200 1.1429 .8888
Il7 .0175 .0200 1.1429 .8786
Bcl2 .0300 .0333 1.1100 .9019
Ccl20 .0275 .0300 1.0909 .9264
BAS2C .9825 1.0300 1.0483 .3072
Gapdh .9800 1.0267 1.0477 .3349
Gapdh .9800 1.0267 1.0477 .3349
BAS2C .8975 .9300 1.0362 .6456
Sod1 .9900 1.0200 1.0303 .2607
Icam1 .0425 .0433 1.0188 .9816
Cdh5_pre .0300 .0300 1.0000 1.0000
Rpl32 .9850 .9800 .9949 .8564
Enpep .0175 .0167 .9543 .9556
Cradd .0500 .0467 .9340 .9420
Ppia 1.0400 .9467 .9103 .3349
Birc5 .0550 .0500 .9091 .9001
Cxcl5 .0075 .0067 .8933 .9397
Ccl5 .0300 .0267 .8900 .9067
Agtr2 .0225 .0200 .8889 .9110
Csf2 .0225 .0200 .8889 .9189
Cflar .0375 .0333 .8880 .9034
Aldoa .9500 .8133 .8561 .2273
Aldoa .9350 .7933 .8484 .1273
Cpb2 .0200 .0167 .8350 .8575
Nos3 .4450 .3700 .8315 .7062
Chga .0250 .0200 .8000 .8240
Agtr1b .0350 .0267 .7629 .7632
AS1R2 .0350 .0267 .7629 .7433
Cxcl11 .0175 .0133 .7600 .8026
Bax .0750 .0567 .7560 .7332
Birc1b .0225 .0167 .7422 .7795
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Bcl2l1 .0275 .0200 .7273 .7560
Casp8 .0275 .0200 .7273 .7560
Ace .1775 .1267 .7138 .5140
Npr1 .4025 .2767 .6875 .4635
Ednra .0250 .0167 .6680 .7481
Edn1 .0150 .0100 .6667 .8090
Edn2 .0150 .0100 .6667 .8090
Edn3_map .0150 .0100 .6667 .8090
Timp1 .3825 .2467 .6450 .4730
Bcl2a1 .0450 .0267 .5933 .6270
Fgf2 .0175 .0100 .5714 .7085
Casp6 .0475 .0267 .5621 .6175
Serpine1 .0375 .0200 .5333 .5042
Kdr .8000 .4200 .5250 .0367
Flt4 .0200 .0100 .5000 .6159
Csf3 .0475 .0233 .4905 .4008
Tek .0825 .0400 .4848 .3847
Ednrb .1150 .0533 .4635 .5551
Il1b .0300 .0133 .4433 .4569
Il3 .0075 .0033 .4400 .6729
Casp1 .1300 .0567 .4362 .3442
Casp3 .0850 .0367 .4318 .2997
Tnfsf10 .5625 .2400 .4267 .0730
Plau .5425 .2300 .4240 .3652
Il15 .1900 .0800 .4211 .4643
Ldha .7625 .3133 .4109 .0370
Cx3cl1 .7075 .2833 .4004 .1571
F3 .0750 .0267 .3560 .4133
Col18a1 .2425 .0767 .3163 .2800
Itga5 .2850 .0900 .3158 .0111
Anxa5 .2475 .0700 .2828 .2315
Mmp9 .0950 .0267 .2811 .4038
Adam17 .3125 .0867 .2774 .2057
Flt1 .0125 .0033 .2640 .5691
Flt3 .0125 .0033 .2640 .5691
Itgb3 .0125 .0033 .2640 .5691
Fn1 .3650 .0933 .2556 .2426
Mmp14 .5850 .1467 .2508 .0067
Vwf .0300 .0067 .2233 .2206
Itgb1 .0950 .0200 .2105 .2228
Plat .2450 .0433 .1767 .2654
Pla2g4c .1850 .0300 .1622 .3967
Nos2 .1425 .0167 .1172 .3450
Pdgfrb .0650 .0067 .1031 .3692
Table 6.3 shows gene expression in the F3 generation. Fold difference indicates a ratio of expression for
MLP Vs Control. Genes exhibiting a two-fold up-regulation are highlighted in blue and genes exhibiting
less than 50% of control expression are shown in red. For a full list of gene names please see appendix.
Significant effects were noted in genes Kdr, Ldha, Itga5 and Mmp14. Data analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female parent,
eg. Con x MLP indicates a cross between a male exposed to control diet and a female exposed to MLP
diet in utero.
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6.4.1.2 Justification of gene choices
Figure 6.1 Genes that were up-regulated two-fold or more.
Figure 6.1 shows common gene expression between generations. Only genes expressing an up-
regulation of two-fold or more are shown within this figure.
Vwf, Flt4, Csf3,
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Mmp1a, Flt1, Fgf2, Edn3, Birc1b,
Ace2, Bcl2, Angpt1, Birc4, Agt,
Angpt2, Edn2, Bcl2l1, Pdgfra, ll3,
Agtr2, Itgav, II11, Edn1, Ifnb1
Il6,
As1r1,
Enpep
Fgf1
Plg,
As1
Cxcl2,
Cxcl11,
Ecgf1,
Gzmb
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Figure 6.2 Genes that were down-regulated 50%.
Figure 6.2 shows common gene expression between generations. Only genes expressing a down-
regulation of 50% or more are shown within this figure.
6.4.1.3 qRT-PCR
As previously described (Section 6.3.2), microarray data analysis highlighted
5 gene targets for further study; Matrix metallopeptidase 9 (MMP9), Granzyme B
(GZMB), Endothelial cell growth factor 1 (ECGF1), Endothelin receptor type A
(EDNRA) and Interleukin 7 (Il7). However, due to the short gene sequence of Il7
(465bp) we were unable to design a working primer and probe set, therefore Il7 was
disregarded. Further to this studies by Heijmans and colleagues (2008) have found
evidence of hypomethylation of IGF-2 in their studies of the Dutch Hunger Winter
Ednra,
Il7
Il1b,
Plat,
Mmp9,
Nos2,
Il15,
Fn1, Pla2g4c,
F3, Pdgfrb,
Adam17, Itgb3,
Itgb1, Itga5
Flt4, Csf3,
Ednrb, Il3,
Casp1,
Casp3,
Tnfsf10
Plau, Ldha,
Cx3cl1,
Col18a1,
Flt3, Mmp14
Fgf2, Ace2,
Npr1, Ace,
Csf2, Edn2,
Cpb2, Fgf1,
Icam1
Casp6, Tfpi,
Tnf, Edn1,
Bax, Plg,
Cradd, Xdh
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(Heijmans et al., 2008). Therefore the decision was made to analyse the mRNA
expression of IGF-2 within this study. The effect of postnatal HF feeding was not
analysed within gene expression analysis. The housekeeper gene used within the real
time PCR analysis was 364B.
6.4.1.3.1 364B expression (housekeeper gene)
364B expression within all 3 generations was similar. There was no effect of
MLP exposure in utero or no effect of mating cross on expression (Figures 6.3, 6.4 &
6.5).
Figure 6.3 F1 generation 364B expression in 10 week old rat kidneys.
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Figure 6.3 364B mRNA expression in 10 week old rat kidneys (F1). Data is shown as mean ± SEM, n
= 6 per group. No significant effects were noted. Data was analysed using a mixed model ANOVA.
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Figure 6.4 F2 generation 364B expression in 10 week old rat kidneys.
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Figure 6.4 364B mRNA expression in 10 week old rat kidneys (F2). Data is shown as mean ± SEM, n
= 6 per group. No significant effects were noted. Data was analysed using a mixed model ANOVA.
For F2 and F3 crosses the dietary origin of the male parent is shown before the female parent, e.g.
Con x MLP indicates a cross between a male exposed to control diet and a female exposed to a MLP
diet in utero.
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Figure 6.5 F3 generation 364B expression in 10 week old rat kidneys.
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Figure 6.5 364B mRNA expression in 10 week old rat kidneys (F3). Data is shown as mean ± SEM, n
= 6 per group. No significant effects were noted. Data was analysed using a mixed model ANOVA.
For F2 and F3 crosses the dietary origin of the male parent is shown before the female parent, e.g.
Con x MLP indicates a cross between a male exposed to control diet and a female exposed to a MLP
diet in utero.
6.4.1.3.2 Matrix metallopeptidase 9 (MMP9) expression
MMP9 expression in 10 week old rat kidneys of the F1 generation (Figure
6.6) was measured relative to expression of 364B. After normalisation of the data,
there was found to be no significant difference between control and MLP-exposed
animals MMP9 mRNA expression at 10 weeks of age. Expression in male and
female animals was also similar.
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Figure 6.7 shows MMP9 mRNA expression in 10 week old rat kidneys of the
F2 generation. After normalisation, MMP9 expression was similar in all mating
crosses. Expression in male and female animals was also similar, however a
significant interaction of sex and mating cross (P<0.05) was noted, with males from
the MLP x MLP mating cross exhibiting lower MMP9 mRNA expression than any
other mating cross.
F3 generation MMP9 mRNA expression (Figure 6.8) was significantly
(P<0.05) lower in the MLP x MLP mating cross (approximately 50%) compared to
controls. Expression in male and female animals was similar.
Figure 6.6 F1 generation MMP9 mRNA expression in 10 week old rat kidneys.
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Figure 6.6 MMP9 mRNA expression in 10 week old rat kidneys (F1). Data is shown as mean ± SEM,
n = 6 per group. No significant effects were noted. Data was analysed using a mixed model ANOVA.
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Figure 6.7 F2 generation MMP9 mRNA expression in 10 week old rat kidneys.
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Figure 6.7 MMP9 mRNA expression in 10 week old rat kidneys (F2). Data is shown as mean ± SEM,
n = 6 per group. A significant interaction of sex and mating cross (P<0.05) was noted. Data was
analysed using a mixed model ANOVA. For F2 and F3 crosses the dietary origin of the male parent is
shown before the female parent, e.g. Con x MLP indicates a cross between a male exposed to control
diet and a female exposed to a MLP diet in utero.
.
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Figure 6.8 F3 generation MMP9 mRNA expression in 10 week old rat kidneys.
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Figure 6.8 MMP9 mRNA expression in 10 week old rat kidneys (F3). Data is shown as mean ± SEM,
n = 6 per group. A significant effect of mating cross (P<0.05) was noted. Data was analysed using a
mixed model ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before
the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a
female exposed to a MLP diet in utero.
6.4.1.3.3 Granzyme B (GZMB) expression
GZMB mRNA expression in 10 week old rat kidneys of the F1 generation
(Figure 6.9) was measured relative to the expression of 364B. After normalisation of
the data, there was found to be a significant effect of maternal diet in utero upon
GZMB expression. In contrast to the microarray results, MLP-exposed offspring had
approximately 30% lower (P<0.05) GZMB expression compared to their control
counterparts. Expression was similar among male and female animals.
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In the F2 generation, GZMB expression (Figure 6.10) was similar
irrespective of mating cross and sex. Figure 6.11 shows F3 generation GZMB
mRNA expression in 10 week rat kidneys. After normalisation the data showed that
expression values between mating crosses were similar. Female animals however,
exhibited approximately 40-60% lower GZMB mRNA expression than male
animals.
Figure 6.9 F1 generation GZMB mRNA expression in 10 week old rat kidneys.
Maternal Diet
MLPControl
G
ZM
B
m
R
N
A
/3
6B
4
m
R
N
A
2.50
2.00
1.50
1.00
0.50
0.00
Female
Male
Sex
Figure 6.9 GZMB mRNA expression in 10 week old rat kidneys (F1). Data is shown as mean ± SEM,
n = 6 per group. A significant effect of maternal diet (P<0.05) was noted. Data was analysed using a
mixed model ANOVA.
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Figure 6.10 F2 generation GZMB mRNA expression in 10 week old rat kidneys.
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Figure 6.10 GZMB mRNA expression in 10 week old rat kidneys (F2). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to a MLP diet in utero.
201
Figure 6.11 F3 generation GZMB mRNA expression in 10 week old rat kidneys.
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Figure 6.11 GZMB mRNA expression in 10 week old rat kidneys (F3). Data is shown as mean ±
SEM, n = 6 per group. A significant effect of sex (P<0.05) was noted. Data was analysed using a
mixed model ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before
the female parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a
female exposed to a MLP diet in utero.
6.4.1.3.4 Endothelial cell growth factor 1 (ECGF1) expression
F1 generation ECGF1 mRNA expression at 10 weeks of age (Figure 6.12)
was measured relative to the expression of 364B. After normalisation the data
showed no significant effects of exposure to a MLP diet in utero. Expression of
mRNA in 10 week rat kidneys from male and female animals was similar.
As in the F1 generation, F2 generation ECGF1 expression at 10 weeks of age
(Figure 6.13), was similar in all mating crosses irrespective of the sex of the animal.
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There was also no effect of mating cross upon ECGF1 mRNA expression in the F3
generation (Figure 6.14). Expression levels in male and female animals were similar.
Figure 6.12 F1 generation ECGF1 mRNA expression in 10 week old rat kidneys.
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Figure 6.12 ECGF1 mRNA expression in 10 week old rat kidneys (F1). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA.
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Figure 6.13 F2 generation ECGF1 mRNA expression in 10 week old rat kidneys.
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Figure 6.13 ECGF1 mRNA expression in 10 week old rat kidneys (F2). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to a MLP diet in utero.
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Figure 6.14 F3 generation ECGF1 mRNA expression in 10 week old rat kidneys.
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Figure 6.14 ECGF1 mRNA expression in 10 week old rat kidneys (F3). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to a MLP diet in utero.
6.4.1.3.5 Endothelin receptor type A (EDNRA) expression
EDNRA expression in 10 week old rat kidneys of the F1 generation (Figure
6.15) was measured relative to expression of 364B. After normalisation and analysis
of the data, there was found to be no significant difference in expression between
control and MLP-exposed animals in utero. Expression levels between sexes
however did differ (P<0.05). Male animals exhibited higher expression than female
animals (approximately 20%) irrespective of maternal diet.
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Figure 6.16 shows the expression of EDNRA mRNA in the kidneys of F2
generation 10 week old animals. Similar to the F1 generataion there was no effect of
maternal diet/ mating cross upon EDNRA expression. Expression in male and female
animals was similar. Expression of EDNRA in the F3 generation (Figure 6.17) was
unaffected by either mating cross or sex of the animal.
Figure 6.15 F1 generation EDNRA mRNA expression in 10 week old rat kidneys.
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Figure 6.15 EDNRA mRNA expression in 10 week old rat kidneys (F1). Data is shown as mean ±
SEM, n = 6 per group. A significant effect of sex (P<0.05) was noted. Data was analysed using a
mixed model ANOVA.
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Figure 6.16 F2 generation EDNRA mRNA expression in 10 week old rat kidneys.
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Figure 6.16 EDNRA mRNA expression in 10 week old rat kidneys (F2). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to a MLP diet in utero.
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Figure 6.17 F3 generation EDNRA mRNA expression in 10 week old rat kidneys.
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Figure 6.17 EDNRA mRNA expression in 10 week old rat kidneys (F3). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to a MLP diet in utero.
6.4.1.3.6 Insulin-like growth factor 2 (IGF-2) expression
Figure 6.18 shows IGF-2 expression in 10 week old rat kidneys of the F1
generation relative to expression of 364B. After normalisation and analysis of the
data, it was apparent that MLP-exposed offspring exhibited lower IGF-2 mRNA
expression (P<0.05) than control animals (approximately 30- 50%). Expression
levels in male and female animals were similar.
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IGF-2 mRNA expression in 10 week old rat kidneys from the F2 generation
(Figure 6.19) was unaffected by both mating cross and sex of the animals. Similarly
in the F3 generation IGF-2 mRNA expression levels in 10 week old rat kidneys
(Figure 6.20) were unaffected by both mating cross and sex.
Figure 6.18 F1 generation IGF-2 mRNA expression in 10 week old rat kidneys.
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Figure 6.18 IGF-2 mRNA expression in 10 week old rat kidneys (F1). Data is shown as mean ± SEM,
n = 6 per group. A significant effect of maternal diet (P<0.05) was noted. Data was analysed using a
mixed model ANOVA.
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Figure 6.19 F2 generation IGF-2 mRNA expression in 10 week old rat kidneys.
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Figure 6.19, IGF-2 mRNA expression in 10 week old rat kidneys (F2). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to a MLP diet in utero.
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Figure 6.20 F3 generation IGF-2 mRNA expression in 10 week old rat kidneys.
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Figure 6.20, IGF-2 mRNA expression in 10 week old rat kidneys (F3). Data is shown as mean ±
SEM, n = 6 per group. No significant effects were noted. Data was analysed using a mixed model
ANOVA. For F2 and F3 crosses the dietary origin of the male parent is shown before the female
parent, e.g. Con x MLP indicates a cross between a male exposed to control diet and a female exposed
to a MLP diet in utero.
6.4.2 DNA Methylation
Global DNA methylation was assessed using the cytosine extension assay
detailed in section 2.7.2. Figure 6.21 shows the methylation results as a ratio of
HpaII to MspI, which is a measure of total percentage methylation.. There was no
effect of maternal diet/ mating cross on DNA methylation in any generation. The
effects of sex and postnatal HF feeding were not analysed due to time constraints.
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Figure 6.21 DNA methylation in 10 week old rat kidneys.
Figure 6.21 DNA methylation status of 10 week old rat kidneys. Data is shown as mean ± SEM, n = 6
per group. No significant effects were noted. Data was analysed using Univariate analysis. For F2 and
F3 crosses the dietary origin of the male parent is shown before the female parent, e.g. Con x MLP
indicates a cross between a male exposed to control diet and a female exposed to a MLP diet in utero.
Arrow indicates increasing methylation.
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6.5 Discussion
6.5.1 Summary of findings
Current thinking is that disease arises due to a mismatch between the prenatal
and postnatal environments (Gluckman and Hanson, 2004). Evidence demonstrates
that rapid catch-up growth following prenatal growth restriction is a predictor for the
metabolic syndrome (Eriksson et al., 2003). It has been argued that deficits in
maternal nutrition during pregnancy are ultimately transmitted to the grandchildren
(James, 2002). This is likely to involve the alteration of DNA through either DNA
methylation and/ or histone modification (Isles, 2005; Waterland et al., 2007). Work
within this thesis has demonstrated that MLP exposure during gestation has
implications for the health of future generations. The current chapter aims to identify
possible gene targets involved in the production of the phenotype associated with the
low protein diet.
Table 6.4 Summary of findings
Generation
F1 F2 F3
qRT-PCR (MMP9) No difference in
expression
Decreased
expression in MLP
male animals
Decreased
expression in MLP x
MLP mating cross,
no effect of sex
qRT-PCR (GZMB) Decreased
expression in MLP
maternal diet group,
no effect of sex
No change with
mating cross or sex
No effect of mating
cross, expression
decreased in
females
qRT-PCR (ECGF1) No change with
maternal diet or sex
No change with
mating cross or sex
No change with
mating cross or sex
qRT-PCR (EDNRA) No effect of maternal
diet, increased
expression in males
No change with
mating cross or sex
No change with
mating cross or sex
qRT-PCR
(IGF-2)
Decreased
expression in MLP
groups, no effect of
sex
No change with
mating cross or sex
No change with
mating cross or sex
DNA methylation No change with
maternal diet
No change with
mating cross
No change with
mating cross
Table 6.4 shows a brief summary of the findings from the assessment of gene expression and DNA
methylation analysis in the F1, F2 and F3 generations
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6.5.2 Effect of prenatal protein restriction on gene expression
Maternal restriction of protein has previously been shown to induce
hypertension from 4 weeks of age (Langley-Evans et al., 1994) coupled with a
reduction in nephron complement (Langley-Evans et al., 1999a) in the F1 generation.
Although the development of hypertension is clearly multifactorial, hypertension is
intrinsically linked to kidney function (Gilbert et al., 2005; Langley-Evans, 2006;
Langley-Evans et al., 1999a; Mackenzie, 1995; Mackenzie et al., 1996). Previous
chapters within this thesis have demonstrated that a hypertensive phenotype is
transmitted from the F1 to the F2 generation. To date there has been very little data
explaining the mechanisms behind these programmed changes. The original aim of
this chapter was to discover and analyse potential gene targets involved in the
reduced nephron complement and hypertensive phenotype outlined within this thesis.
This study is unique in that it is the first to assess the effect of in utero exposure to
MLP diet on renal gene expression in 3 successive generations.
In order to select possible gene targets a decision was made to employ the use
of microarray technology to highlight genes that were differentially expressed
between groups within each generation of animals. From these studies we hoped to
identify genes in which mRNA expression was significantly changed in the F1 and
F2 generations, where we see the hypertensive phenotype and possibly continuing
into the F3 generation. Microarray findings would be backed up by qRT-PCR
studies. To begin this process the pathway focussed Oligo GEArray DNA
Microarray for rat endothelial cell biology was selected to analyse the expression of
113 genes associated with permissibility and vessel tone, angiogenesis, endothelial
cell activation and endothelial cell injury. A pathway focussed DNA microarray was
chosen over a whole genome array as arrays which target the whole genome often
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provide a wealth of data, which can be difficult to interpret. Results from more
focussed microarrays often provide insights into what is happening with in a specific
panel or family of genes.
Results (Tables 6.1-6.3) from the microarray analyses highlighted 4 potential
gene targets that had higher than a 2 fold increase or decrease between groups, which
were common between the F1 and F2 generations, and 1 gene that was down-
regulated 50% in all 3 generations These were Matrix metallopeptidase 9 (MMP9),
Granzyme B (GZMB), Endothelial cell growth factor 1 (ECGF1), Endothelin
receptor type A (EDNRA) and Interlukin 7 (Il7). As previously stated, we were
unable to analyse the expression of Il7 by qRT-PCR. Analysis of the remaining
genes identified by the microarray by qRT-PCR showed no significant effect of
maternal diet on the expression of MMP9, ECGF1 and EDNRA in the F1 generation.
However, post hoc power calculations revealed that MMP9 and ECGF1 analyses
were underpowered. Although sample means in the Con and MLP groups were
substantially different (15%), standard deviations were relatively large and an
increased sample size would have been needed in order for the difference to be
statistically significant (Table 6.5). In contrast, the difference between means for
EDNRA was very small and the risk of Type II error in this data set is low. GZMB
expression was significantly decreased in the F1 generation, but this effect was in the
opposite direction to the results observed in the microarray.
Similarly there was no effect of mating cross on the expression of any of the
selected genes within the F2 generation, with the exception of MMP9 in which
mRNA expression levels were lower in males from the MLP x MLP mating cross.
Again, post hoc analysis of power revealed that the analysis of ECGF1 was
underpowered (Table 6.5).
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The F3 generation exhibited a reduced MMP9 expression in the MLP x MLP
mating cross. The expression of all the other genes were unaffected by dietary
factors. Post hoc analysis suggested that the analysis of the expression of GZMB and
EDNRA were underpowered (Table 6.5).
Table 6.5 Summary of data for power calculations.
Gene Mean
group 1
SD group 1 Mean
group 2
SD Group
2
Samples
required
for
statistical
significance
F1
MMP9 1.189 1.056 1.015 0.575 409
ECGF1 1.017 0.895 0.857 0.297 295
EDNRA 0.697 0.240 0.718 0.185 1735
F2
GZMB 1.663 0.714 1.699 1.141 11484
ECGF1 1.070 0.775 0.802 0.372 88
EDNRA 0.733 0.297 0.729 0.438 158700
F3
GZMB 1.566 0.912 1.379 1.246 586
ECGF1 0.769 0.198 0.810 0.393 1008
EDNRA 0.712 0.220 0.528 0.298 34
Table 6.5 SD = standard deviation. F1 generation group1 = MLP, group 2 = Con. F2 and F3
generations group 1 = MLP x MLP, group 2 = Con x Con. The probability of a type I error (Į) was set
at 0.05 and of a type II error (ȕ) set at 0.10, to give a power (ȕ-1) of 0.90. Means and Standard
deviations from this table were used to calculate the number of samples required for statistical
significance.
The involvement of the expression of GZMB, ECGF1 and EDNRA in the
development of the MLP phenotype observed within this study can therefore be ruled
out, as none of the genes showed altered expression in both the F1 and F2
generations. The involvement of MMP9 can also largely be disregarded as, although
there was lower expression in both the F2 generation MLP x MLP males and the F3
generation MLP x MLP mating cross animals, the hypertensive phenotype observed
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within this thesis is present in both the male and female animals. The qRT-PCR
results of MMP9 were especially unexpected as previous research has indicated that
MMP9 is produced at the first stage of kidney embryogenesis in vivo and it is also
required for branching morphogenesis in vitro (Lelongt et al., 1997; Pohl et al.,
2000). Further to this, MMP9 deficient mice exhibit a 12% reduction in nephron
number and at 12 months of age develop renal impairment and atrophy (Lelongt and
Ronco, 2002). These findings Indicate that MMP9 is required for nephron formation
and preservation of renal function. One possible reason for the negative results for
MMP9 is the age of the animals studied (10 weeks postnatal). Previous research has
indicated that in a mouse model MMP9 expression could not be detected above
background level in the kidney from prenatal day 12 onward (Reponen et al., 1994).
The timing of measurements is likely to be critical when examining gene expression.
Events in utero have the potential to trigger a phenotype to develop. Further to this
gene changes in utero may be transient (Thompson et al., 2005) and therefore not
observable once the phenotype has fully established.
A drawback of the work within this chapter is the poor agreement of the qRT-
PCR studies with the microarray studies, for example Gzmb mRNA expression in the
F1 generation was reduced when analysed by qRT-PCR, however when analysed by
microarray mRNA expression was greater than in controls. These results reinforce
that although microarray technology is a useful tool for selecting candidate genes, all
analyses need to be backed up by qRT-PCR analyses to verify the results. Although
the expression of none of the genes analysed within this investigation were found to
be altered by exposure to MLP, it is important to note that there are several
limitations associated with the use of a pathway focussed microarray technology
utilised within this investigation. For example the array is, by definition, targeted and
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therefore does not analyse the entire genome, and therefore there were limits to the
analysis. There is also the possibility that we selected an inappropriate target array,
an array focussed on the extracellular matrix or a genome wide array looking at
thousands of genes may have yielded more targets for follow up. Although this
technique often provides such a wealth of data it can be challenging to select
candidate genes. In the current investigation we decided to utilise the pathway
focussed endothelial cell microarray as we believed that as we had a hypertensive
phenotype that also displayed a reduced nephron complement this array would be the
best suited for identifying possible candidate genes. Further to the limitations of the
microarray another potential drawback to the work within this chapter is that due to
expense and time constraints we were unable to analyse protein expression to back-
up the findings from both the microarray and qRT-PCR studies.
In addition to the investigation of genes highlighted by the microarray data,
recent research has indicated that individuals exposed to the Dutch Hunger Winter of
1944-45 have differing expression of insulin-like growth factor 2 (IGF-2), compared
to non-exposed controls (Heijmans et al., 2008). Analysis of IGF-2 by qRT-PCR
indicated that its expression was not linked to the phenotype observed within this
investigation as although a lower expression was noted in MLP- exposed offspring of
the F1 generation, no difference in expression was noted within the F2 generation. It
is also worth noting that the lower expression noted within the current study is the
opposite to the greater expression levels noted within the human study (Heijmans et
al., 2008). Although all the genes investigated within this study were found to be
unaffected by MLP exposure it is important to note that the phenotype noted within
this study must be preceded by modifications at the molecular level. Recent research
by Abdel-Hakeem and colleagues (2008) has demonstrated several possible gene
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targets involved in controlling transcription and growth in fetal nephrogenesis
including glial cell line-derived neurotrophic factor (GDNF) which has a critical role
in promoting ureteric bud (UB) branching (Abdel-Hakeem et al., 2008). As
previously stated a possible limitation of this study is the time at which the kidney
samples were taken (10 weeks). Collection of kidney samples during the final stages
of gestation (day 20) would have been advantageous as it would have allowed us to
evaluate expression at a time during which UB branching and mesenchymal
transformation were occurring. The analysis of the whole kidney within the current
investigation may have overlooked regional effects, therefore, the study of gene
expression within the different compartments of the kidney during the different
stages of development would also have been advantageous.
The analysis of methylation indicated no significant differences between
groups. The cytosine extension assay utilised within this investigation is a high
throughput method for the analysis of global methylation. The results obtained were
unexpected as the induction of an altered phenotype by prenatal undernutrition is
thought to involve changes in the epigenetic regulation of specific genes (Goldberg
et al., 2007; Whitelaw, 2006; Whitelaw and Whitelaw, 2006). Previous research has
demonstrated that protein restriction induces changes in hepatic PPARĮ promoter
(Lillycrop et al., 2008) which are subsequently passed onto a second generation
(Burdge et al., 2007a).
It is important to note that the cytosine extension assay has one specific
limitation. The assay analyses global methylation. Therefore large changes in
methylation status at specific promoters may go unnoticed as methylation of the
genome as a whole is unchanged. The current study would therefore benefit from the
analysis of methylation status from a gene-specific view-point, employing the use of
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either genome wide methods of analysis such as Restriction Landmark Genome
Scanning (RLGS), or candidate gene methods such as Direct bisulfite Sequencing.
Although after analysis, results from cytosine extension assay proved not to be
significant, there was however a trend of hypomethylation in all 3 generations. This
is consistent with the work of Sinclair and colleagues (2007) who analysed over 1400
CpG sites and noted a 4% (57 loci) change in total methylation status, 88% of which
were hypomethylated (Sinclair et al., 2007). Interestingly Maloney and colleagues
(2007) who also utilized the cytosine extension assay in order to analyse DNA
methylation, after feeding rats diets deficient in folate, methionine and choline during
pregnancy found no significant change in methylation (Maloney et al., 2007). It is
possible that the methylation analysis within the current investigation was
underpowered and if numbers were increased a significant value might be obtained.
Work within this investigation has demonstrated the passage of a phenotype
consisting of high blood pressure and reduced nephron complement from F1
generation to the F2 generation via both the maternal and paternal lines. Although
there was no change in the expression of genes at the time points monitored in this
investigation, on reflection some of the RT-PCR studies were underpowered which
may explain some of the negative results. However, it must be noted that the
dysregulation of renal genes involved in endothelial cell function and UB branching
at differing stages of development are likely to be involved in providing new insights
into our understanding the molecular machinery behind the phenotype observed
within this thesis.
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7.0 General discussion and future prospects
The original fetal origins hypothesis conceived by Barker and colleagues (1989)
has both evolved and expanded over the last few decades (Barker, 1992; Barker,
1994; Hales, 2001) and now encompasses an abundance of data from both
epidemiological studies (Ravelli, 1998, 1999; Roseboom, 2000, 2001) and animal
models (Kind, 1999; Langley-Evans et al., 1994; Lillycrop et al., 2005; Taylor et al.,
2005). It is well-established that diseases in adult life such as hypertension and CVD
and the subsequent development of the metabolic syndrome emerge as a
consequence of interplay between genetic and environmental factors. Recent
research has concentrated on the role undernutrition in pregnancy plays in the onset
of disease. Whilst the origins of the metabolic syndrome are clearly multifactorial,
nutrition in early life may have a profound influence upon risk and the responses of
the individual to the environmental and lifestyle-related risk factors in adulthood. To
date evidence has suggested that coronary heart disease (Langley-Evans et al., 1998),
hypertension (Langley-Evans et al., 1996d), diabetes (Singhal et al., 2003), obesity
(Breier et al., 2001) and impaired immunity (Beach, 1982) can be nutritionally
programmed in early life and infancy. Previous work using protein restriction in
rodent pregnancy has demonstrated its capacity to induce postnatal hypertension
from as early as 4 weeks of age (Langley-Evans et al., 1996d; Langley and Jackson,
1994) coupled with a reduction in nephron number from birth (Langley-Evans et al.,
1999a) within the F1 generation.
The primary aims of this thesis were to further explore the concept of fetal
programming and ascertain whether the previously described phenotype of
hypertension and reduced nephron number was passed to subsequent generations and
to uncover the mechanism by which this phenotype is programmed in utero via
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identifying key genes involved in this process. The results of this thesis support the
original findings of Beach et al (1982) who noted that nutrient restriction during
gestation had implications for future generations. Work within this thesis also
confirms the existence of this previously described phenotype in the F1 generation
and demonstrates that the phenotype is intergenerationally passed from the F1
generation to the F2 generation via both parental lines without any further dietary
manipulation. This data effectively demonstrates that the course of an individuals
development is not only influenced by a mixture of genetic, environmental and
maternal factors but also grand-maternal and paternal factors.
It has been proposed that undernutrition during pregnancy programmes long-
term changes in gene expression, which subsequently alter metabolism in the
developing fetus resulting in abnormalities in later life (Burdge et al., 2007a; Burdge
et al., 2007b; Waterland et al., 2007). Indeed the expression of genes that either
protect or predispose an organism against these conditions will be further modified
by interactions between the genotype, early life nutrition and the postnatal
environment (Langley-Evans, 2006).
A number of studies have indicated that prenatal undernutrition has the
capacity to modulate the epigenetic regulation of gene expression (Burdge et al.,
2007a; Jaenisch and Bird, 2003). This raises the prospect that undernutrition can
establish heritable changes to the epigenome and, as such, the disease programming
effects of undernutrition in the fetal period may not be limited to the first generation.
Emerging evidence from human and animal studies suggests that transgenerational
effects may occur, whereby the consequences of deficits in maternal nutrition are
subsequently passed on to the grandchildren (Beach, 1982; James, 2002; Pembrey,
1996). Indeed inheritance of epigenetic states is a common occurance in plants
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(Takeda and Paszkowski, 2006). Specific epigenetic changes within tissues and
especially gametes could play a vital role in mediating the transgenerational effect.
Unfortunately prior to commencing this study most mechanistic studies of
epigenetics have focussed on F0 to F1 transmission, with very little evidence of
transmission to further generations. There was, therefore, very little robust
transgenerational work in the programming field. Early work had demonstrated that
maternal diets moderately deficient in zinc resulted in a depressed immune function
in the offspring which persisted until the F3 generation (Beach, 1982). Further to this
Zambrano and colleagues noted that maternal protein restriction resulted in altered
glucose and insulin metabolism in both the F1 and F2 generations (Zambrano et al.,
2005).
During the course of this study interest in the field of transgenerational
effects and epigenetics has increased and several other research groups have also
demonstrated evidence of intergenerational programming. Firstly Burdge and
colleagues (2007a) demonstrated that after restriction of protein to the F0 generation
PPARĮ and GR promoter methylation was significantly lower in F1 and F2
generation offspring. Similarly Pinheiro et al (2008) noted that protein restriction
during gestation had adverse effects on both glucose and leptin metabolism, which
resulted in insulin resistance in the F1 and F2 generations. Torrens and colleagues
(2008) also recently demonstrated that maternal protein restriction during pregnancy
leads to raised systolic blood pressure and endothelial cell dysfunction in both F1 and
F2 generation offspring. All of these studies have one major limitation, they only
assess maternal transmission, as they all use males from outside the study to breed
the F2 generation and therefore do not conclusively demonstrate that these maternal
traits are transmitted to the next generation via programmed influences on the ovum
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as changes to the maternal environment and the composition of proteins in the
developing embryo may play a key role. To date only a limited number of studies
have demonstrated transgenerational programming in the F3 generation and beyond
(Anway et al., 2006b; Beach, 1982). Within the field of protein restriction Benyshek
and colleagues (2006) demonstrated the F3 generation exhibited altered glucose
metabolism (Benyshek et al., 2006), although once again the research has limitations
as animals from outside the experiment were used for breeding. To our knowledge
the data contained within this thesis for the first time demonstrates that maternal
protein restriction during gestation is able to programme both blood pressure and
nephron number in both the maternal and paternal lines.
Current thinking is that the transgenerational passage of phenotypic
information is likely to involve the epigenetic regulation of genes and to date several
studies have demonstrated this principle, probably the most commonly cited is the
work by Waterland and colleagues (2003) who have shown that dietary methyl
supplementation of the diets of yellow agouti (Avy) mice with folic acid, choline,
vitamin B12 and betaine could alter the phenotype off the heterozygous offspring via
increased CpG methylation at the Avy locus (Waterland and Jirtle, 2003). This
effectively demonstrated that nutritional factors during fetal development can modify
gene expression. Since this initial observation several other studies have also
demonstrated epigenetic gene regulation such as Sinclair et al (2007) who fed sheep
a diet deficient in methyl donors for eight days prior to conception and 6 days during
pregnancy resulting in male animals with elevated blood pressure and insulin
resistance, epigenetic analysis of these animals revealed that 4% of the 1400 CpG
islands of the fetal liver monitored differentially methylated. Most of these CpG
islands were either demethylated or hypomethylated (Sinclair et al., 2007). These
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studies are consistent with studies in the rat by Lillycrop and colleagues which also
showed hypomethylation (Lillycrop et al., 2005; Lillycrop et al., 2008; Lillycrop et
al., 2007). Although within the current investigation no significant differences in
DNA methylation were noted, a trend towards hypomethylation was apparent, which
fits with prevailing epigenetic theories regarding the impact of epigenetics on gene
expression. Although there is no doubt that epigenetic mechanisms such as DNA
methylation and histone modification can impact upon the expression of genes and
the development of disease, great care must be taken to ensure that these alterations
are functionally significant. Studies by Lillycrop and colleagues (2008) have
demonstrated that PPARĮ promoter was downregulated 26% in the offspring of rats
fed a low protein diet during gestation whereas studies in the field of cancer suggest
the methylation changes need to be of the order of two-fold or greater before they
have a physiological impact (Veerla et al., 2008).
The mechanism by which the low protein diet modifies epigenetic markers is
still unknown. Figure 7.1 outlines the mechanistic arguments associated with the
field of fetal programming and demonstrates how this thesis has advanced
understanding of the development of disease in subsequent generations. Current
thinking is that the expression of DNMT-1 maybe down-regulated (Lillycrop et al.,
2007). The availability of methyl donors such as methionine and folate is also
thought to be of prime importance. Folate plays an essential role in the one-carbon
metabolism pathway including the re-methylation of homocysteine to methionine,
the precursor of S-adenosylmethionine, which acts as the primary methyl donor in
DNA methylation (Kim, 2004). Experiments have demonstrated that methyl donor
deficiencies have the potential to alter DNA methylation (Cravo et al., 1992).
Supplementation of the low protein diet with folate during rat pregnancy has been
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demonstrated to prevent the establishment of the phenotypes associated with the low
protein diet and normalise DNA methylation patterns (Lillycrop et al., 2007; Torrens
et al., 2006). Recent research with in our lab has indicated that folate
supplementation during pregnancy resulted in the overloading of the maternal system
with folate. Most of this excess folate was stored in the maternal liver. Fetal tissues
were also observed to have accumulated folate. Further to this no differences in
hepatic global DNA methylation was noted in the offspring. Research within our lab
has indicated that folate supplementation against a background of a control protein
diet produced similar effects to the low protein diet alone (Engeham and Langley-
Evans, 2009). This recent data suggests folate availability is not responsible for the
programming effects of the low protein diet.
Although the field of transgenerational programming is fairly new, the
process through which epigenetic mechanisms alter gene expression is fairly well
understood. Two further fundamental questions remain. Firstly, the majority of the
animal models in the programming field show that the effects of transgenerational
programming peter out over time, whereby the F1 and F2 generations are affected
but the F3 generation are unaffected. A possible explanation of this is that the initial
stimulus modifies oocyte development in the F1 generation while they are still in the
womb. Therefore the initial stimulus directly effects the development of the F2
generation. This suggests that there is not truly a transgenerational effect unless the
effects of the intervention/ stimuli are seen within the F3 generation. However, this
explanation can not explain findings in the current investigation as transmission
occurs down both the male and female lines. The reason as to why the F3 generation
is unaffected is unknown, however, it is possible that it is due to the loss of
epigenetic marks laid down by the initial protein insult. Evidence from studies on
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monozygotic twins suggest that the epigenome is constantly changing due to
interaction with the external environment, independently of the genetic sequence
(Fraga et al., 2005). In particular, changes in epigenetic markers have been
associated with aging and the formation of cancer (Fraga and Esteller, 2007). The
ability of the epigenome to change over time indicates another possible explanation
as to why the F3 generation is unaffected in the current investigation.
Secondly, it is not clear how epigenetic marks are transmitted
intergenerationally as widespread reprogramming of the epigenome involving both
active and passive demethylation and the reorganisation of histone modifications
occurs during early development, followed by establishment of a different set of
epigenetic marks associated with different cell lineages (Morgan et al., 2005).
Transgenerational programming could involve epigenetic marks that are resistant to
this de-methylation process, or, it is possible that there is some sort of epigenetic
memory which directs re-methylation. We propose that this is the most plausible
cause of the transgenerational passage of the hypertensive and reduced nephron
complement phenotype.
It must be noted that the epigenetic explanation offered within the current
discussion is not the only viable mechanism as to how programming occurs.
However, as previously stated, it is the most plausible. The glucocorticoid hypothesis
and tissue remodelling may also play a part in the development of the phenotype
associated with the low protein diet in the F1 generation, but they do not explain the
transmission of the phenotype to the F2 generation.
The implications of the present findings for human health are vast. If
maternal undernutrition is able to elicit major effects upon fetal development and the
risk of disease then the field of programming is of major public health importance.
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Furthermore if there is the possibility that these effects upon development and
disease risk have the potential to be transmitted from one generation to another then
research within this field is of paramount importance, especially for countries such as
India and China where the rapid westernisation of the diet will result in a rapid and
prolonged increase in the incidence of metabolic disease, unless there is appropiate
intervention.
Epigenetic programming through the processes of DNA methylation, histone
modification and chromatin remodelling is complex, involving numerous different
mechanistic components and genes with altered transcriptional states. Before
considering any interventions the processes involved must be thoroughly understood.
Interventions may be as simple as improving the quality of the diet for pregnant
women or may involve the administration of therapeutic agents such as folate or
glycine which have been previously shown to cancel out the programming effects of
the low protein diet (Jackson et al., 2002; Torrens et al., 2006). These methods
would ideally work in combination with screening methods for the identification of
the individuals at risk.
Epidemiological evidence from human cohorts and work from animal studies
have clearly demonstrated that fetal programming by nutritional insults during
gestation have huge implications for the risk of disease for several future generations.
To date several different animals models have demonstrated their ability to induce
common phenotypes that consist of CVD and development of the metabolic
syndrome. Future work should concentrate on understanding the mechanisms
associated with these processes as currently no single mechanism has been identified
as being key to the development of these phenotypes. The identification of key genes
involved in the different animal models would provide also provide a key insight into
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the mechanisms involved. Future studies should also allow the separate consideration
of the capacity of programmed male and female offspring to transmit their phenotype
to subsequent generations by utilising both male and female animals from outside the
experiment for breeding purposes. The analysis of epigenetic markers within the
gametes, of programmed animals is also vital in order to understand the transmission
of programmed phenotypes through successive generations. Analysis should be done
using methylation-specific RT-PCR following bisulphite treatment and Chromatin
Immunoprecipitation for the analysis of DNA methylation and histone acetylation.
In conclusion, it is clear that a nutritional protein insult during gestation has
both physiological and metabolic implications for subsequent generations. Although
understanding of the processes involved is limited, research into the role epigenetic
mechanism play in the disease process are likely to be key in understanding how
diseases are passed to subsequent generations. Only once the mechanisms and
processes involved have been characterised can novel therapeutic strategies be
invoked to combat the progression towards disease.
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Figure 7.1 Possible mechanisms involved in the field of fetal programming.
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Figure 7.1 Maternal nutrient restriction is proposed to exert an influence on fetal development and the progression towards disease by either increased placental
glucocorticoids and/or epigenetic modifications that ultimately alter gene expression and promote tissue remodelling, resulting in modified tissue function and the progression
towards disease. It is suspected that epigenetic modifications to the germline have the potential to increase the risk of disease in subsequent generations.
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8.0Appendix
8.1 Addresses of suppliers:
Amersham Biosciences UK Ltd
Amersham Place
Little Chalfont
Buckinghamshire
HP7 9NA
UK
Applied Biosystems Ltd
Lingley House
120 Birchwood Boulevard
Warrington
WA3 7QH
UK
Bio-Rad
1000 Alfred Nobel Drive
Hercules
CA 94547
USA
B & K Universal Ltd
Grimston
Aldbrough
Hull
HU11 4QE
UK
Crystal Chem Inc
1536 Brook Drive, Suite A
Downers Grove
IL 60515
USA
Fisher Scientific UK
Bishop Meadow Road
Loughborough
Leicestershire
LE11 5RD
UK
Invitrogen Ltd
3 Fountain Drive
Inchinnan Business Park
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Paisley
PA4 9RF
UK
Linton Instrumentation
Unit 11 Forge Business Centre
Upper Rose Lane
Palgrave
Diss
Norlfolk
IP22 1AP
UK
MWG Eurofins Operon
Anzingerstr. 7a
85560 Ebersberg
Germany
Perkin-Elmer
940 Winter Street
Waltham
Massachusetts
02451
USA
Promega UK
Chilworth Research Centre
Southampton
SO16 7NS
UK
Roche UK
Charles Avenue
Burgess Hill
West Sussex
RH15 9RY
Sigma-Aldrich Company Ltd
Fancy Road
Poole
Dorset
BH12 4XA
UK
Tecan Ltd
Tecan Way
Weymouth
Dorset
DT4 9TU
UK
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8.2 Preparation of Solutions
8.2.1 Glucose Assay
0.1M Sodium Phosphate buffer
14.2g sodium phosphate in 1L H20
Glucose reagent
Prepared using 100ml of 0.1M sodium phosphate buffer, pH 7.4 and adding 5mg
glucose oxidase, 1mg horseradish peroxidise and 0.1g 2.2’azino-di-3[ethyl-
benzthiazolin-sulphonate] (ABTS).
Glucose Standards
2mg/ml solution of glucose in sodium phosphate buffer.
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8.3 Microarray gene information
Table 8.1 Microarray gene information
Accession
Reference Gene code Gene
NM_017101 Ppia Peptidylprolyl isomerase A
NM_012544 Ace Angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
NM_0010120
06 Ace2
Angiotensin I converting enzyme (peptidyl-
dipeptidase A) 2
NM_020306 Adam17 A disintegrin and metalloproteinase domain 17 (tumor
necrosis factor, alpha, converting enzyme)
XM_344544 Angpt2 Angiopoietin 2
NM_134432 Agt Angiotensinogen (serpin peptidase inhibitor, clade A,
member 8)
NM_031009 Agtr1b Angiotensin receptor 1b
NM_012494 Agtr2 Angiotensin II receptor, type 2
NM_012822 Alox5 Arachidonate 5-lipoxygenase
NM_053546 Angpt1 Angiopoietin 1
NM_013132 Anxa5 Annexin A5
NM_017059 Bax Bcl2-associated X protein
NM_016993 Bcl2 B-cell leukemia/lymphoma 2
NM_133416 Bcl2a1 B-cell leukemia/lymphoma 2 related protein A1
NM_031535 Bcl2l1 Bcl2-like 1
XM_226742 Birc1b Baculoviral IAP repeat-containing 1b
NM_023987 Birc3 Baculoviral IAP repeat-containing 3
NM_022231 Birc4 Baculoviral IAP repeat-containing 4
NM_022274 Birc5 Baculoviral IAP repeat-containing 5
NM_053303 Blr1 Burkitt lymphoma receptor 1
NM_012762 Casp1 Caspase 1
NM_012922 Casp3 Caspase 3, apoptosis related cysteine protease
NM_031775 Casp6 Caspase 6
NM_022277 Casp8 Caspase 8
NM_031530 Ccl2 Chemokine (C-C motif) ligand 2
NM_019233 Ccl20 Chemokine (C-C motif) ligand 20
NM_031116 Ccl5 Chemokine (C-C motif) ligand 5
XM_226213 Cdh5_predicted Cadherin 5 (predicted)
NM_057138 Cflar CASP8 and FADD-like apoptosis regulator
NM_021655 Chga Chromogranin A
XM_241632 Col18a1 Procollagen, type XVIII, alpha 1
NM_053617 Cpb2 Carboxypeptidase B2 (plasma)
XM_235061 Cradd CASP2 and RIPK1 domain containing adaptor withdeath domain (predicted)
XM_340799 Csf2 Colony stimulating factor 2 (granulocyte-macrophage)
NM_017104 Csf3 Colony stimulating factor 3 (granulocyte)
NM_134455 Cx3cl1 Chemokine (C-X3-C motif) ligand 1
NM_030845 Cxcl1 Chemokine (C-X-C motif) ligand 1
NM_182952 Cxcl11 Chemokine (C-X-C motif) ligand 11
NM_053647 Cxcl2 Chemokine (C-X-C motif) ligand 2
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NM_0010121
22 Ecgf1 Endothelial cell growth factor 1 (platelet-derived)
NM_012548 Edn1 Endothelin 1
NM_012549 Edn2 Endothelin 2
XM_345480 Edn3_mapped Endothelin 3 (mapped)
NM_012550 Ednra Endothelin receptor type A
NM_017333 Ednrb Endothelin receptor type B
NM_022251 Enpep Glutamyl aminopeptidase
NM_013057 F3 Coagulation factor III
NM_012846 Fgf1 Fibroblast growth factor 1
NM_019305 Fgf2 Fibroblast growth factor 2
NM_019306 Flt1 FMS-like tyrosine kinase 1
XM_221874 Flt3 FMS-like tyrosine kinase 3
NM_053652 Flt4 Fms-related tyrosine kinase 4
NM_019143 Fn1 Fibronectin 1
NM_138517 Gzmb Granzyme B
NM_012967 Icam1 Intercellular adhesion molecule 1
NM_0010077
25 Icam2 Intercellular adhesion molecule 2
NM_019127 Ifnb1 Interferon beta 1, fibroblast
NM_133519 Il11 Interleukin 11
NM_013129 Il15 Interleukin 15
NM_031512 Il1b Interleukin 1 beta
NM_031513 Il3 Interleukin 3
NM_012589 Il6 Interleukin 6
NM_013110 Il7 Interleukin 7
XM_235707 Itga5 Integrin alpha 5 (mapped)
XM_230950 Itgav_predicted Integrin alpha V (predicted)
NM_017022 Itgb1 Integrin beta 1 (fibronectin receptor beta)
NM_153720 Itgb3 Integrin beta 3
NM_013062 Kdr Kinase insert domain protein receptor
NM_022264 Kit V-kit Hardy-Zuckerman 4 feline sarcoma viral
oncogene homolog
XM_00107338
4 Pla2g4c
Phospholipase A2, group IVC (cytosolic, calcium-
independent)
NM_022214 Cxcl5 Chemokine (C-X-C motif) ligand 5
NM_031056 Mmp14 Matrix metallopeptidase 14 (membrane-inserted)
XM_235794 Mmp1a_predicted Matrix metallopeptidase 1a (interstitial collagenase)(predicted)
NM_031054 Mmp2 Matrix metallopeptidase 2
NM_031055 Mmp9 Matrix metallopeptidase 9
NM_012611 Nos2 Nitric oxide synthase 2, inducible
NM_021838 Nos3 Nitric oxide synthase 3, endothelial cell
NM_031545 Nppb Natriuretic peptide precursor type B
NM_012613 Npr1 Natriuretic peptide receptor 1
NM_031329 Ocln Occludin
XM_214030 Pdgfra Platelet derived growth factor receptor, alphapolypeptide
NM_031525 Pdgfrb Platelet derived growth factor receptor, betapolypeptide
NM_031591 Pecam Platelet/endothelial cell adhesion molecule
NM_0010077
29 Cxcl4 Chemokine (C-X-C motif) ligand 4
NM_053595 Pgf Placental growth factor
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NM_013151 Plat Plasminogen activator, tissue
NM_013085 Plau Plasminogen activator, urokinase
XM_574314 Plg Plasminogen
NM_031557 Ptgis Prostaglandin I2 (prostacyclin) synthase
NM_017232 Ptgs2 Prostaglandin-endoperoxide synthase 2
NM_138879 Sele Selectin, endothelial cell
NM_019177 Sell Selectin, lymphocyte
NM_013114 Selp Selectin, platelet
NM_012620 Serpine1 Serine (or cysteine) peptidase inhibitor, clade E,
member 1
NM_017050 Sod1 Superoxide dismutase 1
XM_342863 Tek Endothelial-specific receptor tyrosine kinase
NM_017200 Tfpi Tissue factor pathway inhibitor
NM_173141 Tfpi2 Tissue factor pathway inhibitor 2
NM_021578 Tgfb1 Transforming growth factor, beta 1
NM_031131 Tgfb2 Transforming growth factor, beta 2
NM_031771 Thbd Thrombomodulin
XM_214778 Thbs2 Thrombospondin 2
NM_053819 Timp1 Tissue inhibitor of metallopeptidase 1
NM_012675 Tnf Tumor necrosis factor (TNF superfamily, member 2)
NM_0010247
71 Tnip2 TNFAIP3 interacting protein 2
XM_344431 Tnfrsf10b_predict
ed
Tumor necrosis factor receptor superfamily, member
10b (predicted)
NM_012870 Tnfrsf11b Tumor necrosis factor receptor superfamily, member11b (osteoprotegerin)
NM_139194 Tnfrsf6 Tumor necrosis factor receptor superfamily, member6
NM_145681 Tnfsf10 Tumor necrosis factor (ligand) superfamily, member10
NM_012908 Faslg Fas ligand (TNF superfamily, member 6)
NM_012889 Vcam1 Vascular cell adhesion molecule 1
NM_031836 Vegfa Vascular endothelial growth factor A
XM_342759 Vwf Von Willebrand factor
NM_017154 Xdh Xanthine dehydrogenase
L08752 PUC18 PUC18 Plasmid DNA
Blank
Blank
SA_00005 AS1R2 Artificial Sequence 1 Related 2 (80% identity)(48/60)
SA_00004 AS1R1 Artificial Sequence 1 Related 1 (90% identity)(54/60)
SA_00003 AS1 Artificial Sequence 1
NM_013226 Rpl32 Ribosomal protein L32
NM_017025 Ldha Lactate dehydrogenase A
NM_012495 Aldoa Aldolase A
NM_012495 Aldoa Aldolase A
NM_017008 Gapdh Glyceraldehyde-3-phosphate dehydrogenase
NM_017008 Gapdh Glyceraldehyde-3-phosphate dehydrogenase
SA_00007 BAS2C Biotinylated Artificial Sequence 2 Complementary
sequence
SA_00007 BAS2C Biotinylated Artificial Sequence 2 Complementary
sequence
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